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We present a novel statistical technique; the sparse reduced rank regression (sRRR) model
which is a strategy for multivariate modelling of high-dimensional imaging responses and
genetic predictors. By adopting penalisation techniques, the model is able to enforce spar-
sity in the regression coefficients, identifying subsets of genetic markers that best explain
the variability observed in subsets of the phenotypes. To properly exploit the rich structure
present in each of the imaging and genetics domains, we additionally propose the use of
several structured penalties within the sRRR model. Using simulation procedures that ac-
curately reflect realistic imaging genetics data, we present detailed evaluations of the sRRR
method in comparison with the more traditional univariate linear modelling approach. In
all settings considered, we show that sRRR possesses better power to detect the deleterious
genetic variants. Moreover, using a simple genetic model, we demonstrate the potential
benefits, in terms of statistical power, of carrying out voxel-wise searches as opposed to
extracting averages over regions of interest in the brain. Since this entails the use of phe-
notypic vectors of enormous dimensionality, we suggest the use of a sparse classification
model as a de-noising step, prior to the imaging genetics study. Finally, we present the
application of a data re-sampling technique within the sRRR model for model selection.
Using this approach we are able to rank the genetic markers in order of importance of as-
sociation to the phenotypes, and similarly rank the phenotypes in order of importance to
the genetic markers. In the very end, we illustrate the application perspective of the pro-
posed statistical models in three real imaging genetics datasets and highlight some potential
associations.
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1.1 Introduction to imaging genetics
Most genetic association studies with neurological disorders to date are based on case-
control designs, and as such they rely on a crude indicator of disease status. However,
over the last few years, interest has shifted towards imaging genetics studies that search
for associations with intermediate phenotypes extracted from magnetic resonance imag-
ing (MRI) scans of the brain. Compared to a dichotomous disease indicator variable, an
imaging-based signature provides a richer quantitative characterisation of the disease at any
given time. The identification of genetic markers that explain the disease-related variabil-
ity observed in brain structure or function, as reflected in structural MRI or functional MRI
(fMRI) scans, can have a great impact in uncovering the underlying disease mechanism
and lead to potential treatments or preventions (Glahn et al., 2007; Thompson et al., 2010).
The field of imaging genetics is currently catching up with the dramatic increase in the
number of genome-wide association (GWA) studies that have been reported across many
different disease areas, and that have been fuelled by recent technological improvements in
genotyping and reductions in cost. The fundamental assumption that underlies the GWA
approach is that extensive common variation in the human genome, as measured for exam-
ple by single nucleotide polymorphisms (SNPs) or copy number variation (CNV) markers,
contributes to the risk of most common disorders. Over the last few years, substantial in-
ternational resources have been directed in an effort to better characterise human genetic
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variation, for instance through the HapMap1 and the Genome 1000 projects2. The latest
genotyping platforms enable the measurement of around 2.5 million SNP and CNV mark-
ers (Lamy et al., 2011).
A number of population-based association studies with neuroimaging phenotypes have
appeared in the literature over the last few years. Based on both the dimensionality of the
phenotype being investigated and the size of the genomic regions being searched for asso-
ciation, we attempt a broad classification of the existing imaging genetic studies into four
main categories. Some studies can be classified as belonging to the candidate-phenotype,
candidate-gene association (CP-CGA) category, meaning that a specific gene or chromo-
somal region is tested for association with a typically low-dimensional phenotype. The as-
sumption is that the particular quantitative phenotypes being measured are able to capture
changes in the brain induced by the disease or other biological conditions being studied.
An example of this approach is described by Joyner et al. (2009), who examine the poten-
tial association between four summary brain structure measures and eleven SNPs, located
in and around the MECP2 gene. They study two populations, one consisting of healthy
controls and patients with psychotic disorders, and one consisting of healthy controls and
patients with mild cognitive impairment and Alzheimer’s disease.
Other studies belong to the candidate-phenotype, genome-wide association (CP-GWA)
category where again, the phenotype has been appropriately identified but the search for
genetic variants has a much wider scope. An example is given by Potkin et al. (2009c),
who use a brain imaging activation signal in the dorsolateral prefrontal cortex as the quan-
titative trait reflecting schizophrenia dysfunction, and present a genome-wide study based
on subjects with chronic schizophrenia and controls matched for age and sex.
The third category includes studies that have taken the opposite approach, and fall into
the brain-wide, candidate-gene association (BW-CGA) class. In this case, the search for
genetic variants is confined to specific chromosomal regions or genes of interest, but is
extended to the entire brain by the means of very high-dimensional phenotypes, typically
based on voxel-based morphometry (VBM) techniques. Filippini et al. (2009) describe one
1http://hapmap.ncbi.nlm.nih.gov
2http://www.1000genomes.org
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such study, in which a whole-brain search for associations between the APOE ε4 allele load
and voxel-wise grey matter volume is carried out by testing for both additive and genotypic
models in a population of patients with Alzheimer’s disease.
Currently, studies in imaging genetics are shifting towards the fourth category, the
brain-wide, genome-wide association (BW-GWA) paradigm, where both the entire genome
and entire brain are searched for non-random associations. A recent example is the study
carried out by Stein et al. (2010). Here, a voxel-wise search for variants that influence
brain structure in Alzheimer’s disease is performed, using approximately 448000 SNPs and
around 31000 voxels across the entire brain. Imaging genetics and especially BW-GWA
studies commonly rely on high-dimensional phenotypes and genotypes. The assumption is
that only a handful of quantitative traits (e.g. voxels or voxel clusters) may be found in a
statistically meaningful association with a handful of genetic markers. The approach thus
requires a statistical framework for the simultaneous identification of genomic regions and
brain regions that are found to be in non-random association.
The most common approach in the literature of imaging genetics has been to fit an enor-
mous number of univariate linear regression models, regressing each phenotype on each
genetic marker one at a time. Hypothesis testing is then carried out by computing a test
statistic for each one of the many possible genotype-phenotype pairs, and an experiment-
wide significance level is attained by correcting for multiple testing. This approach, which
we refer to as the mass-univariate linear modelling (MULM) approach, is appealing be-
cause of its simplicity and because the univariate regression models can be easily fitted
even when only small sample sizes are available. However, it has two major limitations:
(a) each genotype is independently tested for association with one phenotype at a time
(b) each phenotype is independently tested for association with one genotype at a time
Common complex diseases are expected to be caused by multiple genetic markers, each
contributing a small amount to the effect present on the disease phenotypes, rather than by
single mutations with large effects (Stranger et al., 2011; Zondervan and Cardon, 2004).
Because of (a), the MULM approach is unable to capture possible cumulative effects from
multiple markers that jointly contribute to explain the phenotypic variability, and therefore
may not fully exploit the signal that is present in the data. In fact, by using a multi-locus
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penalised regression model, a boost in power compared to the univariate approach has
been recently reported in detecting GWA associations with temporal lobe and hippocampal
volumes (Kohannim et al., 2011).
Moreover, (b) implies that the MULM approach does not fully exploit the additional
power gains that are expected when using multiple quantitative phenotypes. Correlated
phenotypes, and especially voxel-wise phenotypes that have strong structural connections,
are expected to share some common genetic variation; see, for instance, Eyler et al. (2011)
and Chiang et al. (2011) for recent twin studies demonstrating this point. In the latter study,
a two-step strategy was adopted to boost the power to detect GWAs. Firstly, clusters of vox-
els with strong pairwise genetic correlations (thus exhibiting strong genetic homogeneity)
were identified, and subsequently their average values were used as phenotypes for the as-
sociation study. In that sense, a model that fully accounts for the multivariate nature of
the phenotypes can potentially yield higher statistical power due to a stronger association
signal (Breiman, 1996b; Breiman and Friedman, 1997; Ferreira and Purcell, 2009; Lounici
et al., 2010).
Another major challenge in the framework of MULM is related to the need to deter-
mine an experiment-wide significance level that accounts for the multiple testing problem.
The family-wise error rate is routinely controlled by a Bonferroni correction (Hochberg
and Tamhane, 1987) and the false discovery rate can be controlled by procedures proposed
by Benjamini and Hochberg (1995) and Benjamini and Yekutieli (2001). However, in the
context of imaging genetics, the complex dependence structure among both genetic mark-
ers and among phenotypes must be accounted for. For example, Stein et al. (2010) collapse
inferences over the entire set of SNPs at each voxel by taking the minimum p-value. Then,
they correct for the effective dimensionality accounting for the linkage disequilibrium (LD)
among the markers. Other approaches rely on computationally-intensive permutation pro-
cedures, (see for example Potkin et al., 2009b).
1.2 Thesis overview
In this thesis we attempt to address the shortcomings of the current imaging genetics proce-
dures and propose alternative statistical strategies for identifying genetic associations with
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neuroimaging phenotypes. In particular, we propose the use of the sparse reduced-rank
regression (sRRR); a multivariate multiple regression technique that makes explicit use of
the multivariate structure of the response vector by assuming a low rank representation. By
adopting penalisation techniques, the coefficients of the regression model are estimated to
be sparse, effectively performing simultaneous genotype and phenotype variable selection.
We suggest the use of several structural penalties that can take advantage of the specific data
structures in imaging genetics, such as grouping structures of SNPs into genes or pathways
and structural connections of voxels or regions in the brain. By framing the identification
of genetic associations as a variable selection problem rather than one of hypothesis test-
ing, there is no need to rely on multiple testing correction procedures. The fact that the
model includes all available genetic markers and phenotypes also addresses the limitations
due to both (a) and (b) above, and is thus expected to increase the power to detect true
associations.
To compare the power of our method to that of the more conventional MULM ap-
proach, we introduce a detailed simulation framework that associates a small number of
markers with brain-wide phenotypes representing the average grey matter volume of re-
gions of interest (ROIs) in the brain. We use a realistic simulation of both genomic and
phenotypic variation to accurately reflect real imaging genetics datasets. Further realism
is introduced by subsequently removing true causative markers from the study, so that
genotype-phenotype associations can be detected only through markers that are in LD with
these excluded markers. In all settings considered we show that sRRR has better power to
detect the deleterious genetic variants.
In order to quantify the loss of statistical power that may potentially result when extract-
ing ROI averages, we propose a simple mathematical framework comparing the signal-to-
noise ratio (SNR) from the two competing phenotypes: one based on individual voxels and
one based on ROI averages. Through these results we are able to formalise the intuition that
a voxel-wise approach is to be preferred, provided that the majority of voxels considered as
phenotypes are highly representative of the disease. We provide additional simulation ex-
periments to demonstrate the power gains when using voxel-wise phenotypes, compared to
using phenotypes representing ROI averages. Again we simulate realistic voxel-wise phe-
notypes but use toy simulations for the genetic data so that we reduce the complexity in the
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genotypic domain and focus on the comparison of the performance due to the phenotypes
used.
The proposed sRRR model involves regularisation parameters responsible for genotype
and phenotype selection which result in different estimated models. We combine the sRRR
model with a data re-sampling technique, known as stability selection, for the purpose of
model selection. This approach amounts to repeatedly fitting the model to sub-samples
extracted from the data and estimating an importance measure of each variable based on
its frequency of selection across the sub-sampling procedure. This enables us to rank the
genetic markers in order of importance to the phenotypes and similarly rank the phenotypes
in order of importance to the genetic markers. We also discuss some theoretical properties
of this approach and suggest in future work, to look at the joint probabilities (how often
each genotype-phenotype pair is selected) rather than the individual probabilities as an
alternative approach.
Finally, we present three real data applications where we use the sRRRmodel combined
with stability selection to highlight potential genetic associations with imaging measures.
In all studies performed we highlight several possible genetic markers in association with
the imaging phenotypes.
In the first application we perform two CP-CGA studies in a population of patients,
with different disease levels of multiple sclerosis. In both studies we use the same disease-
related phenotypic summary measures. The candidate genes were selected using prior
knowledge; in the first study the genes were selected based on their critical role for epi-
genetic regulation whereas in the second study the genes were selected based on their in-
volvement in glutamate metabolism, both known to be critical for the disease.
Our second application is a CP-CGA study using a sample of healthy individuals, where
we examine their genetic variations in a chromosomal region known to be deleted in pa-
tients with William’s syndrome. Since brain dysfunction, as well as other disease symp-
toms, observed in patients with this syndrome are directly linked to the deleted genetic
material, genetic markers in that region are expected to be associated with similar dys-
functions observed in the general population. For this study we use voxel-wise measures
representing brain activation in three key brain regions, resulting from an fMRI experiment.
Our third application is a voxel-wise BW-GWA study on a sample of Alzheimer’s dis-
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ease patients, patients with progressive and stable mild cognitive impairment, and healthy
subjects. We perform three different experiments, where in each one we use two differ-
ent groups of individuals (grouped according to disease status) to independently assess
variations related to different stages of the disease. In this study brain-wide voxel-wise
measurements, representing longitudinal changes from baseline and 24 month follow up
MRI scans, are used as phenotypes. Based on our SNR results demonstrated earlier, we
first apply a sparse classification approach, in particular a penalised linear discriminant
analysis procedure, to identify a reduced set of voxels that best discriminate the two groups
of individuals. These are then subsequently used for the imaging genetics studies.
1.3 Thesis structure
In Chapter 2 we provide a literature review on penalised regression techniques for vari-
able selection in the context of multiple linear regression. In Chapter 3 we describe the
reduced-rank regression model and discuss its connections with several other multivariate
models. We then propose the sRRR model for performing simultaneous selection in both
the imaging and genetic domains, and suggest a range of possible penalties to be used
within this framework that are suitable for specific data structures characterising imaging
genetics. The simulation experiments comparing the performance of sRRR and MULM
are presented in Chapter 4. In the same chapter we demonstrate the analytical results on
the SNR of ROI averages and voxel-wise phenotypes and provide the additional simula-
tion experiments demonstrating this point. Part of the work from these chapters has been
published in Neuroimage, see [1] in the list of publications.
In Chapter 5 we present the data re-sampling technique for model selection. The mul-
tiple sclerosis study is presented in Chapter 6. This work was a result from a collaboration
with several people, including Dr. Becky Inkster who has been a research associate in Im-
perial College, supervised by Dr. Giovanni Montana during November 2010 - April 2011
and Dr. Eva Strijbis from the Department of Neurology, VU University Medical Center in
Amsterdam. Manuscripts from the two multiple sclerosis studies have been submitted to
Neurobiology of Aging and Neurology, see [4] and [5] in the list of publications.
In the same chapter we also report the William’s syndrome study, which was a col-
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laboration with the group of Prof. Andreas Meyer-Lindenberg from the department of
Psychiatry and Psychotherapy in University of Heidelberg in Germany. The corresponding
work is currently being prepared for publication.
The penalised linear discriminant analysis for voxel filtering and the Alzheimer’s dis-
ease study are presented in Chapter 7. This study was done in collaboration with Eva
Janousova, who was a visiting student in Imperial College supervised by Dr. Giovanni
Montana, during October 2010 - March 2011, Dr. Robin Wolz and Prof. Daniel Rueckert
from the Department of Computing of Imperial College as well as Dr. Jason Stein and
Prof. Paul Thompson from the Laboratory of Neuro Imaging, Department of Neurology,
UCLA School of Medicine in USA. The work from this chapter has been submitted to
Neuroimage, see [3] in the list of publications.
The conclusions and directions for further research are found in Chapter 8.
Parts of the work presented in this thesis have been presented in a number of confer-
ences as poster and oral presentations. In particular, I have presented posters in
• Multi-level and voxel-wide search for genetic associations with imaging phenotypes
using penalized regression. 7th International Imaging Genetics Conference, Irvine,
USA, 17-18 January, 2011
• Genome-wide Association Studies in Imaging Genetics: A Multivariate Approach.
CIC Student Day, GSK Clinical Imaging Centre, 4 November, 2009.
• Genome-wide Association Studies in Imaging Genomics: A Multivariate Approach.
19th annual MASAMB workshop, Imperial College London, 2-3 April, 2009
• Genome-wide Association Studies in Imaging Genomics: A Multivariate Approach.
5th International Imaging Genetics Conference, Irvine, USA, 19-20 January 2009.
(This poster has been awarded one of the two available ‘IIGC 2009 Travel Awards’)
I have also given a talk in
• Penalized Regression Strategies in Imaging Genetics. Creativity Lab, Imperial Col-
lege, 9 February 2011.
Dr. Giovanni Montana has also given several invited talks on our work in the following
conferences:
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• Statistical models for genome-wide studies in neuroimaging genetics and applica-
tions. School of Computing, University of Singapore, 5 September, 2011
• Penalised regression strategies in imaging genetics studies. 7th International Imaging
Genetics Conference, Irvine, USA, 17-18 January, 2011
• Genetic association mapping with imaging phenotypes. International YS Conference
Perspectives for Development of Molecular and Cellular Biology II, 10-12 Novem-
ber, 2010, Yerevan, Armenia (including a conference proceedings publication, see
[2] in the list of publications)
• Genome-wise biomaker discovery in neuroimaging studies. PSI Biomarker (Statisti-
cians in the Pharmaceutical Industry). Roche, Welwyn, UK. 5 November 2010
• Imaging genetics. Multivariate approaches: joint modeling. 16th Human Brain Map-
ping Conference, 6-10 June 2010, Barcelona.
• Sparse multivariate methods to study whole genome genotype-imaging phenotypes
associations. Imaging Genetics Statistical Workshop, Oslo University. 11 June,
2009, Ulleval, Norway.
A contributed talk has also been given by Dr Giovanni Montana in
• Biomarker discovery in imaging genetics. Royal Statistical Society, International
Conference, 7-11 September 2009, Edinburgh, UK
In the remainder of this chapter we introduce some notation and provide a list of the main
abbreviations used in the thesis.
1.4 Notation
We generally denote matrices by capital bold letters and vectors by lower case bold letters.
Individual entries of a matrix or a vector are denoted by the corresponding non-bold letters
with subscripts corresponding to the particular entries. We use the terms phenotype, quan-
titative trait and response interchangeably and similarly for genetic marker, genotype, SNP
and predictor.
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Throughout the thesis, we assume to have observed p genetic markers, x1, . . . , xp and
q quantitative phenotypes y1, . . . , yq on a random sample of n unrelated individuals ex-
tracted from the same polulation. Assuming an additive genetic model, we code each xj
to represent the count of minor alleles recorded at locus j (homozygote of minor allele is
2, heterozygote is 1 and homozygote of major allele is 0). In principle, each phenotype ys
can be any meaningful measure extracted from magnetic resonance (MR) brain images, at
any level of resolution, ranging from a voxel intensity measure to a brain-wide summary
measure. We collect the allele counts observed at the jth genetic marker in the n dimen-
sional column vector xj , for j = 1, . . . , p. The observed value of the sth phenotype is
collected in the n dimensional vector ys, for s = 1, . . . , q. These genotypic and phenotypic
vectors are then arranged in two paired data matrices X = (x1, . . . ,xp) of size n × p, and
Y = (y1, . . . ,yq) of size n × q, respectively. We also denote the ith row vector of X and
Y by xi∙ and yi∙ respectively, where we use the notation {i∙} to distinguish the row vectors
from the column vectors. We also use the notation Ir to denote the r × r identity matrix.






denote the soft thresholding operator, acting on vj , by Sλ(vj) = sign(vj)(|vj|−λ)+, where
λ ≥ 0 is the soft thresholding parameter, and (α)+ = max(α, 0). Similarly, we denote by
Sλ(v) the soft thresholding operator acting in each element of the vector v with a parameter
λ ≥ 0. Some additional notation is also introduced in several sections of the thesis.
1.5 Abbreviations
BOLD blood oxygen level dependence
BW- GWA brain-wide, genome-wide association
BW-CGA brain-wide, candidate-gene association
CCA canonical correlation analysis
CNV copy number variation
CP-CGA candidate-phenotype, candidate-gene association
CP-GWA candidate-phenotype, genome-wide association
CSF cerebrospinal fluid
DTI diffusion tensor imaging
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FDG-PET fluorodeoxyglucose positron emission tomography




Lasso least absolute shrinkage and selection operator
LD linkage disequilibrium
LDA linear discriminant analysis
LVM latent variable model
MAF minor allele frequency
MMLR multivariate multiple linear regression
MNI Montreal Neurological Institute
MR magnetic resonance
MRI magnetic resonance imaging
MULM mass-univariate linear modelling
PLS partial least squares
ROC receiver operating characteristic
ROI region of interest
RRR reduced-rank regression
SNP single nucleotide polymorphism
SNR signal-to-noise ratio
sRRR sparse reduced-rank regression






Penalisation in multiple regression
The multiple linear regression model consists of adding all available predictors (or SNPs)
into a regression model with a univariate response (or quantitative phenotype). Variable
selection is then achieved by searching for a subset of predictors that best predict the re-
sponse. In an imaging genetics setting this would mean that each one of the q imaging
phenotypes ys, for s = 1, . . . , q, is in turn regressed on all p genetic markers. In what
follows, we drop the subscript s, and represent by y a general univariate response or phe-
notype. We also assume that the response vector is mean centered and the predictors are






x2ij = 1 ∀j ∈ {1, . . . , p}. (2.1)
The multiple linear model has the form
y = Xβ + e
where e is the n dimensional, mean centred, residual vector, with variance σ2. Under the
assumption that the design matrix X is full rank, the unbiased estimate of the regression
coefficients, obtained by minimising the residual sum of squares is
βˆOLS = (X′X)−1X′y (2.2)
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with variance
Var(βˆOLS) = (X′X)−1σ2.
In cases where X is rank deficient, i.e. when one or more of the predictors can be writ-
ten as a linear combination of some other predictors, which is the case of perfect multi-
collinearity, then X′X becomes singular and thus not invertible. In that case, βˆOLS is not
uniquely defined. When the predictors are nearly multi-collinear, X′X is nearly singular
and its inverse (X′X)−1 becomes very sensitive to small changes in the data, resulting in re-
gression estimates with inflated variances (Izenman, 2008; Hastie et al., 2001). In fact, the
problem of multi-collinearity is clearly apparent in gene mapping studies involving dense
sets of genetic markers that are commonly characterised by non-random associations due
to LD block patterns in the genome (Daly et al., 2001; Gabriel et al., 2002). An additional
pitfall of the multiple linear regression model has to do with the common scenario in gene
mapping of having much more predictors (SNPs) than observations in the model, i.e. when
p > n. In such cases, X′X is again singular and thus the ordinary least squares (OLS)
solution is not uniquely defined (Izenman, 2008; Hastie et al., 2001).
In the multiple linear regression model, SNP selection is achieved by imposing that
only the causative SNPs have non-zero regression coefficients, which results is a sparse
vector β, i.e. a vector with several zeros. The more traditional variable selection methods
in regression include the forward selection, backward elimination and stepwise selection
methods that add or drop variables from the model sequentially (Miller, 2002; Hastie et al.,
2001). At each step, the variable to be added or dropped is chosen so as to optimise some
criterion. These methods tend to be highly variable due to their discrete nature (Hastie et al.,
2001). They also tend to have high bias since, at each step, the selected variable optimises
the particular step rather than the final model (Hesterberg et al., 2008). All-subsets regres-
sion is another method of selecting the ‘best’ subset of variables. This searches all possible
subsets of variables in order to find the one subset that optimises a criterion. The major dis-
advantage of all-subsets regression lies in its computational complexity, as an exhaustive
search over all possible subsets needs to be performed. Forward stagewise and least an-
gle regression (LARS) are improved algorithms of forward selection that yield more stable
solutions (Efron et al., 2004; Hesterberg et al., 2008).
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Penalisation techniques in regression have been proposed as a way to remedy issues
associated with multi-collinearity and general rank deficiencies of theX′Xmatrix and also
as continuous approaches to variable selection. Penalised regression works by minimising




‖y −Xβ‖22 subject to P (β) ≤ κ
which is equivalent to solving the optimisation problem defined as
βˆP = argmin
β
{‖y −Xβ‖22 + λP (β)} (2.3)
where κ ≥ 0, λ ≥ 0 and P (β) is a penalty function on the regression coefficients. A
one-to-one relationship holds between the constants κ and λ.
The most common form of penalty functions involves the lQ norm of the coefficient
vector




where Q > 0. In particular, this general form of penalised regression was introduced by
Frank and Friedman (1993) as the bridge regression, where the lQ norm of the regression
coefficients is constrained to be less than a pre-specified constant. This model produces
shrunken regression coefficients whose size depends on the choice of the constant κ, or
equivalently λ. Smaller values of κ, or equivalently larger values of λ induce more shrink-
age. Sparse models, having some coefficients exactly equal to zero, can also be produced,
depending on the type of penalty used, i.e choice of the value of Q. As will also be dis-
cussed in more detail in the following sections, for Q ≤ 1 the lQ penalisation can produce
sparse estimates, whereas for Q > 1 the estimated regression coefficients are being shrunk
but never reach zero. Note that for Q = 1 the penalty function is convex and for Q > 1
it is strictly convex. Thus, for Q ≥ 1, the problem defined in equation (2.3) with P (β)
replaced by the lQ norm of the coefficients is a convex optimisation problem. Figure 2.1
represents the lQ penalty function for the special case of two regressors, i.e. |β1|Q + |β2|Q,
for several values of Q. Assuming that the OLS estimate lies outside the constrained lQ
region, the residual sum of squares for (β1, β2) can be considered as elliptical contours
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around the OLS estimate and the lQ constrained solution then corresponds to the first point
were the elliptical contours hit the constrained region. Depending on the shape of the con-
strained region, the contours could hit the constrained region at either of the two axes, thus
setting one of the coefficient estimates equal to zero. It is evident from Figure 2.1 that for
Q ≤ 1 the lQ functions are more diamond-like shapes making it possible for the elliptical
contours to intersect one of the two axes, setting the corresponding coefficient to zero. For
Q > 1 the lQ functions have more circle-like shapes making impossible the intersection
of the contours with the axes, unless the OLS estimates have already assigned a zero co-
efficient to one of the predictors. These results can be generalised to higher dimensions,
with the lQ function for Q ≤ 1 having a rhomboid like shape with multiple corners at the
coefficient axes, allowing for many estimates to be exactly equal to zero. For Q > 1 more
spherical-like shapes again prevent this from happening (Hastie et al., 2001). In the follow-












Figure 2.1: lQ penalty function with two predictors, for Q = 0.5, 1, 2, 5
ing sections we discuss in more detail the special choices of Q = 2 and Q = 1 which are
the most commonly used penalties in multiple regression.
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2.1 Ridge regression
Hoerl and Kennard (1970) introduced ridge regression to deal with rank-deficiency prob-
lems involved in the solution of the unconstrained multiple linear regression model. Ridge
regression works by constraining the l2 norm of the regression coefficients and thus the
corresponding estimates are obtained from
βˆridge = argmin
β
{‖y −Xβ‖22 + μ‖β‖22} .
A unique closed form solution for ridge regression is
βˆridge = (X′X+ μIp)
−1
X′y.
Comparing the ridge estimates with the OLS estimates, defined in equation (2.2), we can
note that ridge regression imposes a penalty on the diagonal of the covariance matrix ofX,
which is replaced by (X′X+μIp). The latter expression is invertible even when the matrix
X′X is not and can thus be applied in situations where X′X is rank deficient, i.e. in the
presence of multi-collinearity and when p > n. An additional attractive property of ridge
regression, resulting from this covariance regularisation, is the so-called grouping effect.
This property ensures that correlated predictors are assigned similar in magnitude regres-
sion coefficients. Unlike ridge regression, the unconstrained multiple regression model, in
the presence of two highly correlated predictors both associated with the response, tends to
give more weight in one of the two variables, or moderate weights to both variables. Such
an approach can result in misleading interpretations of the actual effect of the predictors
on the response. The grouping property of ridge prevents this from happening and instead
assigns approximately equal weights to correlated variables in the model. In fact, Zou and
Hastie (2005), proved that any strictly convex penalty function, such as the ridge penalty,
guarantees that identical variables would get identical coefficients. They also established
that using the l2 penalty, the difference in the magnitude between two estimated coefficients
is proportional to the magnitude of their correlation coefficient.
Since the predictors are standardised, the covariance matrix X′X has the form of a
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correlation matrix. Thus, (X′X+ μIp)−1 has the form:
1 + μ ρ12 . . . ρ1p
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where the ρij are the correlations between variables xi and xj . From this decomposition we
can note that ridge penalty shrinks the correlations by a factor of (1+μ)−1, which suggests
the grouping effect of ridge, and then applies further scaling by a factor of (1 + μ)−1. Note
that as μ→∞ the term (X′X+μIp) becomes more similar to μIp and hence diagonalising
X′X can be considered as an extreme ridge penalisation.
The ridge penalty provides a biased estimator of β since
E(βˆridge) = (X′X+ μIp)−1X′Xβ.
However, the variance of the ridge estimates
Var(βˆridge) = σ2(X′X+ μIp)−1X′X(X′X+ μIp)−1
is reduced compared to the variance of the OLS estimates. In that sense, ridge regres-
sion sacrifices some bias to reduce the variability of the estimates of the coefficients. This
variance reduction is connected with the grouping effect of ridge as it solves possible in-
stabilities of the regression coefficients associated with the presence of multi-collinearity.
However, even though ridge regression results in coefficient estimates that are shrunk to-
wards zero, it does not set any of the coefficients exactly equal to zero and thus does not
achieve variable selection.
2.2 Lasso regression
Tibshirani (1996) suggested constraining the l1 norm of the regression coefficients in the
multiple regression model, proposing the least absolute shrinkage and selection operator
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(Lasso) penalty. By constraining the sum of the absolute values of the coefficients, the
Lasso model is able to perform variable selection as it shrinks the regression coefficients
such that some of them are set exactly equal to zero. The Lasso coefficients are obtained as
βˆlasso = argmin
β
{‖y −Xβ‖22 + λ‖β‖1} (2.4)
where λ ≥ 0 is the regularisation parameter that controls the degree of sparsity, i.e. the
number of non-zero predictors or SNPs in the model. When λ is exactly zero, no penalty
is imposed and all p predictors enter the model. As λ increases away from zero, sparser
solutions are obtained, and less variables are retained. When λ exceeds a maximum value,
denoted by λmax, no variable is selected.
It is easy to show (Tibshirani, 1996) that in the case of an orthogonal design, i.e. when
X′X = Ip the Lasso estimates are given by
βˆlassoj = Sλ/2(x
′
jy) j = 1, . . . , p. (2.5)
From this solution we can note that in the orthogonal case, the Lasso estimates are formed
by applying univariate soft thresholding (UST) to the OLS estimates. That is, the l1 pe-
nalisation shrinks the OLS estimates by subtracting a constant amount, λ
2
, from each of the
OLS coefficients and sets exactly to zero the ones for which |x′jy| < λ2 .
Similar UST relations can be obtained in the more general case, without assuming that
the design matrix is orthogonal, by setting the partial derivative of Equation (2.4) with





− λsj = 0











where we have used the assumption in (2.1) that x′jxj = 1 and we denote by y˜(j) the partial
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For βˆlassoj = 0, we have that
∣∣x′jy˜(j)∣∣ ≤ λ2 . Taking the solutions for βˆlassoj = 0 and







The Lasso estimates cannot be directly obtained from equation (2.7) since the vector y˜(j)
makes a direct use of the actual Lasso estimates. However, in Section 2.6, we discuss
how Equation (2.7) can be used in an iterative algorithm for the computation of the Lasso
estimates.
The Lasso (l1) penalty is not strictly convex and in contrast with ridge, does not assign
identical coefficients to identical variables. In fact, in such cases, Lasso does not have a
unique solution. When a group of highly correlated variables is involved in the analysis,
Lasso tends to randomly select only one from that group to include in the model (Zou and
Hastie, 2005). This might be undesirable in gene mapping since SNPs come in haplotype
blocks, that are in strong LD. Randomly selecting only one SNP from a group of correlated
SNPs to include in the model might lead in reduced power to detect the true causal variant.
Lasso regression has been successfully applied to a number of association studies for
the identification of genetic markers that are highly associated with a disease phenotype of
interest. Hoggart et al. (2008) for example, performed a GWA analysis using a penalised
likelihood approach which is equivalent to Lasso regression. A sparse logistic regression
approach has also been applied by Wu et al. (2009) for the genome-wide analysis of a case
control design, pinpointing the genetic markers that best distinguish cases from controls.
Other recent applications of Lasso regression for genetic association mapping have been
described for example by Shi et al. (2011); Ayers and Cordell (2010); D’Angelo et al.
(2009) and Guo et al. (2009).
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2.3 Elastic Net penalty
Zou and Hastie (2005) suggested the use of a combination of the l1 and l2 norms of the
coefficients as an alternative approach in penalised regression, which they named as elastic
net regression. Accordingly, the elastic net estimates are obtained as
βˆEN = argmin
β
{‖y −Xβκ‖22 + λ ‖βκ‖1 + μ ‖βκ‖22} (2.8)
where λ ≥ 0 and μ ≥ 0 are regularisation parameters introduced for the l1 and l2 penalties,
respectively, and where the scaling factor κ = (1 + μ)−1 has been added to correct for
the double shrinkage caused by applying both the l1 and l2 penalties on the size of the
coefficients (Zou and Hastie, 2005). As discussed earlier, shrinking the coefficients results
in sacrificing some bias to reduce the variance. Double shrinkage would further increase
this bias-variance trade-off and thus result in unnecessary extra bias in the estimates.
As shown by Zou and Hastie (2005), the elastic net estimates enjoy the attractive fea-
tures of both the l1 and l2 penalties. In particular, they maintain the variable selection
properties of Lasso regression as well as the grouping effect on correlated variables of
ridge regression. In that sense, once a variable from a group of highly correlated variables
enters the model then the entire group enters the model as well.
The terms to be minimised in Equation (2.8) can be re-written as
−2y′Xβ + β′κ (X′X+ μIp)β + λ ‖β‖1 .
Minimising this expression with respect to β provides the solution to an equivalent pe-
nalised regression problem having only a constraint on the l1 norm of the coefficients,
whereby the covariance matrix X′X has been replaced by κ (X′X+ μIp). Using this
parametrisation, it can be noted again that the l2 regularisation parameter μ directly in-
fluences the correlations of the predictors and shrinks these by a factor of κ. Moreover, as
discussed earlier, by setting μ to infinity, the expression to be minimised becomes
−2y′Xβ + β′β + λ ‖β‖1
2.4 Laplacian penalty 38
which is equivalent to assuming an orthogonal design, whereby the covariance matrixX′X
has been replaced by the identity matrix, with only an l1 penalty for variable selection. The
optimal β coefficients can then be computed one element at a time by applying UST as in
Equation (2.5) above.
2.4 Laplacian penalty
Information regarding the underlying structured association between the predictors can also
be incorporated in the regression model by the means of a quadratic penalty P (β) = β′Ωβ,
for a p×p positive semi-definite matrixΩ with elements representing the pairwise associa-
tions between the predictors. The positive semi-definiteness ofΩ guarantees the convexity
of the the penalty function P (β). A strictly convex penalty function P (β) can also be
formed by choosing Ω to be a positive definite matrix. Then, regression coefficient esti-
mates of such a penalised regression model are obtained as
βΩ = argmin
β
{‖y −Xβ‖22 + μβ′Ωβ} .
A closed form solution, similar to ridge regression exists such that
βˆΩ = (X′X+ μΩ)−1X′y. (2.9)
Again, the covariance matrixX′X is penalised but this time with a more structured penali-
sation. In fact, ridge regression is a special case of this quadratic penalty with Ω = Ip.
The Laplacian and normalised Laplacian are two possible choices for Ω. These ma-
trices are used to represent a graphical structure of the predictors (Chung, 1997). They are
constructed by assuming that the p predictors are associated according to a graph G, where
each variable is represented by a node on the graph, and a link between a pair of variables
exists if these are connected. The p× p weighted adjacency matrixW of the graph is then
defined to be the matrix with entries wsj representing the weight of association between
variables s and j, if these are connected with a link. When the two variables are not con-
nected wsj = 0. These weights can also be binary, representing only the existence of a link
between two variables. The matrix containing the binary weights is commonly referred
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to as the adjacency matrix. The degree of the jth variable, dj , is defined to illustrate its
strength in the graph G, with dj =
∑p
s=1 |wsj|. This represents the number of variables that
are linked to variable j in the binary case, or the sum of the corresponding absolute weights
in the weighted case. The degrees of the p variables are collected in a p×p diagonal matrix
D, known as the degree matrix. The p× p Laplacian matrix L is then defined as




dj if s = j
−wsj if variables s and j are connected
0 otherwise.

















|wsj| (βs − sign(wsj)βj)2
thus penalising the squared differences of pairs of regression coefficients, based on the
weight connecting the two corresponding variables.
An alternative penalisation strategy involves constraining the function β′Lβ of the re-
gression coefficients, where L is the p× p normalised Laplacian matrix defined as




1 if s = j
− wsj√
dsdj
if the variables s, j are connected
0 otherwise.
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thus penalising the squared difference of pairs of scaled coefficients, scaled according to
their individuals degrees. By construction, the Laplacian or normalised Laplacian matri-
ces are always positive semi-definite. Thus, the corresponding penalty function P (β) is
convex.
The penalised term in the closed form solution in Equation (2.9), with Ω replaced by
the Laplacian matrix, i.e. (X′X+ μL)−1, has the form

1 + μd1 ρ12 − μw12 . . . ρ1p − μw1p




























































It can be observed that the normalised Laplacian (2.11) has a similar effect to the ridge
penalty in the sense that it firstly performs some form of de-correlation. This is achieved by
reducing the size of the pairwise correlation coefficients by subtracting the corresponding
standardised weights connecting the two variables, and further scaling them by a factor of
1+μ. It is notable that to have the desired de-correlation effect, the coefficients wsj’s need
to be of the same sign as the corresponding correlation coefficient ρsj , so that a decrease in
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the magnitude is achieved. This is encouraging a grouping effect on connected variables.
All the entries of the inverted matrix are then subsequently shrunk by a common factor
of 1 + μ, irrespective to their individual ds coefficient. Similarly, the (non-normalised)
Laplacian (2.10) performs a de-correlation step by subtracting the weights connecting the
pairs of variables from their pairwise correlation coefficients. However, it increases the
individual variances from 1 to 1 + μds for each variable xs, which clearly illustrates that
each variable is penalised differently depending on its degree.
More insight into the differences between the Laplacian and the normalised Lapla-
cian penalties in regression can be obtained by considering coordinate-wise updates of the



























where we recall the use of y˜(s) to denote the partial residual, as in Equation (2.6). These
updates are composed of an individual term depending on the variable xs and the partial
residual y˜(s), and a smoothing term that depends on the coefficient estimates of the remain-
ing variables and the corresponding weights connecting these to xs. The smoothing term
for the normalised Laplacian estimate (2.13) depends on the standardised weights, whereas
the corresponding term for the (non-normalised) Laplacian estimate (2.12) depends on the
actual weights. In that sense, using the Laplacian penalty, variables with higher degrees
are further enlarged, encountering a greater smoothing effect. These are then scaled by a
constant depending on the degree of the variable, with variables with higher degrees being
exposed to a greater shrinkage. On the contrary, the coefficient estimates of the normalised
Laplacian are all scaled equally. This observation further supports the earlier statement that
the normalised Laplacian treats the individual variables regardless of their degree, whereas
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the Laplacian penalises differently variables with varying degrees.
Several applications of structured penalisation, using the idea of a quadratic penalty of
the form β′Ωβ, have been presented in the literature. For example, Fei and Huan (2009)
have defined a Laplacian matrix, constructed using a marginalised kernel matrix as the ad-
jacency matrix. They also added an identity matrix to this marginalised kernel to ensure
that the matrix is positive definite. Quanz and Huan (2009) applied the normalised (binary)
Laplacian penalty in logistic regression, and presented applications for disease classifica-
tion using gene expression data and incorporating information from biological pathways.
Similarly with the ridge penalty, the Laplacian or normalised Laplacian penalties do
not impose sparsity, but rather just a smoothing effect on the coefficients that are assigned
to variables, linked according to the graph structure G. Sparse estimates that maintain this
smoothing effect can be obtained by adopting a combination of the Lasso penalty and the
quadratic penalty, as done with the elastic net. In particular, Li and Li (2008) have proposed
the combination of the normalised Laplacian and the Lasso, and presented an application to
genetic pathway data. In follow up work, Li and Li (2010) have also presented an adaptive
version of this penalty, to account for the sign differences between the coefficients being












where β˜ is the OLS estimate, or the estimate from any other penalised regression procedure.
Another application was presented by Daye and Jeng (2009) who suggested the use of
the Lasso penalty together with a Laplacian penalty, with weights based on the pairwise
correlations of the coefficients. This was done in order to impose fusing in the coefficients




where the tuning parameter γ > 0 and ρsj the correlation between xj and xs. A similar
quadratic penalty that encourages a grouping effect on correlated variables was defined by
Tutz and Ulbricht (2009) who combined this with a boosting procedure to achieve variable
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selection. Huang et al. (2011) have also proposed a related model, where they combined
the Laplacian penalty with another (non-convex) penalty for variable selection known as
the minimax concave penalty. They applied this procedure to gene expression data.
2.5 Group Lasso penalty
The penalty considered in this section is another structural penalty that takes into account
naturally grouped structures of the predictors, in the sense that a pre-defined group of vari-
ables is selected to be in or out of the model as a group. The idea of this group selection in
a regression model was first proposed by Bakin (1999) as an extension of Lasso regression
and was then formally defined and named as the group Lasso by Yuan and Lin (2006). The
main motivating example that led to the development of group Lasso is the multi-factor
model since the levels of each factor can be considered to form a group of variables. The
selection of a factor then corresponds to the selection of a group of variables. In addition
to factor selection, predictor variables can also form groups that jointly taken pose some
meaningful structure. In such cases, it might be desirable to select the group as a whole
rather than individual variables. In gene mapping studies such groups can be formed as the
set of SNPs within a gene, or the set of SNPs/genes contributing to certain pathways.
Assume that the p predictor variables are classified into J distinct groups hj , j =
1, . . . , J and each of these groups consists of pj predictors. We denote byXhj the (n× pj)
matrix corresponding to group j and by βhj the (pj × 1) vector of regression coefficients















where ν ≥ 0 is the penalisation parameter that determines the number of non-zero groups
in the model. The group l2,1 penalty is constructed as the l1 norm of the l2 norms of groups
of coefficients. Note that a scaling term √pj is added in the group Lasso penalty. This is
required in order to avoid the inclusion of large groups of variables in the model purely due
to their size.
Friedman et al. (2010) proposed obtaining sparse solutions in both the group and in-
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dividual level, i.e. select sparse groups to be in or out of the model. This is achieved by
adding an extra l1 penalty on the regression vector in the optimisation problem. That is, the











The group l2,1 penalty, with parameter ν ≥ 0, controls the selection of groups while the l1
penalty, with parameter λ ≥ 0, controls the individual variable selection.
2.6 Computational Algorithms
The original algorithm that was proposed to solve the optimisation problem involving an
l1 penalisation, i.e. to obtain the Lasso regression estimates, was based on the observation
that the penalty
∑
j |βj| ≤ κ is equivalent to combining 2p linear constraints of the form∑
j δjβj ≤ κ where the δj’s take the values ±1 and correspond to the 2p possible signs for
the β vector (Tibshirani, 1996). However, when the number of variables p is very large this
approach can be very inefficient. Efron et al. (2004) also proposed a simple modification to
the LARS algorithm for variable selection, under which LARS provides a computational
efficient algorithm to produce the full Lasso solution.
Another efficient algorithm for solving the Lasso problem is the ‘shooting’ procedure,
proposed by Fu (1998). This algorithm is a coordinate descent algorithm that updates each
parameter independently, keeping all the other parameters fixed. This is equivalent to solv-
ing a one-parameter optimisation problem and in cases where such one variable problems
have a simple analytical solution, coordinate descent algorithms can be attractively fast and
simple to use. Friedman et al. (2007), have considered the use of coordinate descent algo-
rithms for solving a class of convex optimisation problems with inequality constraints. For





The coordinate descent algorithm to obtain the Lasso regression estimates that solve the
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optimisation problem defined in equation (2.4), iteratively updates βj , according to equa-
tion (2.14), for all j = 1, . . . , p, while keeping the remaining coefficients βs, s 6= j fixed at
β˜s. Note that (2.14) is equivalent to





y −∑ps=1 xsβ˜s) is the full set of residuals. The coordinate descent algorithm
to solve Lasso is provided below.






4. for j ← 1 to p
5. β˜j ←Sλ/2(β˜j + x′j r˜)
6. until β˜ converge
The initial values for the vector β˜ in the algorithm can be arbitrary. A possible choice could
be the univariate OLS. Friedman et al. (2007) have illustrated through simulations that this
algorithm is very competitive with LARS, in terms of computational efficiency.
Coordinate descent algorithms can be applied to many other penalties. In particular,
Tseng (1988) established that any optimisation problem of the form




where g(.) is differentiable and convex and the functions hj(.), j = 1 . . . , p are convex, can
be solved using a coordinate descent algorithm. Note that the penalty function should be in
a separable form, i.e. can be written as a sum of functions for each parameter independently.
Several penalisation problems, including the elastic net, the sparse Laplacian and group
Lasso, pose the form (2.15), and can thus be solved efficiently using a coordinate descent
algorithm (Friedman et al., 2007).
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Chapter 3
The sparse reduced-rank regression
model
As mentioned earlier, in this thesis we are concerned with the problem of detecting asso-
ciations between high-dimensional genetic and imaging variables, as portrayed in imaging
genetics studies. Such sets of data present a number of computational and statistical chal-
lenges mainly due to their high-dimensionality and the strong correlation patterns present
in each of the imaging and genetics domains. Sample sizes are commonly limited to a few
hundreds of individuals whereas millions of voxels and SNPs can be considered for asso-
ciation. For this reason, as discussed in the introduction, the field of imaging genetics has
been mainly governed by univariate tests assessing the significance of each SNP-phenotype
pair.
In this chapter, we attempt to approach the problem from a different angle, by cast-
ing it as a multivariate reduced-rank regression (RRR) model that accommodates both
high-dimensional predictors and responses. By extending the ideas of penalised regres-
sion into this multivariate model we propose the sparse reduced-rank regression model
(sRRR) which performs simultaneous genotype and phenotype selection, as required in
imaging genetics studies. We also propose the use of alternative structural penalties within
this framework that account for the special structures presented in each of the imaging and
genetics domains. In what follows, we start by giving a brief description of the RRR model
and a review of its connections to other multivariate models, all belonging to the general
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class of latent variable models (LVMs). We then demonstrate the sRRR model using three
different penalties for phenotype and genotype selection.
3.1 The reduced-rank regression model
We recall the notation Y = (y1, . . . ,yq) to represent the q observed phenotypes. We also
recall the assumption that the predictors are mean centered and scaled to have unit length






y2ij = 1 ∀j ∈ {1, . . . , q}.
The standard multivariate multiple linear regression (MMLR) model, which examines
the relationship between a multivariate set of responses and multiple predictors, has the
form
Y = XC+ E (3.1)
where C is the p × q matrix of regression coefficients, and E is the n × q matrix of errors
consisting of zero mean, possibly correlated columns. If n is greater than p and X is full
rank, C could be estimated by minimising the least squares as
Cˆ(R) = (X
′X)−1X′Y (3.2)
where Cˆ(R) is of full rank, R = min (p, q).
Even under such an unrealistic assumption concerning the sample size, there are still a
number of limitations associated with the MMLR model. First, it is well known that little
is gained by formulating the multi-response regression in these terms, in the sense that the
same solution can be obtained by performing q independent regressions, one for each uni-
variate response (Izenman, 2008; Hastie et al., 2001). Thus, the unconstrained regression
model (3.1) essentially makes no use of any structure that may exist in the multivariate
phenotype. Second, in the presence of high-dimensional genetic variables which are com-
monly characterised by patterns of non-random associations, the model would also suffer
from multi-collinearity. As discussed in Chapter 2, this can result in inflated variances of
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the regression coefficients. Moreover, in realistic settings, when n never exceeds p, an-
other major complication is created by the fact thatX′X is singular and thus not invertible.
Lastly, the least squares solution (3.2) involves all predictors and responses, whereas for
imaging genetics studies our interest lies in identifying the most important predictors and
responses that drive the association.
A solution to the first issue above consists of imposing a rank condition on the regres-
sion coefficient matrix, namely that rank(C) is R∗ ≤ min(p, q), as in the RRR model
(Izenman, 1975; Reinsel and Velu, 1998). Reducing the rank leads to an effective decrease
in the number of parameters that need to be estimated and enables the exploitation of the
multivariate nature of the response by assuming that the true association lies in a lower di-
mensional space. Our aim is then to derive an estimation procedure such that the resulting
coefficient matrix C has two important properties: (a) it is of reduced rank R∗, (b) it has
zero-entries in the rows and columns corresponding to all genotypes and phenotypes that
should be excluded from the model.
If C has rank r, with r ∈ {1, . . . , R}, it can be written as a product of a p × r matrix
B and an r × q matrixA, both of full rank, i.e. rank(A)=rank(B)=r. The RRR model thus
has the form
Y = XBA+ E. (3.3)
Note that the decomposition of C into the product of B and A is not unique as BA =
(BQ−1)(QA) for any r × r invertible matrixQ. This latter formulation illustrates a latent
model interpretation of the RRR model. A LVM assumes that the statistical association
between two sets of data is driven through some unobserved variables, latent variables, that
can be estimated from the observed variables. Usually just a few latent variables are enough
to capture this association and thus LVMs commonly benefit from a significant reduction
in the dimensionality. Here, a set of latent variables of the predictor variables is formed as
XB by estimating r linear combinations of the variables inX, reducing the dimensionality
of the predictor variables to a set of r, r ≤ p latent variables. Then, the multiplication by
the r × q matrix A serves as a transformation to the dimension of Y to form a prediction
model for the responses. In fact, there is a close connection between RRR and other LVMs.
More details about the connection of the RRR model and other LVMs are given in Section
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3.1.2.




(Y −XBA)Γ (Y −XBA)′} (3.4)
for a given q×q positive definite matrix Γ. Most commonly, the weight matrix Γ is set to be
either the inverse of the estimated covariance matrix of the responses or the identity matrix.
As detailed in Section 3.1.2, these choices of Γ reveal connections to other multivariate








where H(r) is the q × r matrix whose columns are the first r normalised eigenvectors










whereΘ2(r) is the r×r diagonal matrix with diagonal entries the eigenvalues corresponding
to the r eigenvectors inH(r).




Thus, the rank r estimate of the RRR coefficient matrix C is
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If C is of full rank, i.e. r = min(p, q), then H(r)H′(r) = Ir and the estimate Cˆ(r) reduces
to the unconstrained MMLR coefficient estimate, Cˆ(R). This relation illustrates the fact
that the multivariate nature of the RRR model results by the rank constraint imposed on the
regression coefficient matrix. Moreover, it can be noted that the estimated values of the re-
sponse variables are formed as linear combinations of the unconstrained MMLR estimated
responses.
Yˆ(r) = XCˆ(r) = Yˆ(R)G (3.8)
whereG = Γ 12H(r)H′(r)Γ−
1
2 .
3.1.1 Choosing the rank - The rank trace plot
The search for an ‘optimal’ reduced-rank R∗ can be aided by the rank trace plot (Izenman,
2008). The principle behind this graphical procedure is that when an adequate rank r has
been selected, the estimated RRR coefficient matrix, Cˆ(r), should be close to the full rank
coefficient matrix Cˆ(R), and the estimated residual covariance matrix of the sRRR model
Sˆ(r) = (Y −XCˆ(r))′(Y −XCˆ(r))
should be close to the corresponding full rank residual covariance Sˆ(R) . The rank trace is








where r = 0 denotes the random model with Cˆ(0) = 0 and Sˆ(0) = Sˆyy and ‖ ∙ ‖F denotes
the Frobenius norm. The coefficient ΔCˆ(r) quantifies the relative change in the size of the
regression coefficients between a rank r and the random model (r = 0), holding the full
rank model (r = R) as reference. Similarly, the coefficient ΔSˆ(r) represents the propor-
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tional difference in the corresponding residual covariance matrices. As r varies from 0 to
R in both the x and y axes, both coefficients take values in [0, 1]. The two opposite points
in the plot – those having coordinates (0, 0) and (1, 1) – indicate the two extreme models:
a full rank model (r = R) and a random model (r = 0), respectively. As more ranks are
added, starting at the top-right corner with r = 0, the curve moves towards the origin of the
plot. When a further rank addition does not produce a significant reduction in ΔCˆ(r) and
ΔSˆ(r) , the plot indicates that an ‘optimal’ rank R∗ has been found. In our experience, the
rank corresponding to the point which maximises the curvature yields satisfactory results
– this can be found by fitting a polynomial smoothing spline to the (ΔCˆ(r),ΔSˆ(r)) points
for which second derivatives can be easily evaluated. An illustration of this procedure is
shown in Figure 4.5.
3.1.2 Connection to latent variable models
The RRR model is closely related to two well known multivariate dimensionality reduction
methods: canonical correlation analysis (CCA) and partial least squares (PLS). These
belong to a larger class of LVMs that perform dimensionality reduction in meaningful al-
beit different ways. Both models can be shown to be special cases of RRR for different
choices of the matrix Γ. In this Section we briefly describe these models and clarify their
connection with RRR.
CCA is a well known multivariate technique that reduces the dimensionality of the
original sets of variables by extracting r ≤ min(p, q), mutually orthogonal pairs of latent
variables. These are formed as T = XU and S = YV where U and V are the (p × r)
and (q × r) matrices of weights. Each pair of weight vectors (u,v), forming the columns
of U and V, is obtained so as to produce pairs of maximally correlated latent variables
t = Xu and s = Yv that are orthogonal to the previously extracted latent variable pairs.
The solutions u and v are extracted by maximising the correlation between t and s, the
so-called canonical correlation, given by
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Unique solutions are thus found by solving
max
u,v
u′X′Yv such that u′X′Xu = v′Y′Yv = 1
















and Ξ(r) is a diagonal matrix composed of the square roots of the corresponding r eigen-
values; these coefficients are also equal to the canonical correlations of the r latent variable
pairs. There is a close connection between the solutions of RRR and CCA. When Γ is set
to be proportional to the inverse of the covariance of the responses, estimated as (Y′Y)−1,
the (q × q) matrix R in Equation (3.6) becomes identical to R∗ in Equation (3.9). Conse-
quently, the matrix of weights Uˆ forms a scaled version of Bˆ, defined for RRR in Equation
(3.5). The scaling on each column of Bˆ is a result of the different normalisation constraints
imposed on each optimisation problem. Moreover, the matrix of weights Vˆ can be seen as
a generalised inverse of Aˆ defined for RRR in equation (3.5).
PLS is another widely used multivariate dimensionality reduction technique that finds
pairs of latent variables (t, s) having maximum covariance. In particular, u and v are
extracted by maximising
Cov(t, s) = u′X′Yv such that u′u = v′v = 1.
It can be noted that due to the following covariance decomposition
Cov(Xu,Yv)2 = Corr(Xu,Yv)2Var(Xu)Var(Yv)
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the maximisation of sample covariance explained by the latent factors implies maximising
the sample correlation between factors while also maximising the variance explained by





where H+(r) is the (q × r) matrix whose columns are the first r normalised eigenvectors of
R+, with
R+ = Y′XX′Y.
The diagonal matrixM(r) has entries given by the square roots of the r largest eigenvalues
of R+ which are also equal to the covariances of the r latent variable pairs. Notably,
CCA solutions also solve the PLS problem when the estimated covariance matrices of X
and Y are diagonal matrices. The same connection holds between RRR and PLS when
the covariance of X and the matrix Γ are set to be the identity matrices Ip and Iq. In
fact, the choice of Γ = Iq, recovers another LVM, known as redundancy analysis (RA).
In RA reduced sets of latent variables in the predictor space are extracted such that they
maximise a redundancy index, defined as the variance explained in the response space (Van
Den Wollenberg, 1977).
Another closely related multivariate regression model was developed by Breiman and
Friedman (1997). The authors proposed combining multiple univariate-response regres-
sion estimates to improve prediction accuracy in a multivariate response setting. They sug-
gested estimating a matrix to combine the univariate response estimates such that the mean
squared error of each response estimator was minimised individually. They consequently
showed that the optimal solution is a smoothed version of RRR with Γ = (Y′Y)−1 and
the matrix G (defined in Equation (3.8)) replaced by Γ 12H(R)DH′(R)Γ−
1
2 . Here, H(R) is
composed of the full set of the normalised eigenvectors ofR, defined in Equation (3.6). D
is a diagonal matrix that performs shrinkage on the eigenvector directions, where a greater
shrinkage is applied to those eigenvectors corresponding to smaller eigenvalues. The au-
thors have illustrated, through simulations, that this approach is significantly improving the
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estimation of the individual univariate-response regressions.




uncovers the maximum likeli-
hood estimates (MLE) of the RRR model, under the assumption that the error terms in
Equation (3.3) are identically independently distributed with each i∙ ∼ MVN(0,Σ),
where i∙ is the ith row of the error matrix E and Σ is the error covariance matrix. More-
over, it can be shown that the MLEs of RRR are scaled versions of the corresponding esti-
mates Aˆ and Bˆ resulting by setting Γ = (Y′Y)−1 and the product Cˆ = BˆAˆ is equivalent
for both choices of Γ (Reinsel and Velu, 1998).
3.2 The sparse reduced-rank regression model
In this section we apply the penalisation techniques, in particular Lasso penalties, to the
RRR model to induce the required sparsity in the model, allowing for the identification
of the important variables driving the association. The factorisation of the regression co-
efficient C = BA, as illustrated in Equation (3.3), enables us to apply separate sparsity
constraints on each of A and B related to phenotype and genotype variable selection, re-
spectively. For instance, in CP-GWA studies only sparsity inBmight be required, whereas
in BW-GWA studies bothA and B are required to be sparse.
In high dimensional problems, when the number of variables in both domains greatly
exceeds the number of observations, it is common to assume that the covariance matrices
of X and Y are diagonal. As discussed in Chapter 2, diagonalising the covariances can
also be considered as extreme penalisation (see Section 2.1). In fact, this has been success-
fully done in studies involving genomic and gene expression data that also pose complex
correlational structures (Witten et al., 2009; Parkhomenko et al., 2009; Waaijenborg et al.,
2008). Taking this strategy, i.e. approximating X′X by Ip and also setting Γ equal to Iq,
Equation (3.4) can be rewritten as
M = Tr{YY′} − 2Tr{AY′XB}+ Tr{AA′B′B}.
Noting that the the first term does not depend on A or B and, a sparse rank-one model is
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obtained by solving the corresponding penalised least squares problem,
argmin
a,b
{−2aY′Xb+ aa′b′b+ 2λa‖a‖1 + 2λb‖b‖1}
where an l1 penalty has been added to penalise both coefficients a and b. As with Lasso
regression, constraining the l1 norms of the coefficients results in estimates that are shrunk
towards zero. The penalisation parameters λb and λa control the sparsity, and hence the
number of predictors and responses that are included in the model, respectively. When
λa is zero, no phenotype selection is performed whereas when λb is zero, no genotype
selection is performed.
As mentioned earlier, the estimated coefficients should also satisfy some normalisation
constraints as defined in Equation (3.7). Incorporating these constraints in the optimisation
problem then amounts to optimising the Lagrangian,
argmin
a,b
{−2aY′Xb+ aa′b′b+ 2λa‖a‖1 + 2λb‖b‖1 + δaaa′ + δbb′b}
where δa and δb are Lagrangian multipliers. Our problem is biconvex in a and b and
can be solved iteratively as convex optimisation problems. For fixed a that is satisfying
the normalisation conditions (3.7) (i.e. aa′ = 1) and fixed penalisation parameter λb, the
optimal bˆ should minimise
h(b) = −2aY′Xb+ b′b+ 2λb‖b‖1 + δbb′b.
Differentiating with respect to bs and setting to zero
−2x′sYa+ 2bˆs + 2λbms + 2δbbˆs = 0








3.2 The sparse reduced-rank regression model 56
and for bˆs = 0
|x′sYa| ≤ λb. (3.11)







where the Lagrangian multiplier δb should be chosen such that the b satisfies the nor-
malisation constraints b′b = θ2, where θ2 is the largest eigenvalue of Θ2(r), defined in






For fixed b, satisfying the normalisation constraints (i.e. b′b = θ2) and fixed parameter
λa, the optimal aˆ should minimise
h(a) = −2aY′Xb+ θ2aa′ + 2λa‖a‖1 + δaaa′.






where the Lagrangian multiplier δa should be chosen to satisfy the normalisation conditions






Starting with initial arbitrary coefficient vectors aˆ and bˆ, the solutions are found by using
the updates (3.12) and (3.13) iteratively until convergence. The corresponding rank-one
sRRR Algorithm is detailed below.
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Algorithm sRRR
Input: Data: X,Y; Parameters: λa, λb
Output: Vectors: bˆ, aˆ
1. Find starting vector a0 such that a0a0′ = 1










8. until bˆ and aˆ converge.
After the rank-one sparse solution has been found, further ranks can be obtained from
the residuals of the data matrices, X and Y. In particular, the rth pair of regression coeffi-
cients, denoted as bˆ(r) and aˆ(r), are obtained using the data matrices X(r) and Y(r) and the
residual matrices are formed as
X(r+1) = X(r) − γˆX(r)bˆ(r)
Y(r+1) = Y(r) − δˆY(r)aˆ′(r)
(3.14)
where γˆ and δˆ are obtained from regressing X(r) on X(r)bˆ(r) and Y(r) on Y(r)aˆ′(r), re-
spectively. These are subsequently used to obtain the (r + 1)th regression coefficients. A
schematic illustration of both MMLR and sRRR models is given in Figure 3.1.
Similar algorithms to the sRRR Algorithm presented here have been developed for ob-
taining sparse CCA estimates under the assumption of covariance diagonalisation (Witten
et al., 2009; Parkhomenko et al., 2009; Waaijenborg et al., 2008). Related algorithms ob-
taining sparse PLS estimates have also been developed by Le Cao et al. (2008) and Chun
and Keles¸ (2010). The similarity of these algorithms with sRRR comes from the the as-
sumption that the predictor covariance matrix is diagonal, and also from setting the weight
matrix Γ = Iq since, as discussed in Section 3.1.2, both CCA and PLS are special cases of
the RRR model. Deriving algorithms that solve the problem without these assumptions is
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of interest as this can then serve as a general framework to obtain sparse estimates from the
various associated LVMs. However, this might require alternative optimisation techniques.
As a remedy for the diagonalisation, we suggest, in the following section, the use of alter-
native penalties that take into account the special structure presented by imaging genetics
and can incorporate prior information to improve the detection of true associations.
Figure 3.1: Illustration of the MMLR and sRRR models.
3.3 Structured selection with the sRRR model
Since the introduction of the l1 penalty for variable selection, much focus has been placed
on developing alternative penalties which possess better properties or that account for spe-
cific data structures. For example, penalties like group or sparse group Lasso, assume that a
meaningful grouping pattern exists, and enforce the model to jointly select variables within
a group. Graph structured penalties, like the sparse Laplacian, enables us to consider more
general associations, represented by the means of a graph, by encouraging the joint selec-
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tion of connected variables. Taking advantage of such prior information can be beneficial
in identifying true signals.
The formulation of the sRRR model, which can be solved iteratively for a and b, while
holding the other one fixed, gives us the flexibility to adopt different convex penalties for
phenotype and genotype selection. The final algorithm only changes in the corresponding
step where the relevant vector is updated, i.e. Step 4 for a and Step 5 for b in the sRRR
Algorithm. In the following two sections, we derive the corresponding updates for each
vector using (1) the sparse group Lasso penalty and (2) the sparse Laplacian penalty. Before
doing this, we first discuss how each penalty could be used to account for the special
structure of each of the imaging and genetics domains.
3.3.1 Grouped structures
Voxel-wise imaging phenotypes pose a special 3D structure with strong structural con-
nections. This structure is divided into several meaningful anatomical regions, each with
known functions. A graphical illustration of brain ROIs based on an anatomical atlas is
shown in Figure 4.1 in Chapter 4. For most diseases, it is sensible to expect a homoge-
neous pattern of genetic association, either within the entire region, or localised in smaller
parts of the region. Adopting the sparse group Lasso penalty in such cases enforces the se-
lection of ROIs as groups of voxels, and also enables the identification of smaller localised
effects by further selecting subsets of voxels within the ROIs. Such an approach is also
expected to eliminate falsely selected voxels that are randomly scattered in the brain.
In the genetic domain, SNPs can also be grouped into meaningful structures. First of
all, SNPs are naturally grouped into genes. Using group Lasso, one might perform variable
selection at the gene level rather than the SNP level. Moreover, with the additional applica-
tion of the l1 penalty, selection at the SNP level can be performed while still accounting for
the grouped gene structures in the genome. For example, Zhou et al. (2010) have presented
a candidate gene application, where they grouped SNPs into genes and adopted the sparse
group Lasso penalty within the logistic regression model to identify genetic markers asso-
ciated with breast cancer status. Based on simulation results, the authors have illustrated
a potential benefit of this approach to identify relatively rare variants that could be missed
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from the single-SNP Lasso analysis. Gene based results are also easier to interpret, since
biological function is known at the gene level. However, the association might be driven
by only one (or a few) SNPs within the gene, in which case grouping might be undesirable.
SNPs can also be grouped according to their LD structure by defining groups of neigh-
bouring markers with strong LD. This approach is similar to tagging SNPs, where a reduced
set of landmark markers that maintains most of the genetic variability is extracted by se-
lecting one representative marker among such groups. Another interesting application of
grouped structures in the genome lies in using prior information on gene function to group
genes and associated SNPs into gene sets or pathways. By jointly considering the effects
of multiple SNPs or genes within a biological pathway, significant associations might be
identified that would otherwise be missed when considering markers individually. For ex-
ample, in the context of GWAs, Silver and Montana (2011) proposed the use of a variant
of group Lasso, which allows for groups to overlap, and demonstrated through simulations
that such an approach compares favourably to other standard pathway selection approaches
which are commonly based on combining univariate results.
In what follows, we show how the sparse group Lasso penalty can be adopted in the
sRRR model, by deriving the equivalent update for the regression coefficients a and b
for phenotype and genotype selection, respectively. To do so, we first introduce some
additional notation to represent the grouping structure in the phenotypes. We assume that
the matrix of responses Y can be sorted in K groups gk, k = 1, . . . , K , each of length qk,
and we denote byYgk and agk the n× qk matrix and 1× qk vector corresponding to group
k, and by ygkt and agkt the t
th variable and coefficient in group k.
By adopting the sparse group Lasso penalty for phenotype selection, the sparse coeffi-
cient vector aˆ is obtained by minimising




where the l2,1 penalty accounts for group selection, while the l1 penalty accounts for in-
dividual variable selection. Following the procedure of Friedman et al. (2010), we solve
this by first noticing that the first part (first two terms) of the function h(a) is differentiable
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and convex and that the second part (last two terms) forms a separable convex penalty for
each group in Y. This suggests that the function h(a) can be optimised by a group-wise
coordinate descent algorithm. Differentiating with respect to group gk and setting to zero




if aˆgk 6= 0 and ‖sgk‖2 ≤ 1 otherwise, and mgkt = sign(aˆgkt ) if
aˆgkt 6= 0 and |mgkt | ≤ 1 otherwise for t ∈ {1, . . . , qk}. The entire group is then set to zero






‖b′X′Ygk − λamgk‖22 (3.15)
is less than or equal to 1, for anymgk such that |mgkt | ≤ 1, for all t = 1, . . . , qk. To check












∣∣b′X′ygkt ∣∣ > λa.






































Hence, we set the group of coefficients aˆgk = 0, if
‖Sλa(b′X′Ygk)‖2 ≤ νak (3.16)
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otherwise we need to solve a one-parameter problem for the kth group by minimising
h(agk) = −2agkY′gkXb+ (θ2 + δa)agka′gk + 2νak‖agk‖2 + 2λa‖agk‖1.
The first part of the algorithm (first 3 terms) is convex and differentiable and the last term
is a sum of convex penalty functions that is separable for each coordinate of agk . Thus,
for each non-zero group we can optimise the above function in a coordinate-wise manner.
Taking the first derivative with respect to the tth coordinate of agk and setting to zero
b′X′ygkt + (θ
2 + δa)aˆgkt + νak
aˆgkt
‖aˆgk‖2
+ λargkt = 0
where rgkt = sign(aˆgkt ) if aˆgkt 6= 0 and |rgkt | ≤ 1 otherwise. Therefore
aˆgkt =
(










(‖Sλa(b′X′Ygk)‖2 − νak) .








∀t ∈ [1, qk].









Again, δa should be chosen such that aa′ = 1. Thus, using sparse group Lasso for pheno-
type selection within the sRRR model amounts to replacing Step 4 in the sRRR Algorithm
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by
Algorithm
1. for k←1 to K





Note that the grouping penalty is highly dependent on the actual size of the group, in the
sense that larger groups are more likely to enter the model than smaller groups. In fact, the
decision whether the group k coefficients are going to be set to zero or not is based on the













which is obviously larger for larger groups (that is groups with large qk’s). In that sense,
the parameter νak should be chosen accordingly to account for the different group sizes. A
common approach to this problem is to use νak = νa
√
qk, for each group k ∈ {1, . . . , K}













(|b′X′ygkt | − λa)2+
) 1
2
which is not favouring larger groups. Note that the sum in (3.17) is over the non-zero ele-
ments of the thresholding |b′X′ygkt | − λa. Intuitively, correcting for the size of the group
could potentially miss associations arising from a very small number of responses that be-
long to a large sized group. An alternative approach could instead correct for the number of
non-zero elements in each group after the soft-thresholding has been performed. However,
the scenario mentioned above is expected to be rare when a meaningful grouping structure
exists and thus when the use of the grouped penalties is supported. Other corrections, rep-
resenting for example the amount of correlation within each group or any other meaningful
measure, can also be accommodated.
Similarly, we assume that the matrix of predictors X can be sorted into J groups hj ,
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j = 1, . . . , J , each of length pj , and denote byXhj and bhj the n×pj matrix and the pj×1
vector corresponding to group j. Adopting the sparse group Lasso penalty for predictor
selection then amounts to minimising

















where δb should be chosen such that b′b = θ2 and νbj can be adjusted to correct for
group size. When sparse group Lasso for genotype selection is desired Step 5 in the sRRR
Algorithm can be replaced by
Algorithm













Imaging phenotypes pose an interesting graphical structure representing communications
between each region or even each voxel in the brain. Brain networks representing struc-
tural connectivity can be constructed from structural MRI, by evaluating the covariation of
grey matter measures between different structures, or from diffusion tensor imaging (DTI)
representing white matter connections in the brain. Functional connectivity networks can
be constructed for example from fMRI by evaluating temporal correlations of activity be-
tween brain regions (Bassett and Bullmore, 2009; Rubinov and Sporns, 2010). Figure 3.2
gives a schematic illustration of how structural and functional networks are constructed.
Such brain networks can be exploited using the Laplacian penalty to encourage the se-
lection of functionally related or anatomically connected areas that are likely to share com-
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Figure 3.2: Schematic illustration of brain networks constructed from structural MRI, DTI
or fMRI data. In each case, an association matrix is first constructed with entries represent-
ing the weights connecting two regions in the brain. This can also be binary representing
the existence or absence of an association. A corresponding graphical representation, where
brain regions are represented by nodes in the graph, and the links between two regions are
represented by edges, is shown. The figure was adapted from Bassett and Bullmore (2009).
mon genetic variability. Moreover, structural and functional brain network abnormalities
have been reported in patients suffering for several diseases and especially psychiatric dis-
orders like schizophrenia and neurodegenerative disorders like Alzheimers disease (Bassett
and Bullmore, 2009). In that sense, using a Laplacian matrix that illustrates the variations
between brain networks in patients and healthy individuals can direct the simultaneous se-
lection of areas that are differentially connected in cases and controls, and possibly aid the
detection of the underlying genetic association.
Another possible application of this graphical penalty is by considering the 3D structure
of the voxels within the brain. For example, a 3D Gaussian kernel can be used to generate
the weights for the Laplacian matrix, so that the weight between voxel j and voxel s rep-
resents their physical distance (with adjacent voxels having the largest coefficient and the
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coefficient decreasing as the distance between the two voxels increases). This will have a
3D smoothing-like effect, encouraging the selection of localised regions in the brain. This
is a sensible approach to take considering again the expected homogeneous genetic pat-
terns in neighbouring voxels of the brain. However, as with covariance matrices, the use of
a q × q matrix is computationally challenging and therefore may not be very practical.
Genetic pathways or interactions can also be interpreted by the means of a graph, where
associated genes are connected by a link. For example, Figure 3.3 illustrates the links be-
tween the APOE gene and 9 other genes through pathways (meaning that the two connected
genes act together in a pathway) or physical interactions. Incorporating such prior biologi-
cal information can direct the model towards identifying meaningful associations (possibly
coming from multiple markers each contributing a small effect towards a biological func-
tion) that otherwise could be missed from the analysis. For example, Li and Li (2008) have
applied the sparse Laplacian to gene expression data, using pathway information, to iden-
tify subnetworks associated with survival times from brain cancer. In follow up work, Li
and Li (2010) presented a similar application, searching for subnetworks associated with
brain ageing. Another possible graphical structure connecting SNPs in the genome could
use the LD coefficients between two SNPs as the weight connecting the two variables (as
done for example by Daye and Jeng (2009) and Tutz and Ulbricht (2009) who considered
different applications). Smoothing would then encourage SNPs in strong LD to be selected
together.
We now show how the sparse Laplacian penalty can be adopted in the sRRR model
by deriving the equivalent update for the regression coefficients a and b for phenotype
and genotype selection, respectively. We assume that we can represent our responses
graphically, where two responses yj and ys are connected by a weighted link with weight
wjs. Then using the sparse Laplacian penalty for phenotype selection in the sRRR model
amounts to optimising
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Figure 3.3: Schematic illustration of a network between the APOE gene and 9 other genes.
The links connecting the genes represent either pathway-related links (green lines) or phys-
ical interaction links (blue lines). The plot was created using the GeneMANIA software
(http://www.genemania.org/)
Taking the partial derivative with respect to as and setting to zero





aj + λams = 0





∣∣∣∣∣ ≤ λa. (3.18)
If aˆs 6= 0 then
aˆs =
1
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Combining (3.18) and (3.19) gives
aˆs =
1










where δa is chosen such that aa′ = 1. Note that this estimate for as depends on the other
coefficients aj , j 6= s. Thus, to apply the sparse Laplacian for phenotype selection, Step

















7. until aˆ converges
Similarly, to derive the equivalent update for the regression coefficient b, we assume
that the association between the predictors can be represented by a graph, where variables
xs and xj are connected with a weight wsj . Adopting the sparse Laplacian penalty in the
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where δb is chosen such that b′b = θ2. Equivalently, to apply the sparse Laplacian for

















7. until bˆ converges
3.4 Discussion
In this chapter, we have introduced the use of a sparse multivariate regression model for
detecting associations between high-dimensional genetic and imaging variables. The tra-
ditional approach to multivariate regression is to estimate the coefficients by ordinary least
squares and to use the resulting estimates for prediction. However, such an approach makes
no use of the multivariate nature of the response. The suggested RRR model exploits this
information by assuming that the association between the genotypes and phenotypes lies in
a lower dimensional space. The predictions are thus obtained from a subspace of the space
spanned by the predictor variables.
An essential ingredient in our formulation is provided by the sparsity constraints, which
effectively allow us to select highly predictive genetic markers. When thousands of mark-
ers are included in the model as potential causal variants, the large majority of them are not
expected to be related with the disease under study. As a consequence, variable selection is
required to estimate the true underlying sparse regression model. Sparsity at the phenotypic
level is also required when the number of candidate quantitative traits entering the regres-
sion model is large; for instance, when there are several candidate ROIs or in whole-brain
analyses carried out at the voxel-level. In these cases, it is not known with certainty which
quantitative phenotypes provide a good proxy for the disease. The proposed sRRR model
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performs variable selection in the phenotypic domain as well and is able to discover them
alongside the causal genetic markers.
The suggested model assumes the existence of multiple ranks each capturing different
genetic effects on the disease phenotypes. The ranks have a latent variable interpretation
and in fact the model belongs to the general class of LVMs. LVMs have recently gained
popularity in the exploratory analysis of genetic data. Such approaches offer practical
ways to deal with the widespread correlation patterns seen in genomic data, and yield inter-
pretable results. For instance, it has been observed that the first few principal components
– latent variables that explain as much sample variance as possible – extracted from genetic
markers capture the ancestral information contained in the sample and aid in the identifi-
cation of population sub-structure (Reich et al., 2008). Principal components also have a
precise genealogical interpretation (McVean, 2009) and have been used for detecting tag-
ging SNPs (Lin and Altman, 2004). In case-control association studies, LVMs such as
principal component regression (Wang and Abbott, 2008), PLS (Sarkis et al., 2006), and
independent components analysis (ICA) - that seeks for latent variables that satisfy some
optimal properties subject to mutual independence - (Dawy et al., 2005) have also been
proposed to exploit correlations among SNPs.
In the analysis of imaging data, LVMs have been used widely, for instance in the mod-
elling of correlation patterns and detecting dependence amongst brain regions. For exam-
ple, CCA has been used for the segmentation of MR spectroscopic images (Laudadio et al.,
2005) and to estimate the shapes of obscured anatomical sections of the brain from visible
structures in MRI (Liu et al., 2004). It has also been used to extract highly correlated modes
of variation in shape between a number of different anatomical structures within the brain
(Rao et al., 2006). In fMRI studies, CCA has been proposed to identify activations of low
contrast in the brain, where by accounting for neighbouring correlated voxels it showed
increased sensitivity to detect true signals, relative to single voxel analyses (Friman et al.,
2001; Nandy and Cordes, 2003). RRR with regularised covariance matrices has also been
used as a predictive model of brain activation (Kustra, 2006).
Within the emerging field of imaging genetics, LVMs have only recently made their
first appearance. A non-linear extension of CCA, kernel CCA, has been used to investi-
gate the association between a set of candidate SNPs and a set of voxels taken from the
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entire brain image (Hardoon et al., 2009) – in practice, a linear kernel was used, corre-
sponding to a standard linear CCA. Another LVM proposed for imaging genetics studies
is an extension of ICA, called parallel ICA (pICA), that computes a dependence measure
between two paired sets of variables. In pICA, latent variables are extracted by maximising
the between-domain correlation while ensuring that all the extracted variables are as inde-
pendent as possible within each domain (Liu et al., 2008b). Both kernel CCA and pICA
find shared hidden factors that may explain the dependence between genetic and imaging
variables. However, the lack of sparsity in the solutions found by these models makes their
interpretation particularly difficult as there are no rigorous criteria to rank genotypes and
phenotypes by importance. Our model provides a solution to this problem by performing
simultaneous variable selection in both domains in a predictive modelling fashion. The em-
phasis on variable selection is particularly important when the underlying (and unobserved)
model that generated the ‘true’ association has a sparse representation, which is precisely
the case in association mapping.
The RRR model offers a general framework for several widely used LVMs which con-
stitute special cases of the model for different choices of the weight matrix Γ. The use of
Γ = Iq and the assumption of diagonal covariance of the predictor variables in our deriva-
tion of the sRRR model, which is a common procedure in high dimensional problems,
results in an estimation algorithm that is similar to other algorithms proposed for sparse
CCA and sparse PLS. As a remedy for the diagonalisation we suggest the use of alternative
structural penalties within the sRRR model for which we provide estimation algorithms.
Such penalties can account for the specific correlation structures presented by the imaging
genetics data. They also offer a way to incorporate prior knowledge in the model that can




In this chapter, we assess the power of the proposed sRRR model in comparison with the
more conventional MULM approach using simulated data that accurately reflect the pat-
terns observed in real imaging genetics data. We also attempt to quantify the loss of power
that may potentially result when extracting ROI averages to reduce the dimensionality in
the phenotypic domain. We demonstrate this by both analytic and simulation results, where
for the latter, we simulate realistic voxel-wise phenotypes and compare the power obtained
using each of the competing phenotypes; one based on individual voxels and one based on
ROI averages.
4.1 Comparing sRRR and MULM
4.1.1 Data simulation procedure
We have developed a realistic simulation framework for assessing the performance of any
statistical approach for population-based association mapping with neuroimaging pheno-
types. Our simulation procedure initially generates genomes that make up a large hu-
man population. We used the FREGENE (FoRward Evolution of GENomic rEgions)
genome simulator to generate a large population of human genomes. The simulation pro-
cess evolves the population forwards in time, over several non-overlapping generations,
by keeping track of complete ancestral information. The simulations are set up so as to
reproduce the effects of salient evolutionary forces, such as mutation, recombination and
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selection, with parameters chosen to mimic the evolutionary processes inferred from real
human populations. At the end of the simulation, each genome in the population is repre-
sented by a high dimensional vector of biallelic genetic markers, that is then paired up with
a multivariate neuroimaging vector derived from real MRI data. Finally, a precise statistical
association linking a handful of genotypes and a handful of phenotypes is induced in the
population by modifying the quantitative phenotypes according to a genetic model.
From this large target population, repeated random samples of any size can be ex-
tracted. For each sample, the true underlying genotype-phenotype dependence is known,
and the performance of any statistical method for detecting genetic associations can be eas-
ily assessed. The use of data simulated under a predetermined genetic model enables us
to study the performance of competing statistical models in an unbiased fashion by means
of performance measures, such as receiver operating characteristic (ROC) curves, which
would otherwise be impossible to evaluate in real studies. Our approach also provides a
framework for characterising the statistical power required to detect true non-random as-
sociations. A detailed description of our simulation and calibration procedures is provided
below.
Genotype simulation: The simulation of a large human population was carried out us-
ing the simulation software FREGENE (Hoggart et al., 2007). The software implements
a forward-in-time simulation procedure in which each individual’s genome consists of a
single linear chromosome having minor allele counts. The population evolves over non-
overlapping generations according to a Wright-Fisher model, with specific control over the
population genetic parameters including selection coefficients, recombination, migration
rates, population size and structure. Using FREGENE, we initially generated a panmic-
tic human population that mimics the evolution of N = 10000 diploid individuals along
200000 generations. We used a per site mutation rate of 2.3×10−8, a per site cross over rate
of 1.1×10−8, and a per site gene conversion rate of 4.5×10−9, with 80% of recombination
events occurring in hotspots, with a 2kb hotspot length. Selection was also introduced,
with the proportion of sites under selection set to 5 × 10−4. Each simulated sequence was
20Mb long. SNPs having a minor allele frequency (MAF) smaller than 0.05 were initially
removed, leaving a total of p = 37748markers. Of these, k = 10markers having MAF=0.2
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were pre-selected to act as causative SNPs – these were randomly chosen only once, and
were then held fixed in all subsequent simulations and analyses. The causative SNPs are
only used to introduce genetic effects on the phenotypes (see below for details), and are
removed from each data set prior to any statistical analysis.
Phenotype simulation: Brain phenotypes were generated using MRI data obtained from
the publicly available Alzheimer Disease Neuroimaging Initiative (ADNI) database1. The
primary goal of ADNI is to test whether serial imaging and non-imaging measures can be
combined to measure the progression of mild cognitive impairment and early Alzheimer’s
disease. Data is collected at a range of academic institutions and private corporations, and
subjects have been recruited from over 50 sites across the U.S. and Canada. Complete
background and methodological detail of the ADNI data can be found on the project web-
site2. For our study we only used baseline T1 MRI scans from 189 subjects with mild
cognitive impairment. The ADNI T1 MRI scans have initial resolution of 0.9375× 0.9375
× 1.2 mm3 (3D MP-RAGE sequence, TR = 2400 ms, TE = 1000 ms, FA = 8◦) and were
preprocessed with the SPM5 ‘optimised’ VBM procedure (Good et al., 2001), using a
unified segmentation and warping method, followed by modulation of grey matter (GM)
segmented images by the Jacobian of the warping. This produces GM images in standard
space that still retain units of GM volume of the individual. The resulting images, 2.0 ×
2.0 × 2.0 mm3 resolution in Montreal Neurological Institute (MNI) space were used with
no applied smoothing.
From each image we extracted the mean modulated GM value from q = 111 anatomical
ROIs defined by the GSK CIC Atlas (Tziortzi et al., 2011). The GSK CIC Atlas is based on
the Harvard-Oxford atlas3 but offers a 6-level hierarchy, from a coarse 3-region (GM, cere-
bral white matter (WM) and cerebrospinal fluid (CSF)) version to a fine 111-region version
(illustrated in Figure 4.1). After regressing out the effect of sex and age, we estimated the
ROI means, all collected in a vector μ = (μ1, μ2, . . . , μq), and their covariance matrix Σ.
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Figure 4.1: Sagittal, coronal and axial views of the GSK CIC Atlas defining 111 regions
of interest.
simulating a vector yi∙ = (yi1, yi2, . . . , yiq) drawn from the multivariate normal distribution
with parameters (μ,Σ). The values in yi∙ can be interpreted as baseline GMmeasurements,
unlinked to genotypes, prior to the introduction of genetic effects.
Genetic effects. We induced genetic effects in l = 6 ROIs using an additive genetic
model involving the k = 10 causative SNPs. To simplify notation, we let the first k geno-
types correspond to the causal SNPs, and the first l phenotypes correspond to the affected
ROIs. Recalling that yj is the simulated baseline GM value for ROI j, the target phenotypes
have their GM intensity reduced as per









for j = 1, . . . , l. Each wj term represents the reduction due to the additive genetic model
on ROI j. The parameter δj controls the overall effect size on phenotype j, whereas
ζj1, . . . , ζjk are parameters controlling the contribution of each one of the k causative mark-
ers.
Compared to the average baseline GM value (calibrated on real data), we require the
mean intensity value of the jth affected ROI to be reduced by exactly γj × 100%, where
γj ∈ [0, 1] represents the overall genetic effect size. Therefore we impose that E(y∗j ) =
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shows that the percentage reduction in GM at the jth ROI depends on the mean baseline
value, the observed MAFms for each causative SNP s (s = 1, . . . , k) and the δj parameter
(j = 1, . . . , l). In our simulation settings, we control the effect size γj , and since all other
parameters are observed in the population, δj is then uniquely determined. We also report





Assuming that all SNPs contribute equally, it can be noted that the effect on the mean
GM of ROI j caused by a single causative SNP with MAF m is exactly 2δjm/kE(yj).
When a randomly selected individual has maximal allele dosage at all k causative SNPs,
γj takes its maximal value 2δj/E(yj).
Simulation parameter settings. In our simulations we set ζjs = 1/k so that each causal
SNP affects each ROI equally. Effect sizes represented by the γj parameters were selected
to introduce a 6%, 8% and 10% reduction in mean GM in each affected ROI. The corre-
sponding average proportions of variance explained by the genetic effects are 5%, 8% and
12%, respectively. The maximally attainable per-SNP effects, observed when an individual
is homozygous for the disease allele, are 3%, 4% and 5%, respectively. These effect sizes
were selected with reference to previous imaging genetics findings. For instance, Filippini
et al. (2009) reported a 10% reduction in GM in homozygote APOE ε4 subjects relative
to subjects with no ε4 alleles (corresponding to our baseline GM values), and Joyner et al.
(2009) reported a maximum genetic effect of 9.8%. Therefore the genetic effect sizes
chosen in our simulation studies are meant to characterise the statistical power when the
per-SNP effects are relatively small and when multiple disease alleles contribute additively.
Each simulation scenario consists of a unique parameter combination (γ, n) indicating the
overall genetic effect size and sample size, respectively. In order to avoid biases introduced
by random sampling, for each simulation scenario we always report on average perfor-
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mance measures, where the average is taken over a total of B = 200 independent samples
extracted from the population.
4.1.2 Performance assessment criteria
We evaluate the performance of sRRR, and compare it to MULM’s performance, by means
of ROC curves. In each curve, sensitivity (true positive rate) is plotted against 1-specificity
(false positive rate) (Fawcett, 2004). This eschews multiple-testing correction or other
model selection issues, as sensitivities can be compared for a given specificity. We sepa-
rately evaluate the detection performance in genetic and imaging domains. In the sRRR,
the “detected” SNPs correspond to all non-zero entries of bˆ(r) (r = 1, . . . , R∗). As the
penalty parameter λb is increased away from zero, sparser solutions are obtained and a
smaller number of SNPs is retained. In MULM, SNPs are ordered in decreasing order of
significance, according to the p−value associated to each SNP-ROI pair.
Since the true causative markers have been removed from the data, we define “true
signal” SNPs as those that are LD-linked with at least one causal SNP. Specifically, any de-
tected SNP whose R2 (pair-wise squared correlation) coefficient with any of the causative
SNPs is at least 0.8 is considered a true positive, with all others labelled as false posi-
tives. This LD threshold is commonly used in the literature, for example for tagging SNPs
(De Bakker et al., 2005; Wang et al., 2005). While the specific threshold may impact
the absolute performance somewhat, the relative performance between statistical methods
will be unaffected. We measure sensitivity as the proportion of true signal SNPs correctly
detected, and false positive rate as the proportion of true null SNPs incorrectly detected.
Analogously for ROIs, sRRR selects a phenotype when its corresponding coefficient in
aˆ(r) (r = 1, . . . , R∗) has a non-zero element; the number of detected ROIs from MULM is
then obtained accordingly from the ordered list of SNP-ROI pairs.
4.1.3 Results
The map of LD among the first 1000 available markers in the simulated population is repre-
sented in Figure 4.2. The LD patterns resemble those observed in real human populations,
where neighbouring markers tend to be in high LD, and the pairwise LD coefficient be-
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tween two markers declines with the distance between them. We report on simulation
results obtained from subsets of the entire set of available markers, with the number of
markers, p taking values of 1990, 9990, 19990 and 37738. Figure 4.3 shows the number of
LD-linked SNPs as a function of the LD threshold. Our threshold of 0.8 gives exactly 51
LD-linked SNPs, which correspond to approximately 2.56%, 0.51%, 0.26% and 0.14% of
the total number of SNPs, respectively for the four values of p that we have considered.
Pairwise correlations among q = 111 ROIs defined by the GSK CIC Atlas, estimated us-
Figure 4.2: A map of all pairwise LD co-
efficients for a subset of 1000 FREGENE-
simulated SNPs used in this study. The
simulated genetic data present the typi-
cal LD structure observed in real popula-
tions, where markers that are physically
close to each other on the chromosome are



























Figure 4.3: Number of LD-linked SNPs
(out of 1990 SNPs) as a function of the
LD threshold. Most SNPs have R2 with
causative SNPs that is 0.4 or less; only 51
SNPs with R2 exceeding 0.8 were marked
as “true” signal SNPs after the causal SNPs
were removed from the analysis.
ing the 189 subjects from the ADNI data set, are shown in Figure 4.4. The inset shows
the correlations among the 6 affected ROIs in the frontal cortex. The inter-regional correla-
tions in the ADNI dataset were mostly positive and strongest amongst cortical regions, with
cerebellar and thalamic regions nearly independent of cortical regions. When applying the
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Figure 4.4: All pairwise correlations among q = 111 ROIs defined by the GSK CIC Atlas
and estimated using n = 189 subjects from the ADNI data set. The inset shows the correla-
tions among the 6 affected ROIs in the frontal cortex: left and right each of precentral gyrus
(41, 42), anterior dorsolateral prefrontal cortex (43, 44), posterior dorsolateral prefrontal
cortex (45, 46).
sRRR model, a decision has to be made on how many ranks to select and how many vari-
ables to retain from each rank in both the genotype and phenotype spaces. In the statistical
analysis of only one data set, these parameters would be optimally tuned using model se-
lection criteria such as the cross-validated prediction error or using other data re-sampling
techniques (see Chapter 5 for details). In our simulation study however, in which B = 200
samples are extracted from the population for each given parameter setting, performing
model selection is not feasible due to time and computation constraints. Guided by rank
trace plots (see Figure 4.5), described in Section 3.1.1, we take the reduced-rank for all
sRRR models to be R∗ = 3. However, the choice of how many SNPs and ROIs to retain
from each one of the three ranks (i.e. how many zero coefficients to enforce in each a(r)
and b(r), with r = 1, 2, 3) is difficult. When R∗ = 3, a model selection procedure would
provide the optimal allocation (h1, h2, h3), meaning that h1 > 0 variables are selected from
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Figure 4.5: Rank trace plot. The x-axis represents ΔCˆ, and the y-axis represents ΔSˆ,
as described in Section 3.1.1. For each reduced-rank r ranging from 0 (top-right corner) to
R (bottom-left corner) there is a corresponding point (ΔCˆ(r),ΔSˆ(r)) along the curve. A
suitable rank R∗ can be selected by locating the point at which curvature is maximal – in
this example, based on γ = 0.06 and n = 1000, this point corresponds to R∗ = 4 and is
marked by the vertical and horizontal lines. However, for all of our experiments, we use
R∗ = 3 as we have empirically observed that this choice gives a satisfactory performance
and the gain of including a further rank is only minimal.
the first rank, h2 > 0 from the second, and h3 > 0 from the third. For most results reported
here, we have applied the simplest possible rule of uniform allocation across ranks: we
vary the total number of variables to be retained, g, and use the allocation (g/3, g/3, g/3),
meaning that 1/3 of the g variables to be retained (either SNPs or ROIs) is selected from
each rank. In some cases we have tested the (g − 2, 1, 1) rule – we select all but two vari-
ables from the first rank, and then one variable for each one of the remaining two ranks.
Although these allocations are arbitrary and do not guarantee that the sRRR model will al-
ways produce optimal ROC curves, they free us from the computational burden introduced
by any data-intensive model selection procedure, thus allowing us to carry out an exhaus-
tive exploration of several parameter combinations, including different effect and sample
sizes. Due to lack of optimisation, the results obtained using sRRR are conservative, a full
procedure that includes model selection will generally perform better.
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Figure 4.6 shows the ROC curves for SNP selection obtained from applying sRRR
with three different reduced ranks R∗ = 1, 2, 3 on p = 1990 SNPs and with a 6% effect
size; the sample sizes are 500 (a) and 1000 (b), respectively. The corresponding ROC
curves obtained from MULM are also shown for comparison. These curves show that
sRRR demonstrates consistently better power than MULM for every level of specificity.
As expected after inspection of the rank trace plots, when only one rank is used, not all
LD-linked SNPs are detected by sRRR and thus MULM performs slightly better for some
portions of the corresponding curve. In all cases, a notable gain in performance is obtained
when increasing the rank from 1 to 2, with performances then improving marginally less
as more ranks are added. This is in agreement with the rank trace plots and confirms that
the true signal is captured by the first few ranks.
Figure 4.6: ROC curves for SNP selection with a genetic effect size γ = 0.06 and sample
sizes n = 500 (a) and n = 1000 (b). The four ROC curves refer to sRRR with R∗ = 1, 2, 3
and to the MULM approach. For almost all specificities considered, the sRRR method
has always higher sensitivity than linear models – only when n = 500 and R∗ = 1 the
MULM approach performs slightly better for some portions of the curve. The sensitivity
of sRRR increases substantially when adding two ranks, and increases again when adding
three ranks. All results are obtained as averages of B = 200 replicates.
Figure 4.7 shows the SNP detection performance when R∗ = 3 is used, with genetic
effect sizes γ = 0.06 in the first row, and γ = 0.1 in the second row, and sample sizes
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n = 500 (a) and n = 1000 (b). In all cases, while power falls off appreciably for high
specificity, the sRRR method always has better sensitivity. Interestingly, whilst the sensi-
tivity of MULM improves with larger genetic effects and sample sizes, it only increases
linearly with false positive rates. In contrast, as the signal gets stronger or the sample size
gets larger, the performance of sRRR improves by a larger factor especially at lower false
positive levels (i.e. higher specificity) – this can be appreciated by the higher curvature of
the sRRR ROC curves. It is also important to remember that such high sensitivity is ob-
tained despite no attempt being made to select the best sparsity parameters – for instance,
even if sRRR was able to detect more than g/3 true positives in the first rank, these will
possibly be undetected under the (g/3, g/3, g/3) allocation rule.
To understand how the performance of sRRR scales from thousands to tens of thousands
of total SNPs, we computed sensitivity and false positive rates of sRRR and MULM for
various values of p while equating g (the number of selected SNPs from each of the two
methods). Table 4.1 reports on our findings for a model with γ = 0.06 and n = 1000, where
p ranges from 1990 to 37738 and g ranges from 30 to 450. For every setting considered,
sRRR has lower false positive risk (0.60 to 0.95 that of MULM) and larger power (1.72
to 4.66 times greater than MULM). Remarkably, the relative power of sRRR compared to
MULM gets larger as p increases, for any value of g, but particularly so for smaller values
of g, when fewer SNPs are selected. For one setting, Figure 4.8 illustrates that the power
ratio increases with the number of SNPs considered, with sRRR’s power increasing by a
large factor when nearly 40k markers are included. This provides reassurance that, in full-
scale GWA studies, sRRR can achieve a much higher power than MULM, while keeping
the false positive rate at acceptable levels. Under our simulated genetic effects, the power
of either method rarely reaches the desired 80% thus indicating the serious challenge of
BW-GWA studies with even n = 1000 subjects.
An assessment of the ROI selection performance using ROC curves is reported in Figure
4.9 for effect sizes of 6% (a) and 10% (b), with a sample size of 500 subjects. In these
Figures we illustrate the effect of the two allocation rules uniform allocation, and the (g −
2, 1, 1) selecting most variables from rank 1. For the smaller effect size of γ = 0.06, sRRR
has higher sensitivity compared to MULM, at all specificity levels, and for both rules.
However, the limitation of these arbitrary allocation rules is evident when a genetic effect
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Figure 4.7: ROC curves for SNP selection with a genetic effect size γ = 0.06 (row 1) and
γ = 0.1 (row 2), R∗ = 3 selected ranks and sample sizes n = 500 (a) and n = 1000 (b).
sRRR always outperforms MULM. With a larger sample size and genetic effect, the gain
in sensitivity obtained from MULM is approximately the same at all specificities. On the
other hand, the sRRR model yields higher gains in sensitivities corresponding to low false
positive levels, which results in curves with higher curvature. All results are obtained as
averages of B = 200 replicates.
size γ = 0.1 is used, in plot (b). Clearly, sRRR is able to detect the most important ROIs
from rank 1, and the rule (g − 2, 1, 1) provides high sensitivity at low false positive rates.
However, since 2 ROIs also need to be selected from the second and third rank, MULM
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outperforms sRRR at lower false positive rates in this instance. At a slightly higher false
positive level, when all the affected ROIs have been selected, sRRR achieves better power.
The limitation of the (g/3, g/3, g/3) allocation is also demonstrated here – although sRRR
achieves very high sensitivity and essentially detects all the affected ROIs with a false
discovery rate of about 10%, it has low power at lower false discovery rates (corresponding
to smaller values for g), because only 1/3 of the total g variables can enter the model for
each rank.
Figure 4.8: Comparison of sRRR and MULM for large p: shown here is the ratio of SNP
sensitivities (sRRR/MULM) as a function of the total number of SNPs included in the
study. The genetic effect size is γ = 0.06,R∗ = 3 selected ranks and sample size n = 1000.
All results are obtained as averages of B = 200 replicates. This result suggests that the
potential power gain coming from the sRRR model can be much higher in GWAs when the
number of available SNPs is much more than 40k. For further details see Table 4.1.
4.2 ROI averages and potential loss of power
Extracting ROI summaries, such as the average value across all voxels within a ROI (e.g.
an anatomical region), is a common procedure in imaging genetics as an attempt to reduce
dimensionality. In this section we propose a simple mathematical framework demonstrat-
ing that such an approach can potentially yield a smaller SNR, compared to the alternative
approach that uses all voxels directly, without any summarisation. We consider the case
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p g g/p αsRRR αMULM αsRRR/αMULM πsRRR πMULM πsRRR/πMULM
1990 30 0.0151 0.0065 0.0108 0.6044 0.3201 0.1577 2.0292
9990 0.0030 0.0015 0.0024 0.6199 0.2825 0.1054 2.6809
19990 0.0015 0.0008 0.0012 0.6249 0.2683 0.0866 3.0997
37738 0.0008 0.0004 0.0007 0.6117 0.2607 0.0640 4.0720
1990 60 0.0302 0.0165 0.0240 0.6887 0.4953 0.2110 2.3476
9990 0.0060 0.0036 0.0052 0.6986 0.4400 0.1363 3.2288
19990 0.0030 0.0019 0.0026 0.7108 0.4098 0.1134 3.6128
37738 0.0016 0.0010 0.0014 0.7011 0.4019 0.0862 4.6633
1990 120 0.0603 0.0413 0.0509 0.8114 0.6439 0.2792 2.3062
9990 0.0120 0.0087 0.0106 0.8177 0.5581 0.1814 3.0773
19990 0.0060 0.0045 0.0054 0.8236 0.5192 0.1452 3.5760
37738 0.0032 0.0024 0.0029 0.8204 0.4968 0.1093 4.5444
1990 150 0.0754 0.0540 0.0640 0.8435 0.6865 0.3056 2.2464
9990 0.0150 0.0114 0.0134 0.8479 0.5946 0.1970 3.0189
19990 0.0075 0.0058 0.0069 0.8466 0.5698 0.1563 3.6462
37738 0.0040 0.0031 0.0037 0.8508 0.5266 0.1203 4.3773
1990 210 0.1055 0.0798 0.0904 0.8829 0.7533 0.3511 2.1458
9990 0.0210 0.0170 0.0191 0.8873 0.6431 0.2227 2.8873
19990 0.0105 0.0086 0.0097 0.8864 0.6055 0.1749 3.4619
37738 0.0056 0.0046 0.0052 0.8890 0.5620 0.1360 4.1327
1990 300 0.1508 0.1184 0.1286 0.9204 0.8005 0.4112 1.9468
9990 0.0300 0.0254 0.0276 0.9211 0.6754 0.2515 2.6858
19990 0.0150 0.0129 0.0140 0.9200 0.6316 0.1949 3.2404
37738 0.0079 0.0068 0.0074 0.9192 0.5982 0.1545 3.8718
1990 450 0.2261 0.1808 0.1902 0.9503 0.8580 0.4985 1.7211
9990 0.0450 0.0393 0.0414 0.9489 0.7054 0.2934 2.4039
19990 0.0225 0.0200 0.0211 0.9459 0.6723 0.2258 2.9774
37738 0.0119 0.0106 0.0113 0.9451 0.6351 0.1779 3.5691
Table 4.1: False positive rate and power comparisons: p is the total number of available
SNPs; g is the target number of selected SNPs; αsRRR and αMULM are the false positive
rates (1-specificity) achieved by sRRR andMULM, respectively. πsRRR and πMULM are the
power (sensitivity) achieved by sRRR and MULM, respectively. In sRRR, we set R∗ = 3
and use the uniform allocation rule (g/3, g/3, g/3). Note that due to possible redundancies
between the sets of g/3 SNPs selected from each rank, the actual number of ‘unique’
SNPs, selected over all ranks, is usually somewhat less than the target number g, illustrated
in this table. For any value of g, as the total number of SNPs in the study gets larger, the
ratio αsRRR/αMULM remains constant and always below 1, indicating that sRRR achieves
smaller false positive rate, while the ratio πsRRR/πMULM is always above 1, indicating
that sRRR achieves higher power. Remarkably, the relative power of sRRR compared to
MULM gets larger as p increases, for any value of g, but particularly so for smaller values
of g. The sample size is n = 1000 and the genetic effect is γ = 0.06. All results are
obtained as averages of B = 200 replicates.
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Figure 4.9: ROC curves for ROI selection: n = 500, R∗ = 3 and genetic effect size (a)
γ = 0.06 and (b) γ = 0.1. For the latter genetic effect sRRR has worse sensitivity for
lower false positive rates, and the MULM approach shows good performance. Notably, for
the lower genetic effect, sRRR outperforms MULM. All results are obtained as averages of
B = 200 replicates.
where all voxels have been grouped into K disjoint anatomical ROIs, and a single aver-
age is taken to represent each ROI. We show that a notable reduction in signal is expected
when only a small subregion of a ROI is truly dependent on the genetic factors. When
this is the case, taking averages will decrease the statistical power to detect the true genetic
associations.
We first recall the notation introduced in Chapter 3 in Section 3.3.1. In particular, we
assume that, within a ROI k, there are exactly qk voxels, and we refer to this group of voxels
within ROI k as gk, for k = 1, . . . , K . Furthermore, we denote the reduced n × qk matrix
corresponding to ROI k observed on all n subjects by Ygk , and take ygkj , to be the vector
containing the n observations for the jth voxel in ROI k. We then construct the n × K
matrix, Y , such that its kth column, yk, represents the average of the voxels across the
kth ROI. We aim to quantify the SNR of both Y and Y, to study whether taking averages
across ROIs decreases the SNR. This is achieved by assuming a genetic model, according
to which we pose that
Y = Xba+ E (4.1)
Chapter 4. Power Studies 87
where the 1×q coefficient vector a has non-zero entries only for the voxels that are assumed
to be involved in the disease. The p × 1 vector b contains the genetic coefficients, which
can be zero for those genetic markers that do not contribute in explaining the variability in
the response. The n× q matrix E corresponds to the model residuals.
Suppose that, among all the available ROIs, only d < K depend on genetic effects,
whereas the remaining ones do not. For notational simplicity, we arrange theK ROIs gk in
the following order: the first d ROIs, i.e. those indexed k = 1, . . . , d, are the affected ones,
and the remaining ones, indexed by k = d+1, . . . , K are the unaffected ones. Furthermore,
we assume that the signal of genetic association is localised in a percentage 0 < tk ≤ 1
of the overall number of voxels contained in a ROI k, for k = 1, . . . , d, constituting the
affected voxels. We call these tkqk voxels the signal voxels, and we also assume that these
are ordered to appear first in each group gk. Figure 4.10 provides a schematic illustration
of a set of K ROIs (in this case, a brain atlas): a selected ROI k (coloured in dark yel-
low), could either contain all signal voxels, all having the same signal intensity (denoted in
black), or only contain a varying number of signal voxels, each one having varying signal
intensities (denoted by grades of black).
Figure 4.10: Sagittal view of a color-coded atlas of the brain. A ROI k (in dark yellow) has
been picked to illustrate two possible scenarios: (a) all the voxels within the ROI are signal
voxels, (b) the signal is gathered in a smaller subregion of the ROI. The signal intensity is
represented by shades of black.
According to this model, the jth voxel in ROI gk is then modelled such that
ygkj = Xbagkj + egkj
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for k = 1, . . . , d and j = 1, . . . , tkqk, or egkj otherwise, where agkj is the coefficient cor-
responding to the jth voxel of ROI k. Extracting ROI averages then amounts to estimating

























for k = 1, . . . , d and j = 1, . . . , tkqk, or otherwise this is 0. Analogously, the average SNR












This expression may be simplified further by imposing that the coefficients in a are such
that their weighted sum of squares, with weights given by the inverse of the variances, is
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for k = 1, . . . , d and 0 otherwise. From this, it can be seen that the average SNR for the















































A value of Q less than 1 means that extracting ROI averages leads to a lower SNR than the
one present at the voxel level.
As the number of possible scenarios is too large, we consider here only one case consist-
ing of a single affected ROI containing a proportion tk of signal voxels, as in Figure 4.10.
Furthermore, we assume that all the non-zero coefficients in a are equal, thus agkj = m for













By assuming that everything but tk is fixed in this expression, we can see that the maxi-
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mum value ofQ is reached when all of the voxels within the affected ROI are signal voxels,
that is tk = 1, and Q decreases towards its minimum value as tk decreases. Moreover, Q
decreases with increasing residual variances and increasing (positive) residual pairwise co-


















According to this model, when the proportion of signal voxels is small or when the residual
variances and covariances are large, we expect a potential power loss when using ROI
averages as the phenotypes to be tested for genetic association.
The ratioQ is also directly proportional to the number of voxels in the data, q, meaning
that Q is increasing/decreasing with increasing/decreasing q. When q is extremely large,
as in whole brain studies, a large proportion of voxels are expected to only contribute to
noise, in terms of the disease. In that case, the SNR of Y would be very small, making
the ratio Q more favourable towards Y. In this case, even though the signal is reduced by
taking the average across the entire ROI, the SNR in the ROI phenotypes is larger than the
one present in the voxel-wise phenotypes where a large amount of noise voxels are also
considered. These observations suggest that removing all noise voxels, i.e. voxels that are
not detectably associated with the disease, prior to the imaging genetics study may increase
the statistical power. In Chapter 7 we describe a possible approach to do this voxel filtering
(see Section 7.2.2) and subsequently present a real data application using brain-wide voxel-
wise phenotypes.
4.2.1 Simulation illustration
To illustrate the effect of ROI averaging as discussed above, we perform a simulation study
where we compare the performance of sRRR using three different penalties for phenotype
selection: the group Lasso, the sparse group Lasso (both applied on voxel-wise pheno-
types), and the standard Lasso (applied on phenotypes representing ROI averages). To do
so, we simulate realistic imaging voxel-wise data, following a similar procedure as de-
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scribed in Section 4.1.1 and induce a genetic association from toy simulated genetic data
on the phenotypes, following the simulation setting and assumptions described above.
Genotype simulation: In order to simplify the simulation setting and enable the assess-
ment of the effect of averaging only, we simulate ‘toy’ genotype data, rather than using
realistic genotypes as in the previous simulations. In particular, we simulate p = 2000 ge-
netic markers from a multinomial distribution for a population of N = 10, 000 individuals
to form the matrix of genotypesX. The simulation procedure is as follows:
For each genetic marker xs, s = 1, . . . , p
1. Randomly extract its MAFms from a uniform distribution U [0.1, 0.5]
2. For each individual i, i = 1, . . . , N
Simulate xis from a multinomial distribution with probabilities (1−ms)2,
2ms(1−ms) andm2s of observing 0, 1 and 2 minor alleles, respectively.
In this way, we still simulate markers taking the values 0, 1, 2 with varying MAFs (uni-
formly distributed in [0.1, 0.5]) but avoid the complex structure of LD present in the real
genetic data.
Phenotype simulation: We simulate the voxel-wise phenotypes such that they mimic the
true covariance patterns observed in real data. As done in the previous simulation experi-
ments, we use the 189 real images extracted from the ADNI database and preprocessed as
described in Section 4.1.1. The resulting modulated GM images, 2.0× 2.0× 2.0 mm3 res-
olution in MNI space, are additionally smoothed for this experiment. This is done to reduce
the impact of the remaining inter-subject variabilty in brain shape, since we consider voxel-
wise measurements. From each image, we extract the GM intensity values from q = 8315
voxels classified into 8 distinct anatomical regions according to the GSK CIC Atlas. The
number of voxels within each ROI range between 577 and 1711 with a mean number of
1039.38 voxels. After regressing out the effect of sex and age, we estimate the 8315×8315
voxel covariance matrix Σ using a shrinkage covariance estimator (Scha¨fer and Strimmer,
2005) and collect the mean values for each voxel in the vector μ = (μ1, μ2, . . . , μq). Then,
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for each individual i in the simulated population of 10k individuals, we generate the voxel-
wise residual vector ei = (ei1, ei2, . . . , eiq) from the multivariate normal distribution with
parameters (μ,Σ). These residual vectors constitute the columns of the residual matrix E
in Equation (4.1).
Genetic effects: We randomly pick 3 SNPs (all having MAFs of 0.2) from the simulated
genotypes to be the causative markers, and one of the eight ROIs, say the kth in order,
to be the affected ROI with 852 voxels. We then generate the voxel-wise phenotypes Y
with a percentage of tk voxels in the affected ROI having true signal, i.e. a total of tkqk
signal voxels, according to the model in (4.1). The coefficients a and b in the simulation
procedure are selected such that the condition (4.4) is satisfied and such that the per-voxel
SNR (SNRgkj - as defined in Equation (4.2)) is set to be 5% and 10%. The ROI average
phenotypesYare then subsequently extracted from the voxel-wise data.
Monte Carlo experiments: We extract a sample of n = 1000 individuals from the simu-
lated population {X,Y,Y} and fit the three models: (1) group Lasso on {X,Y} where we
select 3 SNPs and 1 group of voxels, (2) sparse group Lasso on {X,Y} where we select 3
SNPs, 1 group of voxels and tkqk voxels within the selected group and (3) Lasso on {X,Y}
where we select 3 SNPs and 1 ROI average. We repeat the procedure 200 times and report
on the average SNP, ROI and voxel sensitivity results. For each experiment we vary the
proportion of signal voxels within the affected ROI, in particular tk ranges from 0.05 to 1,
and compare the corresponding power of the three methods to detect the true associations.
Figure 4.11 shows the proportion of correctly identified SNPs, ROIs and voxels (rows 1-3),
while varying the percentage of signal voxels within the affected ROI. In the first experi-
ment, column (a), we fix the per voxel SNR to be 5% and in the second, column (b), 10%.
We observe a great increase in power to detect the true SNPs, ROI and voxels when using
the voxel-wise phenotypes and the group or sparse group Lasso penalties. As expected,
this power difference is more profound when the signal is concentrated in smaller sets of
voxels within the affected ROI. Notably the two level approach, i.e. the sparse group Lasso
model, that does variable selection both in the individual variable level (voxel) as well as
in the group level (ROI) further improves on the single level group Lasso approach when
the proportion of signal voxels is very low.
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(a) SNR per voxel 5% (b) SNR per voxel 10%








































































































Figure 4.11: SNP, ROI and voxel sensitivity (rows 1-3) while varying the percentage of
signal voxels, tk, within the affected ROI, for the three methods; group Lasso (group -
black full line), sparse group Lasso (sgroup - red dashed line), Lasso for ROI averages
(averages - dotted-dashed green line). The left and right columns correspond to results
with the per-voxel SNR fixed to 5% and 10%, respectively.
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4.3 Discussion
We have presented detailed simulations to evaluate the performance of the proposed sRRR
model. Our results indicate that sRRR is a promising approach and compares very favourably
to the more traditional univariate approach in detecting the most important variables in both
the genetic and imaging domains. To the best of our knowledge, our extensive simulation
results provide a first characterisation of the statistical power of imaging genetics studies,
for both univariate and multivariate approaches. Our simulation framework can also be
used for assessing the performance of any statistical approach in imaging genetics.
The simulation results presented in this chapter also highlighted the importance of
model selection, i.e. determining an adequate reduced rank as well as tuning the regu-
larisation parameters that control the amount of variables in the model. The selection of
the reduced rank R∗ was accomplished by the means of a graphical device - the rank trace
plot, which we found to perform well in practice. Permutation-based procedures, cross-
validation and parametric test statistics have also been proposed in similar problems (Rein-
sel and Velu, 1998; Waaijenborg et al., 2008; Witten et al., 2009). Possible approaches for
the selection of the regularisation parameters are discussed in Chapter 5, where we also
suggest the combination of the sRRR model with a data re-sampling technique that allows
us to rank the variables in order of importance in the model.
In this chapter, we have also assessed the potential loss of power resulting from extract-
ing ROI averages as the phenotypes to be used in the imaging genetics studies. Under some
simplified scenarios, we showed that when the contribution to the overall signal is concen-
trated in smaller subregions of the brain, the SNR of the ROI averages decreases relative
to the SNR obtained by considering all voxels directly. We further demonstrated this point
using simulations where we observed higher power to detect true associations when using
voxel-wise phenotypes compared to phenotypes representing ROI averages. On the other
hand, we noted that, as one would expect, when the number of voxels in the data is very
large, while the signal is only localised in small regions, a voxel-wise approach may suffer
from the high noise level. This observation then warrants a de-noising step to be carried
out before the imaging genetics study, whereby voxels that are not believed to contain any
signal should be removed from the analysis. This issue is further addressed in Chapter 7.
95
Chapter 5
Variable ranking and model selection
5.1 Introduction
As illustrated in the previous chapters, sparse models arising from penalisation techniques,
such as the Lasso regression or the sRRR model, depend on parameters referred to as the
penalisation or regularisation parameters. These determine the amount of sparsity in the
model, and equivalently the number of variables to be retained. Different values of the
regularisation parameters will give rise to different models, hence these should be properly
tuned for model selection.
A common approach to model selection consists of determining the value of the regular-
isation parameter that minimises a cross-validated error criterion. For example, the predic-
tion error is a commonly used error measure in regression. For a sparse model depending
on a regularisation parameter λ, cross-validation is generally achieved by searching for
candidate values of λ over the range [0, λmax]. Holding the value of λ fixed, a full K-fold
cross-validation procedure can be performed as follows. Assuming a random sample with
n subjects, the sample is divided into K sets each consisting of roughly n/K subjects. At
each run, one of the K sets is left out constituting the testing set, while the remaining sub-
jects form the training set. The sparse model is then fitted based on the training set, and
the error measure is estimated by evaluating the performance of the corresponding fit on
the testing set. The procedure is repeated by cycling through all possible K testing sets,
and the cross-validated error is evaluated to be the average error measure across allK runs.
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Model selection is then performed by tuning λ such that it corresponds to the minimum
cross-validated error (Hastie et al., 2001).
The cross-validation procedure can avoid over-fitting by selecting the model which has
optimised out-of-sample performance, and thus is expected to have good generalisation
properties. However, a drawback of this approach is given by the fact that minimising an
error criterion does not necessarily lead to the true underlying sparsity pattern. In addition
to this, a fixed value of the regularisation parameter can reveal different sets of selected
variables in each fold of the cross-validation procedure. In that sense, the error measure
averaged across all K partitions is not necessarily a good indicator of the importance of a
unique set of variables. Furthermore, after tuning the regularisation parameter, the selected
model is applied to the entire sample which again can yield different sparsity patterns,
compared to the ones observed in the various folds of the cross-validation procedure. Thus,
cross-validation can perform poorly for the specific purpose of variable selection.
Re-sampling approaches, such as bootstrap based procedures, are alternative approaches
to cross-validation for model selection and validation (Hastie et al., 2001). By repeatedly
extracting samples with replacement from the original data bootstrap estimates of the pre-
diction error can be obtained. An example is the leave-one-out bootstrap estimator where
for each observation the error is averaged across all bootstrap samples not containing that
observation. Variants with improved properties, such as the .632+ estimator, which is
a compromise between the leave-one-out bootstrap error and the error obtained from the
original set of data, also exist (Hastie et al., 2001; Efron and Tibshirani, 1997). Similarly
with cross validation, this approach also relies on the optimisation of an error measure that
is not necessarily a good indicator of the importance of a unique set of variables. A re-
lated approach is described by Breiman (1996a) who proposed the application of bootstrap
sampling for obtaining improved model parameter estimates. This was achieved by aver-
aging the estimates obtained from the bootstrap samples and is referred to as the bagging
(bootstrap aggregating) estimate. A variant of this approach, the subagging (sub-sample ag-
gregating) estimate was proposed by Bu¨chlmann and Yu (2002), where sub-samples drawn
without replacement were used instead of bootstrap samples.
In this chapter, we address the model selection problem for the sRRR model, by com-
bining it with a data re-sampling technique that has been specifically proposed for sparse
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modelling, known as stability selection (Meinshausen and Bu¨hlmann, 2010). Rather than
trying to optimise an error criterion, this procedure aims to estimate how important each
variable is over repeated fitting of the sparse model on random subsets of the data. The
final selection of variables is then based on their frequency of selection throughout the re-
sampling procedure. This data re-sampling technique combined with variable selection, is
expected to provide results with better generalisations in terms of the importance of each
variable in the model, and with better control on the expected number of false positives. In
the following sections, we first describe the ideas of this data re-sampling technique based
on a penalised regression model with univariate response, as originally presented by Mein-
shausen and Bu¨hlmann (2010). We then extend these ideas to the sRRR and illustrate its
application on several simulated datasets. We finally suggest, as a promising direction for
further research, an extension of this procedure where the frequency of the joint selection
of SNP-phenotype pairs is considered.
5.2 Stability selection in multiple regression
We recall the penalised regression model with an observed univariate response vector y
and multiple predictors x1, . . . ,xp on a random sample of n individuals
βˆ = argmin
β
{‖y −Xβ‖22 + λP (β)}
where P (β) is the penalty function that promotes sparsity in the model and λ is the regulari-
sation parameter that determines the amount of sparsity. For each value of the regularisation
parameter λ, the penalised regression model reveals a setG(λ) = {j : βˆj(λ) 6= 0}, consist-
ing of the indices of the variables that have been estimated to have a non-zero regression
coefficient. The objective is to uncover the true positive set, S, containing all the predictors
that are truly associated with the response. This is defined such that S = {k : β˜k 6= 0},
where the β˜k’s are the true coefficients of the model underlying the association between
the response and the predictors. A good variable selection technique then aims to iden-
tify as many variables as possible from the set S, while also controlling the corresponding
amount of false detections, i.e. the number of variables belonging in the negative set,
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N = {k : β˜k = 0}, that are falsely declared as positives.
Rather than tuning the regularisation parameter λ, to estimate the best G(λ), stabil-
ity selection is used, which as explained above seeks to find a stable set of variables
over a range of values [λmin, λmax] of the parameter, where λmax corresponds to the null
model and λmin ∈ (0, λmax) corresponds to a Lasso solution. In particular, for a given
λ ∈ [λmin, λmax], the stability selection approach consists of performing repeated random
sampling from the n subjects, typically of size bn/2c, without replacement, and fitting
the penalised regression model on each random sub-sample. Each one of the B random
sub-samples provides a sparse estimate βˆ(b), revealing the set of selected variables
G(b)(λ) = {j : βˆ(b)j (λ) 6= 0} for b = 1, . . . , B.
In what follows, we drop the (b) superscript and let G(λ) represent the selected set of
variables from a random sub-sample. The probability of selection of each variable is then
given by
Πk(λ) = P (k ∈ G(λ))
with the probability being with respect to random sub-sampling. The final set of variables
is then obtained by thresholding the maximum selection probabilities across the range of
the regularisation parameter. That is, for a probability cut-off π ∈ (0, 1), the estimated set
of selected variables is given by
Sˆ =
{
k : Πˆk ≥ π
}
where Πˆk = maxλ∈ΛΠk(λ) is the maximum selection probability of variable xk over the
range of λ which is defined as Λ = [λmin, λmax]. Using this approach, Meinshausen and
Bu¨hlmann (2010) provide theoretical properties both asymptotically and also assuming
finite sample size. A detailed discussion on these theoretical results is provided in the
following sections.
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5.2.1 Finite sample error control
In this section we elaborate on the theoretical results on error control that Meinshausen and
Bu¨hlmann (2010) have demonstrated in the case of a finite sample size. To do this, we first
introduce some additional notation. We define the number of falsely selected variables as
the intersection between the set of negative variables and the set of selected variables from
the sub-sampling procedure to be
F = |N ∩ Sˆ|.





and the expected number of uniquely selected variables across Λ by
u(Λ) = E(|G(Λ)|).








which depends on the threshold on the selection probabilities, on u(Λ) and on p. The result
above is based on some assumptions and two lemmas which we detail below along with a
sketch of the proof.
Assumptions:
The distribution of {1{k ∈ G(λ)}, k ∈ N} is exchangeable (A1)
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Lemmas:
ΠSIMk (λ) ≥ 2Πk(λ)− 1 (L1)










where we use the following definition
ΠSIMk (λ) = P (k ∈ {G(b1)(λ) ∩G(b2)(λ)})
to represent the simultaneous selection probability for each variable xk, from two disjoint
random sub-samples (b1 and b2) each of size bn/2c.
Sketch of the proof:
1. Using the assumptions (A1) and (A2) it can be shown that
P (k ∈ G(Λ)) ≤ u(Λ)
p
∀k ∈ N
2. Using the result from Step 1 and lemmas (L1) and (L2) it can be shown that





















Within the same framework of stability selection, Meinshausen and Bu¨hlmann (2010) have
also introduced an extension to Lasso regression by introducing some extra source of ran-
domness in the model, which they refer to as the randomised Lasso. As the authors have
shown, such an extension leads to improved asymptotic variable selection properties, com-
pared to the Lasso model. Variable selection consistency, i.e. selecting the true sparsity
pattern when the sample size is increasing towards infinity, has been established for the
original Lasso model under certain assumptions on the design matrix. The strongest such
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assumption requires that the design satisfies a condition known as the irrepresentable con-
dition (Zhao and Yu, 2006). The randomised Lasso approach has been proposed in an
attempt to weaken these assumptions.
This approach works by repeatedly fitting the Lasso model with random weights, Wk,
as scale factors for the regularisation parameter of each variable k. In each step of the










It is suggested the random weights,Wk’s, are selected using the following technique: with
probability pw ∈ (0, 1) set Wk = α, with α ∈ (0, 1], otherwise set Wk = 1. The latter
corresponds to no randomisation for the kth variable. It is suggested that reasonable values
of the parameter α lie in (0.2, 0.8). This randomisation technique can be easily accommo-
dated within the algorithms used to solve the original Lasso problem, by re-weighting the
corresponding variables based on their randomised weights. In particular, this corresponds
to replacing xk by xkWk, for k = 1, . . . , p, prior to applying the algorithm.
Meinshausen and Bu¨hlmann (2010) have shown that the randomised Lasso can achieve
variable selection consistency in the high-dimensional case, under much weaker assump-
tions on the design matrix. As suggested by previous works, the false variables tend to be
included in the model when the irrepresentable condition does not hold. The idea of the
random weighting scheme lies in that randomly re-scaling the variables can make the false
variables less sensitive to this condition, and thus decrease their frequency of selection.
It can be noted that using this randomised Lasso approach combined with stability
selection, the final selection of the variables becomes even more conservative. As suggested
by the asymptotic results derived in the original paper, although the method guarantees that
no noise variables will be selected, it also implies that variables with small effects, i.e.
small coefficients in the corresponding true underlying model, will be missed from this
variable selection procedure.
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5.3 Stability selection in sRRR
In the multi-response case, where a set of predictor variables {x1, . . . , xp}, is used to ex-
plain the variation observed in a set of responses {y1, . . . , yq}, variable selection techniques
aim to simultaneously uncover the subset of predictors and the subset of responses that
drive the association. Assuming that the underlying association of the two sets of variables
can be modelled according to a (rank one) RRR model,
Y = Xba+ E
then interest lies in estimating the true sets, Sx = {k : b˜k 6= 0} and Sy = {j : a˜j 6= 0},
consisting of the predictors and responses respectively, that contribute to the underlying
true model. The corresponding negative sets contain all the remaining noise variables and
are defined as Nx = {k : b˜k = 0} and Ny = {j : a˜j = 0}.
The sRRR model introduced in Chapter 3 depends on two regularisation parameters; λb
determining the set of selected predictors and λa defining the set of selected responses. As
with the univariate penalised regression model, model selection is required for the proper
tuning of these parameters. This model selection problem can be approached in a similar
manner, by the means of stability selection, by combining the sRRR model with data re-
sampling and estimating the frequency of selection for each variable. In fact, the concept
of stability selection is quite general in nature and the approach as well as the theoreti-
cal results on the finite sample error control are easily extended to any sparse modelling
approach.
The parameter space in sRRR is two-dimensional, since both λa and λb are allowed to
lie in [λamin, λamax] and [λbmin, λbmax] respectively. At each point in this 2D parameter
space λ = (λa, λb), and for each sub-sample b = 1 . . . , B, the sRRR model estimates the
sets of selected variables,
G(b)x (λ) = {k : bˆ(b)k (λ) 6= 0}
G(b)y (λ) = {j : aˆ(b)j (λ) 6= 0}.
As before, we drop the (b) superscript and let Gx(λ) and Gy(λ) represent the selected sets
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of variables from a random sub-sample. The probability of selecting the kth predictor and
the probability of selecting the jth response are then defined as
Πxk(λ) = P (k ∈ Gx(λ))
Πyj(λ) = P (j ∈ Gy(λ)).
Considering the cut-offs πx, πy ∈ (0, 1), the final sets of selected variables are obtained as
Sˆx =
{
k : Πˆxk ≥ πx
}





j : Πˆyj ≥ πy
}
where Πˆyj = max
λ∈Λ
Πyj(λ) (5.2)
where Λ denotes the 2D space containing all possible parameter combinations λ. The
number of falsely selected variables are then defined as
Fx = |Nx ∩ Sˆx|
Fy = |Ny ∩ Sˆy|.
For each set of selected variables, Sˆx and Sˆy, error bounds can be derived under the same
assumptions and following the same proof described in page 100. That is, assuming that
the distribution of {1{k ∈ Gx(λ)}, k ∈ Nx} is exchangeable and that the model does better









where ux(Λ) = E(|Gx(Λ)|) is the expected number of uniquely selected predictors across
the parameter space Λ with Gx(Λ) =
⋃
λ∈ΛGx(λ). Similarly, assuming that the distri-
bution of {1{j ∈ Gy(λ)}, j ∈ Ny} is exchangeable and that the model does better than
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where uy(Λ) = E(|Gy(Λ)|) is the expected number of uniquely selected responses across
Λ, with Gy(Λ) =
⋃
λ∈ΛGy(λ).
The final estimated sets Sˆx and Sˆy represent the variables that are having the greatest
impact in one rank of the sRRR model. The subsequent ranks of the model can then be
obtained by removing the effect of the selected variables from the data. Commonly, this
could be done by regressing out the estimated rank from each data matrix, as detailed in
Equations (3.14) in Chapter 3. However, the output of stability selection is a set of indices
corresponding to the variables that have shown to be more important in the model, rather
than an estimated model with estimated regression coefficients that can be directly used to
regress out the effect of the current rank. For this reason, once the final sets of selected
variables are obtained, we form the reduced n× |Sˆx| matrixXSˆx and the reduced n× |Sˆy|
matrixYSˆy . Using the reduced data matrices, we fit a (non-sparse) RRR model, estimating
the regression coefficient vectors bˆSˆx and aˆSˆy . The effect of the selected variables is then
removed from the original data by replacingX andY by
X− γˆXSˆxbˆSˆx
Y − δˆYSˆy aˆ′Sˆy




, respectively. Having removed the effect of the selected variables in the current
rank of the sRRR model, we then repeat the same procedure to obtain the results for the
next rank of the model. The complete approach of sRRR with stability selection is detailed
in the algorithm below
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Algorithm sRRR with stability selection
Input: Data X,Y (of sample size n); range of parameters (λamin, λamax), (λbmin, λbmax);
number of sub-samples B; number of ranks R∗; probability thresholds πx, πy
Output: Selection probabilities Πˆxk ∀k and Πˆyj ∀j, for each rank r = 1, . . . , R∗
1. for r ← 1 to R∗
2. for b← 1 to B
3. Extract a random sub-sample of size bn/2c
4. for λa ← λamin to λamax
5. for λb ← λbmin to λbmax
6. Estimate the sparse vectors bˆ(b)(λa, λb) and aˆ(b)(λa, λb)
7. v(b)xk (λa, λb)←1{bˆ(b)k (λa, λb) 6= 0} ∀k






v(b)xk (λa, λb) ∀k, λa, λb






v(b)yj (λa, λb) ∀j, λa, λb
12. Πˆyj ←maxλ∈ΛΠyj(λa, λb)
13. Sˆx ←{k : Πˆxk ≥ πx}
14. Sˆy ←{j : Πˆyj ≥ πy}
15. X← X− γˆXSˆxbˆSˆx
16. Y ← Y − δˆYSˆy aˆ′Sˆy
The idea of randomised Lasso can also be accommodated within the sRRR framework.
As introduced earlier, the randomised Lasso adds some randomisation in the stability se-
lection procedure by applying random weights on the regularisation parameters. The re-
gression coefficients are thus obtained as
aˆ, bˆ = argmin
a,b
{











with random weights Wk for k = 1, . . . , p and Uj for j = 1, . . . , q, selected such that
Wk = α with probability pw andWk = 1 otherwise, and similarly Uj = δ with probability
5.3 Stability selection in sRRR 106
pu and Uj = 1 otherwise, for some fixed values of α, δ ∈ (0, 1]. The solution to sRRR with
randomised Lasso is equivalent to the solution to sRRR with variables xk, k = 1, . . . , p,
and yj , j = 1, . . . , q, replaced by xkWk and yjUj , respectively, which can be considered
as an additional step between Steps 3 and 4 of the sRRR with stability selection Algorithm.
5.3.1 Illustrations
Toy data illustration
We illustrate the use of sRRR with stability selection using a toy simulation example. In
particular, we simulate fake genotypes, consisting of p = 100 SNPs for a population of
n = 500 individuals, using the procedure described in Section 4.2.1 of Chapter 4. A set of
q = 100 phenotypes for the N individuals are then simulated such that
Y = XBA+ E
whereB is p×2, with non-zero entries corresponding to the first 3 entries in its 1st column
as well as the 4th and 5th entries in its 2nd column. The matrix A is 2 × q, with non-zero
entries corresponding to the first 3 entries in its 1st row as well as the 4th and 5th elements
in its 2nd row. In that sense, we simulate two ranks, where in the first rank the association
is between x1, x2, x3 and y1, y2, y3. In the second rank, x4 and x5 are associated with y4
and y5. The columns of E are simulated from a normal distribution N(0, 1).
We apply the sRRRmodel toB = 200 sub-samples of size bn/2c = 250 extracted from
the original set of data, and examine a range of parameter combinations corresponding to
a range of number of selected predictors and a range of number of selected responses.
For each parameter combination, we estimate the selection probabilities for each of the
predictor and each of the response variables. To proceed to the next rank, we regress
out any variable having a maximum selection probability, i.e. Πˆxk and Πˆyj as defined in
equations (5.1) and (5.2), greater than or equal to 0.5. A threshold of 0.5 means that any
SNP or phenotype selected in at least half of the sub-samples is deemed to be important
for that factor, and its effect will be removed before re-fitting the model and extracting the
next rank.
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In Figure 5.1 we illustrate the selection probabilities for the predictors and the responses
(row 1 and 2 respectively) for ranks 1, 2 and 3 of the sRRR model. In each such plot, the
probability of selecting predictor xk, say, is illustrated as a line while varying the number
of selected predictors. The probability reported at each point along this line, represents the
maximum selection probability at a fixed λ˜b, where the maximum is taken over all possible
values of the λa parameter, i.e. maxλa Πxk(λa, λ˜b). Similarly, in relation to the responses,
the lines in the plots represent maxλb Πxk(λ˜a, λb) while varying λ˜a. Note that the final sets
of selected variables are determined by the maximum selection probabilities of all possible
parameter combinations, i.e. Πˆxk and Πˆyj as shown in Equations (5.1) and (5.2). However,
the paths of selection probabilities, as discussed above, are used for illustration purposes.
Notably, the variables involved in the first simulated rank of the model stand out in the
rank 1 analysis of the sRRR model. These are illustrated in red in Figure 5.1. The variables
from the second simulated rank, which are illustrated in green in the same figure, have
very low selection probabilities in the first rank of the analysis, which is comparable to the
probabilities of the noise variables. However, as soon as the variables selected in the first
rank are regressed out, the variables from the second simulated rank become evident in the
subsequent rank 2 analysis. Finally, when these are also regressed out (i.e. in the rank 3
analysis), no further variables stand out.
Realistic data illustration
In this section, we illustrate the use of sRRR combined with stability selection on a set of
realistically simulated imaging genetics data which was generated according to the sim-
ulation procedure presented in Section 4.1.1 in Chapter 4. For this illustration, we use
p = 37738 simulated SNPs and q = 111 ROIs, with the same 10 causative SNPs and the
same 6 affected phenotypes as the ones described in the experiments in Section 4.1.1. As
before, the causative SNPs are removed from the data and the interest is shifted in identi-
fying the markers that are in strong LD (R2 ≥ 0.8) with any of the causative SNPs. There
are 51 such markers and these comprise our true set Sx, whereas the true set of phenotypes
Sy consists of the 6 affected ROIs. The negative sets Nx and Ny include all the remaining
genetic markers and phenotypes. The induced genetic effect in the illustrations below is
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Figure 5.1: Selection probabilities for the predictors (row 1) and the responses (row 2) in
rank 1,2 and 3 analyses (from left to right). Simulated genetic markers and phenotypes
that are associated in the first and second ranks are illustrated in red and green respectively,
whereas the noise variables are denoted by black dotted lines.
either γ = 0.1 or γ = 0.08. For each of the genetic effects we extract a single sample of
size n = 1000 from the simulated population of 10k individuals and we subsequently use
that sample, treating it as a ‘real’ dataset, to illustrate how sRRR combined with stability
selection works in practice. We first report on the results obtained from the dataset with a
genetic effect γ = 0.1, both without and with the additional randomisation introduced by
randomised Lasso. We then report on the results obtained by applying the sRRR model
(without randomisation) on the dataset with the γ = 0.08 genetic effect size.
In all cases, we apply the sRRR model to B = 1000 sub-samples of size bn/2c = 500
extracted from the original set of data, and examine a range of parameter combinations
corresponding to a range of number of selected predictors and a range of number of selected
responses. As before, to proceed to the next rank, we regress out any variable having a
maximum selection probability greater than or equal to 0.5. We summarise the results
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(number of true and false SNPs and ROIs) obtained for the first 2 ranks of the sRRR model
applied in the simulated dataset with an effect size of γ = 0.1, in Table 5.1. For rank 3
all the selection probabilities were considerably low (< 0.3) and are thus not illustrated
here. A graphical representation of the corresponding selection probabilities for the SNPs
(row 1) and for the ROIs (row 2) is given in Figure 5.2. Notably, even with a naively
chosen threshold of 0.5 on the selection probabilities, we are able to identify 48 out of
the 51 markers in the true set Sx. However, this is achieved at the cost of declaring 44
SNPs belonging in the negative set Nx as positives. This corresponds to 0.94 sensitivity
and 0.999 specificity. The phenotypic selection on the other hand pinpoints directly to
the 6 true phenotypes in the first rank of the model, with no additional false variables
selected. Note that since all affected ROIs have been selected in rank 1 and have been
regressed out from the data, the true affected ROIs are subsequently not selected from
rank 2. However, the ROIs selected are all highly correlated with the 6 affected ROIs: all
pairwise correlations between the affected and selected ROIs exceed 0.6. Moreover, the
two phenotypes that show a considerably higher rate of selection (as shown in Figure 5.2)
have a pairwise correlation coefficient of 0.9 with at least one of the 6 affected phenotypes.
rank |Sˆx| |Sˆx ∩ Sx| |Sˆx ∩Nx| |Sˆy| |Sˆy ∩ Sy| |Sˆy ∩Ny|
1 25 17 8 6 6 0
2 67 31 36 5 0 5
Total 92 48 44 11 6 5
Table 5.1: Number of selected SNPs, |Sˆx|, with a probability threshold πx = 0.5 and the
subsequent numbers of true and false positives |Sˆx ∩ Sx| and |Sˆx ∩ Nx|, for rank 1 and 2
of the sRRR model. Similarly, the number of selected ROIs, |Sˆy|, with πy = 0.5 and the
corresponding numbers of true and false positives |Sˆy ∩ Sy| and |Sˆy ∩Ny|.
Using exactly the same set of data (i.e. with a genetic effect γ = 0.1), we also assessed
the effect of randomised Lasso applied in sRRR, with the randomisation parameters arbi-
trarily chosen to be pw = pu = 0.5 and α = δ = 0.5. The results of the corresponding
sRRR rank 1 analysis are illustrated in Figure 5.3. The selection probabilities (both for
the true as well as the noise variables) are all shrunk considerably compared to the ones
obtained without the additional randomisation, as shown in Figure 5.2. A discrimination
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Genetic effect γ = 0.1 - no randomisation
Figure 5.2: Stability selection plots for SNPs (row 1) and ROIs (row 2) of the rank 1 and
2 (left and right) of the sRRR model. The associated variables are illustrated by red lines,
whereas the noise variables are illustrated in black dotted lines.
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between the true and noise variables is still apparent, however thresholds of as low as 0.2-
0.3 are required to select any SNPs from this analysis. This suggests that the randomised
Lasso idea might not be suitable for the more realistic scenarios with smaller effect sizes.
Genetic effect γ = 0.1 - with randomisation
Figure 5.3: Stability selection plots for the SNPs (left) and for the ROIs (right), of rank 1 of
the sRRR model with randomisation. The associated variables are illustrated by red lines,
whereas the noise variables are illustrated in black dotted lines.
We also conducted a further experiment where the sRRR model (without randomisa-
tion) was applied in the simulated dataset with a lower genetic effect γ = 0.08. The results
from this analysis are illustrated in Figure 5.4. The selection probabilities for both the
SNPs and the ROIs in this experiment are all much lower than the ones observed in the
experiment with the higher effect size γ = 0.1. Again, in this case, a very low probability
threshold is required in order to select any variables. However, it is notable that by simply
ordering the variables (in decreasing order of their selection probabilities) we are still able
to capture some of the underlying association. This suggests that even if the probabilities
are low, the relative ordering of the variables can still be meaningful.
5.3.2 Joint selection probabilities
So far we have considered the individual maximum selection probabilities, for each pre-
dictor and response variable, obtained over all possible parameter combinations. In this
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Genetic effect γ = 0.08 - no randomisation
Figure 5.4: Stability selection plots for SNPs (left plot) and ROIs (right plot) of rank 1 of
the sRRR model. The associated variables are illustrated by red lines, whereas the noise
variables are illustrated in black dotted lines.
section, we suggest that one can possibly better exploit the multivariate structure of the
data, by considering the frequency with which a specific predictor and a specific response
are selected together, rather than individually. Intuitively, the joint probability is expected
to be a better measure in distinguishing true from random associations. Consider, for ex-
ample, the probability of selecting a predictor xk. This can be decomposed as
P (select xk) = P (select xk ∩ select yj)︸ ︷︷ ︸ + P (select xk ∩ not select yj)︸ ︷︷ ︸ .
(Q1) (Q2)
If there is an association between xk and yj , then the individual probability P (select xk)
would be mainly driven by (Q1), whereas if no such association exists, then (Q1) and (Q2)
are expected to contribute approximately by the same amount to P (select xk). In that sense,
looking at how often two variables (one predictor and one response) are selected together,
can lead to improved power to detect the true underlying associations. In what follows, we
attempt to formalise the idea of joint probabilities and examine the corresponding expected
false positive bounds.
Chapter 5. Variable ranking and model selection 113
At a fixed parameter combination λ = (λa, λb), the probability of selecting xk and yj
jointly is defined as
ΠJkj(λ) = P (k ∈ Gx(λ) ∩ j ∈ Gy(λ))
The final sets of selected variables are defined as
SJx =
{
k : ΠˆJk∙ ≥ πxy
}






j : ΠˆJ∙j ≥ πxy
}




and the sets of falsely selected variables are defined as F Jx = |Nx∩SˆJx| and F Jy = |Ny∩SˆJy |.
An equivalent inequality, as that in (L1), that is ΠJ,SIMkj (λ) ≤ 2ΠJkj(λ)− 1 holds for the
joint probabilities, where
ΠJ,SIMkj (λ) = P
[(
k ∈ G(b1)x (λ) ∩ j ∈ G(b1)y (λ)
) ∩ (k ∈ G(b2)x (λ) ∩ j ∈ G(b2)y (λ))]
is the probability of selecting predictor k and response j simultaneously from two disjoint
random sub-samples, denoted by (b1) and (b2). We can see this by expressing the joint
probability ΠJkj(λ) in terms of the simultaneous probability as
ΠJkj(λ) = Π
J,SIM
kj (λ) + P
[(
k ∈ G(b1)x (λ) ∩ j ∈ G(b1)y (λ)
) ∩ (k /∈ G(b2)x (λ) ∪ j /∈ G(b2)y (λ))]
≤ ΠJ,SIMkj (λ) + P (k /∈ Gx(λ) ∪ j /∈ Gy(λ))
= ΠJ,SIMkj (λ) + 1− ΠJkj(λ)
⇒ ΠJ,SIMkj (λ) ≤ 2ΠJkj(λ)− 1.
Moreover, the equivalent of (L2) holds, that is if P (k ∈ Gx(λ) ∩ j ∈ Gy(λ)) ≤  then
P (ΠJ,SIMkj (λ) ≥ ξ) ≤ 
2
ξ
. To see this, we let A(λ) denote the event that variables xk and yj
are simultaneously selected at a fixed parameter λ
A(λ) = (k ∈ G(b1)x (λ) ∩ j ∈ G(b1)y (λ)) ∩ (k ∈ G(b2)x (λ) ∩ j ∈ G(b2)y (λ))
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Then if P (k ∈ Gx(λ) ∩ j ∈ Gy(λ)) ≤ 
E(ΠJ,SIMkj (λ)) = E (E (I{A(λ)} = 1|(X,Y))) = P (I{A(λ)} = 1)
≤ P (k ∈ Gx(λ) ∩ j ∈ Gy(λ))2
≤ 2
Using these two lemmas, if we find a bound  such that P (k ∈ Gx(λ)∩j ∈ Gy(λ)) ≤  for
k ∈ Nx and for all λ and j, then we can bound the probability of observing a high selection
probability ΠˆJk∙ for a negative variable k ∈ Nx, and thus bound the expected false positives
(as in steps 2 and 3 in the sketch of the proof in page 100). By denoting by Ct the event
that variable xk was selected in Gx(λt) and by Dt the event that variable yj was selected in
Gy(λt), where λt is the tth parameter combination in Λ, we have




















= P [∪λ∈Λ(k ∈ Gx(λ) ∩ j ∈ Gy(λ))]




= 1 or if P
[(
∪|Λ|t=1 (∪s 6=t(Ct ∩ Ds))
)]
= 0,
supporting the intuitive sense that if the variables xk and yj are selected together at every
single parameter or if one of them is never selected across all possible parameters examined,
then taking the joint probabilities is equivalent to looking at the unions of selected sets over
all possible parameters.
Using this result we can bound P [∪λ∈Λ(k ∈ Gx(λ) ∩ j ∈ Gy(λ))] for k ∈ Nx and for
all j such that
P [∪λ∈Λ(k ∈ Gx(λ) ∩ j ∈ Gy(λ))] ≤ P (k ∈ ∪λ∈ΛGx(λ)) ≤ ux(Λ)
p
(5.3)
where the final part of this inequality is obtained using the exchangeability assumption and
the assumption that the model does better than random guessing, as shown by Meinshausen
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and Bu¨hlmann (2010) (corresponding to step 1 in the sketch of the proof in page 100). Then























A bound on the expected false positives is then determined as





















Similarly, an equivalent bound on the false positive responses is obtained as







We thus arrive at the equivalent bounds as the bound obtained previously for the individual
probabilities.
5.4 Discussion
In this chapter, we elaborated on a variable selection and ranking technique which is based
on data re-sampling, known as stability selection. A related approach to stability selection,
where re-sampling was used for the purpose of variable selection, is the bolasso (bootstrap-
enhanced Lasso) proposed by Bach (2008). This entails repeatedly fitting the Lasso model
to samples extracted with replacement from the original sample and reporting on the in-
tersection of selected variables across the bootstrapping procedure. Model selection con-
sistency, under several assumptions, has been established for bolasso both in the low and
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high-dimensional scenarios (Bach, 2008, 2009). The final set of selected variables, being
the intersection of the variables selected from the several bootstrap samples, is equivalent
to using a probability threshold of 1 in the stability selection context. Another closely re-
lated two-step bootstrap-based procedure, referred to as the random Lasso, was recently
introduced by Wang et al. (2011). In the first step the Lasso model was applied in bootstrap
samples, each consisting of different subsets of randomly selected predictors, and a mea-
sure of importance (the average regression coefficient across the re-sampling procedure)
was generated for each predictor. This measure was subsequently used in the second step
where the Lasso model was again applied to bootstrap samples, but this time each sam-
ple consisting of different subsets of variables selected with probabilities proportional to
their importance measures. The average regression coefficients from this final bootstrap
procedure were shown to yield good predictive performance through simulations and a real
microarray data application.
Other applications of re-sampling procedures combined with Lasso regression involve
the actual tuning of the regularisation parameter, or finding adaptive weights for each vari-
able, rather than the estimation of an importance measure of the variables. For example,
an m out of n bootstrap-based approach has been proposed for the estimation of adaptive
weights for the Lasso model that leads to consistent model selection (Hall et al., 2009).
This approach works by first estimating a
√
n consistent estimator of the regression vector
from the original set of data, such as the OLS estimator. By extracting bootstrap samples
of the residuals of this estimated fit of size m < n, samples of bootstrapped responses are
formed, and these are subsequently used in the Lasso model to estimate the sparse vectors.
The set of optimal, adaptive, Lasso parameters are then selected by minimising the sum
of squared differences between the bootstrap estimator and the
√
n consistent estimator
across the re-sampling procedure. Similar ideas have been employed by Chatterjee and
Lahiri (2011), who extracted bootstrapped residuals from the fit of a√n consistent estima-
tor which was thresholded prior to the estimation of the fit, such that near zero estimates
were set exactly to zero.
An important difference between stability selection and bootstrap-based procedures lies
in the re-sampling technique used. While stability selection extracts sub-samples (typically
of size bn/2c) without replacement, the bootstrap based approach extracts samples of the
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same size of the original sample, i.e. n, with replacement. The latter has the advantage of
a larger sample size and therefore a possible enhancement in power. However, sampling
with replacement might introduce extra bias in the model from possible overlaps between
observations within each extracted sample. Moreover, stability selection, as introduced by
Meinshausen and Bu¨hlmann (2010), offers a formalisation of such re-sampling approaches
for the purpose of variable selection in high dimensional settings. Using the suggested
approach, the authors provide theoretical properties both asymptotically and also assum-
ing finite sample size. The latter is particularly important for real data applications that
commonly consist of only a few tens or hundreds of individuals.
In this chapter, we have illustrated the use of sRRR combined with stability for model
selection. The finite sample error bounds of stability selection and the idea of randomised
Lasso, where additional randomisation is applied on the regularisation parameter of each
variable were extended to the sRRR model. We demonstrated the application of this pro-
cedure through toy and realistically simulated data, which we treated as real datasets for
the illustration of the approach. Using the realistically simulated data, we observed that
the randomised Lasso procedure applied to the sRRR model can result in much shrunken
selection probabilities for both noise and signal variables making its application more dif-
ficult in real life problems. Without the additional randomisation, the suggested procedure
showed promising results in identifying the true (simulated) associations.
A drawback of this model selection procedure relates to its need to determine addi-
tional parameters, involving the range of the regularisation parameters searched and the
probability thresholds, used to define the final sets of selected variables. Optimising these
parameters can be difficult in practice. We instead suggest to report on the relative rank-
ing of the variables based on their frequency of selection, which based on the simulated
examples seems informative even when the corresponding probabilities are considerably
low. However, the sRRR model assumes the existence of multiple ranks, where subsequent
ranks are found by regressing out the effect captured in the current ones. For this reason,
a probability threshold is required to determine the set of variables, whose effect is to be
regressed out prior to the subsequent analysis. In the simulation experiments, we used
a threshold of 0.5, thus removing the effect of variables that have been selected in more
than half of the sub-samples. We follow the same procedure in the real data applications
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presented in Chapters 6 and 7.
We have also extended the theory to joint, rather than individual, probabilities, which
represent the frequency with which a SNP-phenotype pair is selected. In particular, we
have shown that the equivalent bound on the expected false positives holds true in the
case of joint probabilities as well. We believe that further elaboration of these ideas could
potentially lead to improved bounds on the expected false positives, and more importantly,





In this chapter, we present two real imaging genetics applications. The first one is based on
a sample of patients with multiple sclerosis. The second application is based on a healthy
sample, where we examine varations related to a genetic disorder, the Williams syndrome.
6.1 Multiple Sclerosis
6.1.1 Introduction
Multiple sclerosis (MS) is an inflammatory disease involving demyelination and neurode-
generation (Hauser and Oksenberg, 2006). The disease is characterised by autoimmune
attacks against myelin in the central nervous system leading to varying degrees of relaps-
ing or progressive neurological impairments (Vukusic and Confavreux, 2007). The clinical
course and disease progression of MS is highly variable, and is likely to depend on com-
plex heritable and environmental factors (Oksenberg and Baranzini, 2010; Lauer, 2010;
Urdinguio et al., 2009).
The most well established genetic association with MS involves genes in the human
leukocyte antigen (HLA) region that are responsible for the immune systems response. In
particular, association studies have revealed evidence that the HLA-class II DRB1∗1501
allele influences disease susceptibility across diverse populations (Disanto et al., 2010). A
number of non-HLA genes have also been recently identified the majority of which relate
to immune system functions, as reviewed by Hoffjan and Akkad (2010); Oksenberg and
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Baranzini (2010) and Disanto et al. (2010). The complex heterogeneous phenotype of the
MS disease is however characterised by several additional disease features, such as myelin
loss and neurodegeneration. Different stages of these features are well reflected in the MRI
scans of MS patients (Barkhof et al., 2003; Fisher et al., 2008; VanWalderveen et al., 2001)
and imaging genetics studies using such MS-related intermediate phenotypes have started
to appear in the literature (see for example Xia et al., 2010; Okuda et al., 2009).
Increased concentrations of glutamate in the CSF of MS patients have been associ-
ated with the severity and course of the disease (Barkhatova et al., 1998). Supporting
this, in vivo spectroscopy studies have shown alterations in glutamate metabolism in acute
MS lesions and normal appearing white matter (Srinivasan et al., 2005). In addition, post
mortem studies have shown altered glutamate transporter expression in MS brain tissue
(Vallejo-Illarramendi et al., 2006), altered expression of metabotropic glutamate recep-
tors (Geurts et al., 2003, 2005) and altered expression of glutamate metabolising enzymes
(Werner et al., 2001), which implies an important role for the complete group of glutamate-
related proteins. Furthermore, glutamate transporter polymorphisms have been found to
affect the glutamate concentration in MS brain tissue (Baranzini et al., 2010; Pampliega
et al., 2008) suggesting that genetic variants of glutamate-related proteins can modulate
glutamate homeostasis.
Growing evidence also supports a role of epigenetics in MS (Urdinguio et al., 2009).
This includes findings for epigenetic drug targets (Faraco et al., 2011; Aljada et al., 2010),
evidence that epigenetic factors regulate the expression of MS disease susceptibility genes
(Miralve`s et al., 2007), and evidence linking epigenetic events to inflammation and neu-
rodegeneration (Kim et al., 2009b). Inter-individual differences in epigenetic events (e.g.,
the degree of methylation or acetylation) can be partly explained by genetic variability
(Schalkwyk et al., 2010; El-Maarri et al., 2009).
In this work, we performed two separate imaging genetics studies to examine for poten-
tial associations between several key genetic markers and a range of disease-related pheno-
types obtained from a sample of MS patients. Given the growing evidence that epigenetics
plays a role in MS, in the first study we used prior biological knowledge to selectively
examine genes that are critical for epigenetic regulation. In the second study, based on
previous findings linking glutamate metabolism related genes and MS, we searched for as-
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sociations with a selected set of SNPs known to be involved in glutamate metabolism. In
both experiments we consider q = 7 MRI-derived neuroimaging phenotypes that capture
the MS-related features:
(1) normalised grey matter volume (NGMV)
(2) normalised white matter volume (NWMV)
(3) normalised brain volume (NBV)
(4) T1 - T2 lesion load ratio (T1/T2)
(5) T1 lesion load change over a 1 year period (ΔT1LL)
(6) T2 lesion load change over a 1 year period (ΔT2LL)
(7) percentage of brain volume change over a 1 year period (PBVC)
For each study, we apply the sRRR model combined with stability selection, with B =
1000 sub-samples, to identify genetic associations with the multivariate phenotypic vector.
In order to simultaneously detect subsets of genetic markers and subsets of the pheno-
types that show stronger associations, we adopt Lasso penalties in the sRRR model for
both genotype and phenotype selection. In addition to this multivariate analysis, we per-
form two additional comparative analyses. In particular, treating each of the 7 phenotypes
independently, we perform a Lasso regression analysis combined with stability selection,
to identify genetic markers associated with each phenotype independently. In each case
we use B = 1000 sub-samples. We also search for pairwise univariate SNP-phenotype
associations using the MULM approach, where we correct for multiple testing using the
Bonferroni correction. We examine the consistency across the three different approaches,
to aid the detection of the most important associations.
6.1.2 Methods
Subject collection: 326 patients were recruited from two specialised referral centres: 187
from the University Hospital in Basel and 139 from the VU University Medical Center
in Amsterdam. Both centres participated in the GeneMSA consortium, an international
multi-centre effort to study genome-wide effects on MS susceptibility (Baranzini et al.,
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2009). Patients with a diagnosis of clinically definite MS with a relapse onset of the disease
were included (Polman et al., 2005). The clinical subtype was classified either as relapsing
remitting MS (RRMS) or secondary progressive MS (SPMS). The latter was defined by
at least six months of worsening neurological disability not explained by clinical relapse.
In all included subjects, disability was assessed with the expanded disability status scale
(EDSS) at baseline and follow-up after one year (Kurtzke, 1983).
Image acquisition: MR imaging was performed on two 1.5T MR systems (Amsterdam:
Siemens Vision and Basel: Siemens Avanto) at baseline and at one-year follow-up. Dual
echo proton density (PD)-T2-weighted images were acquired (TR: 2000-4000ms; TE 14-
20 / 80-108 ms), with interleaved axial 3.0 mm-thick slices and an in-plane resolution of 1.0
× 1.0 mm2. Post-contrast T1-weighted spin-echo images (TR: 467-650 ms; TE 8-17 ms;
axial 3.0 mm-thick slices with an in-plane resolution of 1.0× 1.0 mm2) were also obtained.
For brain volume measurement, isotropic (1× 1× 1 mm3) T1-weighted anatomical images
were acquired (TR: 7-20.8 ms; TE 2-4 ms; TI 300-400 ms).
MRI phenotypes: Marking and measurement of focal WM lesions was performed at the
University Hospital in Basel, using commercial semi-automatic software (AMIRA 3.1.1;
Mercury Computer Systems Inc). T2 hyperintense lesions and T1 hypointense lesions were
manually outlined on the PD images. Subsequently, T1 and T2 volume changes as well as
the T1/T2 lesion load ratio were calculated for these lesion categories. Brain volume analy-
ses were performed at the Imaging Analysis Centre in Amsterdam. Normalised grey matter,
white matter and total brain volumes as well as the percentage of brain volume change after
one year were estimated using SIENA(X) (version 2.2) from the FMRIB software library
(Smith et al., 2002). Subsequently, all T1-weighted images were registered to MNI-152
standard space using the skull as a scaling constraint. The volumetric scaling factor was
then applied to correct GM and WM volumes (derived from the automated tissue segmen-
tation) for head size (i.e., NGMV and NWMV). Scans of all subjects and the resulting
segmentation maps were visually inspected for scan quality and segmentation quality, re-
spectively. The effects of age and sex were regressed out of the 7 extracted phenotypes.
Pairwise correlations amongst the 7 neuroimaging phenotypes are illustrated in Figure 6.1.
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NGMV NWMV NBV T1/T2 ΔT1LL ΔT2LL PBVC
Figure 6.1: Pairwise correlations between the 7 phenotypes. NBV is highly correlated
with NGMV and NWMV, whereas the other pairwise phenotype correlations are low or
moderate.
Genotyping and gene selection: Genotyping was performed using Illuminas Sentrix
HumanHap 550 Beadchip. 467 SNPs belonging in genes with well-established roles in-
volving epigenetic regulation were selected for the epigenetic analysis. For the second glu-
tamate metabolism experiment, the candidate group consisted of 2023 SNPs, belonging in
genes involved in glutamatergic neurotransmission. In each experiment, we also included
a second group of ‘null’ genetic variants to act as a ‘negative control’ in our analyses. This
null group consisted of 3997 SNPs that showed the smallest associations with NBV (i.e.
highest univariate regression p−values), with age and disease duration used as additional
covariates. We also included a ‘positive control’ in our experiments by adding the MS sus-
ceptibility gene variant, HLA DRB1*1501 (tagging SNP rs3135388), given prior evidence
that HLA DRB1*1501 is associated with MS.
Quality control procedures were applied to the two sets of genotype data, collected
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on the 326 patients. These involved removing SNPs showing large deviations from Hardy-
Weinberg equilibrium (HWE) (p-value< 0.01) and SNPs having lowMAF (< 0.10). SNPs
having one or more missing values were also removed from the data. The final numbers of
SNPs, after quality control, for each experiment and in both the candidate and null groups
are given in Table 6.1. In Table 6.2 we provide the demographics for the 326 individuals
included in the study.
Experiment cand neg pos tot
Epigenetic 293 2526 1 2820
Glutamate 1292 2517 1 3810
Table 6.1: Number of SNPs for each group of candidate (cand), negative control (neg)
and positive control (pos), for each experiment (epigenetic and glutamate). The final, total,
number of SNPs included in the analysis is also provided (tot).
Disease group nG (male) age-bl duration
RRMS 262 (73) 42.33 (10.11) 129.11 (88.78)
SPMS 64 (25) 53.44 (8.50) 225.14 (107.61)
Table 6.2: Sample size (nG), number of males (male), mean age at baseline (age-bl),
mean disease duration in months (duration) for each disease class (RRMS and SPMS).
The corresponding standard deviations are given in brackets.
6.1.3 Results on epigenetic analysis
sRRR results: Table 6.3 summarises the top associations for the epigenetic analysis result-
ing from the sRRR model. The rank 1 analysis of the sRRR model indicated the rs2522129
SNP, belonging in the SIRT4 gene, one of the candidate genes in the epigenetic group, as
the one with the highest selection probability across the sub-sampling procedure; selection
probability of 0.52. The SNPs rs2675231 and rs2389963 belonging in the HDAC11 and
HDAC9 genes, both candidate genes from the epigenetic group, were also ranked among
the top sRRR results with selection probabilities 0.37 and 0.36, respectively. NBV,ΔT2LL,
NWMV and PBVC were the corresponding highly associated phenotypes, selected with
probabilities 0.72, 0.66, 0.63 and 0.61 respectively. The genotype and phenotype selection
probabilities are illustrated in Figure 6.2.
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SNP Gene Chr MAF HWE Πˆxk
rs2522129 SIRT4 12 0.17 1.00 0.52
rs8097442 18 0.29 0.51 0.41
rs169382 ARL15 5 0.35 1.00 0.39
rs2675231 HDAC11 3 0.15 0.67 0.37
rs7007113 ZMAT4 8 0.35 0.54 0.37









Table 6.3: The top 6 SNPs and the phenotypes from the sRRR rank 1 epigenetic analysis,
ranked according to their selection probabilities. For each marker also provided are: the
corresponding gene annotation where applicable, the chromosome, the MAF, the HWE p-
value and the selection probability. SNPs and the corresponding genes belonging in the
candidate epigenetic group are denoted in italics.


























Figure 6.2: Selection probabili ties for the SNPs (left plot) and phenotypes (right plot) for
the rank 1 analysis of the sRRR model. For the SNP probabilities, SNPs belonging in the
candidate group are illustrated in red and a horizontal line on the 0.5 probability threshold
is illustrated in dark blue. For the phenotype probabilities, each phenotype is denoted by a
different colour according to the legend.
Lasso and MULM results: The top SNPs from the Lasso and MULM analysis of the
NBV, ΔT2LL, NWMV, PBVC and NGMV that scored highly in the sRRR analysis are
given in Tables 6.4 and 6.5. The corresponding analyses for the other two phenotypes
were also performed, but are not presented here. Note that for the MULM analysis, no
SNP survived multiple testing correction. The SNPs reported here correspond to the ones
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having the minimum uncorrected p−values for each phenotype.
In agreement with the sRRR results, the rs2522129 SIRT4 SNP ranked among the top
results of the NBV, NWMV and NGMV Lasso analyses with probabilities 0.62, 0.34 and
0.54, respectively. The same SNP had also the minimum p−value 0.003 with NBV. Sim-
ilarly, the HDAC11 rs2675231 SNP that was among the top results of the sRRR analysis
was also among the top Lasso results of NBV, NWMV and NGMV analyses, with proba-
bilities 0.60, 0.37 and 0.49, respectively. The same SNP was also among the top MULM
SNPs with minimum pairwise p−value 0.01 with NBV. The PBVC Lasso regression anal-
ysis has also revealed among its top results the other sRRR SNP belonging in the HDAC9
gene, rs2389963, selected with a probability 0.61. The same SNP had also the minimum
p−value 0.0001 with PBVC.
Another HDAC9 SNP, rs2074633, was also included among the top results of the NBV
and NGMV Lasso regression analyses and was among the top MULM NBV results with
p−value 0.02. A further SNP from the HDAC9 gene, rs7796078, was also revealed in the
MULM results, associated with NWMV with a 0.01 p−value. The Lasso analysis of NBV
and NWMV have also revealed the rs2804919 SNP, belonging in the SIRT5 gene, which
was selected with probabilities 0.43 and 0.49, respectively. The same SNP was also among
the top NBV MULM results with p−value 0.04.
Summary of results: Our results revealed consistent association across the three dif-
ferent models with the SIRT4 (sirtuin 4) gene. Further evidence on a functionally related
gene SIRT5 (sirtuin 5) has also emerged from the MULM and Lasso analyses. SIRT4 and
SIRT5 genes encode proteins that are uniquely and specifically expressed in the mitochon-
dria (Huang et al., 2010). Our findings thus support the growing literature suggesting that
MS is associated with mitochondrial dysfunction, related to the neurodegeneration found
in MS patients (Witte et al., 2010; Lu et al., 2000). SIRT4 downregulates the mitochondrial
matrix enzyme, glutamate dehydrogenase, leading to increased levels of glutamate (Haigis
et al., 2006). As discussed in the introduction of this section, glutamate plays a key role
in MS disease, and this supports the possible association of SIRT4 with MS. SIRT5 shows
deacetylase activity towards the mitochondrial protein, cytochrome C, which plays a cen-
tral role in oxidative metabolism and apoptosis initiation (Huang et al., 2010). Evidence
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Phenotype SNP Gene Chr MAF HWE Πˆk
NBV rs2522129 SIRT4 12 0.17 1.00 0.62
rs2675231 HDAC11 3 0.15 0.66 0.60
rs2074633 HDAC9 7 0.24 0.88 0.46
rs2804919 SIRT5 6 0.31 0.70 0.43
rs1562004 MBD1 18 0.35 0.54 0.40
rs13402768 MBD5 2 0.20 1.00 0.34
ΔT2LL rs1438507 TCERG1L 10 0.39 0.91 0.66
rs3734464 PARK2 6 0.11 0.56 0.65
rs10087036 8 0.39 0.73 0.61
rs13123618 SEC24B 4 0.18 0.57 0.61
rs169382 ARL15 5 0.35 1.00 0.54
rs6674129 KAZ 1 0.45 0.31 0.54
NWMV rs2804919 SIRT5 6 0.31 0.70 0.49
rs10415904 19 0.13 0.47 0.48
rs2816850 LRRC8D 1 0.17 0.84 0.39
rs2585184 8 0.47 0.52 0.37
rs2675231 HDAC11 3 0.15 0.66 0.37
rs2522129 SIRT4 12 0.17 1.00 0.34
PBVC rs1025256 12 0.26 0.02 0.62
rs2389963 HDAC9 7 0.33 0.45 0.61
rs1286831 INADL 1 0.20 0.87 0.61
rs2057137 14 0.17 0.84 0.60
rs983689 11 0.50 0.91 0.58
rs4777927 15 0.33 0.17 0.55
NGMV rs2522129 SIRT4 12 0.17 1.00 0.54
rs2675231 HDAC11 3 0.15 0.66 0.49
rs2074633 HDAC9 7 0.24 0.88 0.49
rs736232 20 0.24 0.45 0.48
rs1358621 2 0.37 0.91 0.40
rs2038574 DNMT2 10 0.14 0.35 0.39
Table 6.4: The top 6 SNPs from the Lasso analysis of the NBV, ΔT2LL, NWMV, PBVC
and NGMV that scored highly on the corresponding sRRR analysis. In each analysis the
SNPs are ranked according to their selection probabilities and for each marker also pro-
vided are: the corresponding gene annotation where applicable, the chromosome, the MAF,
the HWE p-value and the selection probability. SNPs and the corresponding genes belong-
ing in the candidate epigenetic group are denoted in italics.
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Phenotype SNP Gene Chr MAF HWE p−value
NBV rs2522129 SIRT4 12 0.17 1.00 0.003
rs2675231 HDAC11 3 0.15 0.66 0.01
rs2074633 HDAC9 7 0.24 0.88 0.02
rs1562004 MBD1 18 0.35 0.54 0.03
rs2804919 SIRT5 6 0.31 0.70 0.04
rs13402768 MBD5 2 0.20 1.00 0.06
ΔT2LL rs3734464 PARK2 6 0.11 0.56 0.0003
rs13123618 SEC24B 4 0.18 0.57 0.0006
rs12622685 2 0.36 0.90 0.003
rs10087036 8 0.39 0.73 0.003
rs7765598 RWDD1 6 0.30 0.43 0.003
rs8097442 18 0.29 0.50 0.003
NWMV rs10415904 19 0.13 0.47 0.001
rs12519569 EPB41L4A 5 0.30 0.01 0.007
rs2816850 LRRC8D 1 0.17 0.84 0.007
rs325723 3 0.23 0.35 0.01
rs11887120 DNMT3A 2 0.40 0.17 0.01
rs7796078 HDAC9 7 0.32 0.61 0.01
PBVC rs2389963 HDAC9 7 0.33 0.45 0.0001
rs2057137 14 0.16 0.84 0.0003
rs7621892 3 0.42 0.65 0.0007
rs1025256 12 0.26 0.02 0.0008
rs919098 11 0.28 0.42 0.001
rs1286831 INADL 1 0.20 0.87 0.001
NGMV rs11254408 DNMT2 10 0.13 0.23 0.005
rs7924149 DNMT2 10 0.13 0.23 0.005
rs11254451 DNMT2 10 0.13 0.33 0.005
rs2038574 DNMT2 10 0.13 0.34 0.006
rs1358621 2 0.37 0.91 0.006
rs9972613 ACSBG1 15 0.46 0.58 0.009
Table 6.5: The top 6 SNPs from the MULM analysis of NBV, ΔT2LL, NWMV, PBVC
and NGMV that scored highly on the corresponding sRRR analysis. In each analysis the
SNPs are ranked according to their p-values and for each marker also provided are: the
corresponding gene annotation where applicable, the chromosome, the MAF and the HWE
p-value. SNPs and the corresponding genes belonging in the candidate epigenetic group
are denoted in italics.
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also exists linking SIRT genes with ageing and the onset of neurodegenerative disorders
(De Oliveira et al., 2010). Drugs that target SIRTs have shown initial promise for treating
the neurodegenerative component of MS (Aljada et al., 2010). Furthermore, environmen-
tal factors that contribute to MS disease onset or progression might be mediated through
epigenetic changes. For example, sirtuin enzyme activity has been linked with environ-
mental factors, relevant to MS, in that mitochondrial protein acetylation is modulated by
nutritional status (as reviewed by Kelly, 2010).
The three models also identified possible associations with the HDAC9 (histone deacety-
lase 9) and HDAC11 (histone deacetylase 11) genes. Recent evidence has shown that
HDAC9 plays a key regulatory role in dendritic growth (Sugo et al., 2010). There is also
evidence that HDAC9 regulates FOXP3 (Li et al., 2007), the expression of which is de-
creased in MS patients (Wan and Flavell, 2007). HDAC11 is predominantly expressed in
the brain (Gao et al., 2002) in the nuclei of mature neurons and oligodendrocytes (Liu et al.,
2008a). Changes in oligodendroglial histone deacetylation patterns in chronic MS lesions
relative to early MS lesions have been observed, suggesting that histone deacetylation in-
efficiency is associated with disease progression (Pedre et al., 2011).
6.1.4 Results on glutamate analysis
sRRR results: Table 6.6 summarises the top associations for the glutamate analysis resulting
from the sRRR model. All top 20 SNPs reported in the rank 1 of the analysis, with selec-
tion probabilities ≥ 0.40, belong to the candidate glutamate group. In particular, 6 SNPs
belonging in the GRIN2A gene, scored on top of the list, all having selection probabilities
≥0.50. The top ranked GRIN2A SNP was rs3859123, which was selected with probability
0.64. The remaining SNPs in rank 1 included 5 more SNPs in the GRIN2A gene, 7 in the
GRM7 gene, 1 in the GRM1 gene and 1 in the GRIK4 gene. NBV, NGMV and NWMV
were the corresponding highly associated phenotypes, selected with probabilities 0.82, 0.76
and 0.74, respectively.
In the second rank of the sRRR model, no SNP had a selection probability exceeding
0.50. However, the 5 top SNPs belonged to the glutamate candidate group. In particular,
2 SNPs in the GRIA4 gene and two GRIN2B SNPs scored top of the list. One more SNP
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from the GRIK4 gene was also among the highly scoring SNPs. Again, NBV, NGMV
and NWMV were the most associated phenotypes. Figure 6.1.4 illustrates the selection
probabilities for the SNPs and the phenotypes for the rank 1 and 2 sRRR analysis.
SNP Gene Chr MAF HWE Πˆxk
Rank 1
rs3859123 GRIN2A 16 0.32 1.00 0.64
rs9927924 GRIN2A 16 0.36 0.40 0.56
rs6497658 GRIN2A 16 0.42 0.91 0.52
rs13338243 GRIN2A 16 0.44 0.91 0.51
rs1070484 GRIN2A 16 0.31 0.31 0.50
rs3104703 GRIN2A 16 0.50 0.04 0.50
rs10775270 GRIN2A 16 0.33 0.45 0.49
rs17824908 GRM7 3 0.25 0.77 0.47
rs11131063 GRM7 3 0.25 0.77 0.46
rs6497676 GRIN2A 16 0.33 0.45 0.44
rs10872587 GRM1 6 0.33 0.45 0.43
rs2156633 GRIK4 11 0.28 0.59 0.42
rs1353828 GRM7 3 0.25 1.00 0.42
rs9880404 GRM7 3 0.25 0.88 0.42
rs837688 GRIN2A 16 0.39 0.30 0.42
rs12922641 GRIN2A 16 0.35 0.54 0.41
rs7205180 GRIN2A 16 0.49 0.12 0.41
rs1318267 GRM7 3 0.20 0.09 0.41
rs339804 GRM7 3 0.36 0.55 0.40
rs414907 GRM7 3 0.36 0.28 0.40
Rank 2
rs637569 GRIA4 11 0.48 0.06 0.44
rs1939153 GRIA4 11 0.50 0.02 0.44
rs2268122 GRIN2B 12 0.12 0.20 0.43
rs11610518 GRIN2B 12 0.11 1.00 0.40
rs4344499 GRIK4 11 0.23 0.64 0.40
rs2793823 ADAM30 1 0.14 0.09 0.40
rs835573 NOTCH2 1 0.14 0.09 0.40
















Table 6.6: The top SNPs (with selection probabilities ≥ 0.4) and the phenotypes from the
sRRR rank 1 and 2 glutamate analysis, ranked according to their selection probabilities.
For each marker also provided are: the corresponding gene annotation where applicable,
the chromosome, the MAF, the HWE p-value and the selection probability. SNPs and the
corresponding genes belonging in the candidate glutamate group are denoted in italics.
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Figure 6.3: Selection probabilities for the SNPs (top row) and phenotypes (bottom row) for
the rank 1 (left plot) and rank 2 (right plot) analysis of the sRRR model. For the SNP prob-
abilities, SNPs belonging in the candidate group are illustrated in red and a horizontal line
on the 0.5 probability threshold is illustrated in dark blue. For the phenotype probabilities,
each phenotype is denoted by a different colour according to the legend in the right plot.
Lasso and MULM results: The top SNPs from the Lasso and MULM analysis of the
NBV, NGMV, NWMV and ΔT2LL that scored highly in the sRRR analysis are given in
Tables 6.7 and 6.8. The corresponding analyses for the other three phenotypes were also
performed, but are not presented here. Note that the SNPs reported for the MULM analysis
correspond to the ones having the minimum uncorrected p−values for each phenotype.
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The top sRRR rank 1 SNP, rs3859123, which belongs in GRIN2A, also appeared among
the top results of the NBV Lasso regression analysis, selected with probability 0.51. The
same SNP was also among the top MULM results in association with NBV (p−value
0.0003) and NWMV (p−value 0.001). Several other GRIN2A SNPs showed an associ-
ation with NBV and NWMV by the Lasso and the MULM analyses, most of which were
in agreement with the corresponding GRIN2A SNPs selected in the first rank of the sRRR
model. Several GRM7 SNPs (but different from the ones selected by the sRRRmodel) were
also among the top NBV Lasso results and among the NGMVMULM results. The GRIK4
rs2156633 SNP that was among the top rank 1 sRRR results was also among the top NBV
Lasso results, selected with a probability 0.38. The rs7483764 SNP belonging in GRM5
gene, showed significant association withΔT2LL using MULM, after per-phenotype Bon-
ferroni multiple testing correction. The corresponding uncorrected p−value was 0.00002.
The same SNP was also selected by the Lasso model with a selection probability of 0.51
and was selected in the first rank of the sRRR model with a selection probability of 0.36.
Summary of results: Our studies identified consistent associations with SNPs belong-
ing in the GRIN2A gene that codes for the NMDA receptor (NMDAR) subunit 2A. NM-
DARs are expressed on neurons, astrocytes, oligodendrocyte processes and on the compact
myelin that ensheaths axons in the cerebral white matter. When excessively stimulated or
activated, NMDARs increase intracellular Ca2+ and as such are a major contributor to neu-
ronal and oligodentrocyte death (Trapp and Stys, 2009; Salter and Fern, 2005; Micu et al.,
2006). GRIN2A SNPs have also been implicated in modifying the age of onset of Hunt-
ingtons disease (Arning et al., 2007), increasing the risk of susceptibility to schizophrenia
(Iwayama-Shigeno et al., 2005; Tang et al., 2006) and have also been found to modify
hippocampal and amygdala volumes in healthy individuals (Inoue et al., 2010).
Weaker evidence for an association between the GRM5 gene, coding for the metabotropic
glutamate receptor 5 (mGluR5), andΔT2LL has also emerged from the Lasso and MULM
analyses. Additional evidence of association of the GRM7 gene, coding for the metabotropic
glutamate receptor 7 (mGluR7) has also emerged from the different models. In vivo,
mGluR 5 modulation in inflammatory brain lesions has been previously reported in sev-
eral neurological diseases, including MS (Aronica et al., 2000, 2001; Geurts et al., 2003,
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Phenotype SNP Gene Chr MAF HWE Πˆk
NBV rs301434 SLC1A1 9 0.44 0.65 0.58
rs3859123 GRIN2A 16 0.32 1.00 0.51
rs3792452 GRM7 3 0.19 0.85 0.39
rs2156633 GRIK4 11 0.28 0.59 0.38
rs12922641 GRIN2A 16 0.35 0.54 0.38
rs2237734 GRM8 7 0.21 0.73 0.37
NGMV rs301434 SLC1A1 9 0.44 0.65 0.50
rs3737989 SLC1A7 1 0.19 0.58 0.44
rs1358621 2 0.37 0.91 0.44
rs2237734 GRM8 7 0.21 0.73 0.42
rs6476878 SLC1A1 9 0.34 1.00 0.41
rs4857458 3 0.49 0.18 0.41
NWMV rs12922641 GRIN2A 16 0.35 0.54 0.48
rs2251036 GRIK1 21 0.32 0.52 0.43
rs1568447 17 0.38 0.56 0.42
rs325723 3 0.23 0.36 0.42
rs10415904 19 0.13 0.47 0.40
rs2299456 GRM8 7 0.18 0.70 0.40
ΔT2LL rs13123618 SEC24B 4 0.18 0.57 0.62
rs10087036 8 0.39 0.73 0.58
rs3734464 PARK2 6 0.11 0.56 0.55
rs1438507 TCERG1L 10 0.39 0.91 0.52
rs7483764 GRM5 11 0.11 0.15 0.51
rs12197749 GRM1 6 0.19 0.47 0.50
Table 6.7: The top 6 SNPs from the Lasso analysis of NBV, NGMV, NWMV and ΔT2LL
that scored highly on the corresponding sRRR analysis. In each analysis the SNPs are
ranked according to their selection probabilities and for each marker also provided are:
the corresponding gene annotation where applicable, the chromosome, the MAF, the HWE
p-value and the selection probability. SNPs and the corresponding genes belonging in the
candidate glutamate group are denoted in italics.
2005). A recent report showed an effect of mGluR5 expression on brain inflammatory re-
sponses after glutamate induced excitoxicity (Drouin-Ouellet et al., 2011). Less evidence
exists about the function of mGluR7, and thus its association with MS is not clear. How-
ever, animal studies have shown an abundant expression of mGluR 7 in the hippocampus
and amygdala (Kinoshita et al., 1998).
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Phenotype SNP Gene Chr MAF HWE p−value
NBV rs3859123 GRIN2A 16 0.32 1.00 0.0003
rs3104703 GRIN2A 16 0.50 0.04 0.001
rs2237734 GRM8 7 0.21 0.73 0.003
rs9927924 GRIN2A 16 0.36 0.40 0.003
rs6497658 GRIN2A 16 0.42 0.91 0.004
rs2300238 GRIN2B 12 0.41 0.36 0.005
NGMV rs13066750 GRM7 3 0.43 0.21 0.004
rs6476878 SLC1A1 9 0.34 1.00 0.004
rs12487494 GRM7 3 0.45 0.31 0.005
rs779738 GRM7 3 0.44 0.12 0.005
rs17047503 GRM7 3 0.16 1.00 0.005
rs978826 GRM7 3 0.45 0.43 0.006
NWMV rs9927924 GRIN2A 16 0.36 0.40 0.0004
rs3859123 GRIN2A 16 0.32 1.00 0.001
rs11866570 GRIN2A 16 0.11 0.77 0.001
rs10415904 19 0.13 0.47 0.002
rs379182 GRIK1 21 0.13 0.80 0.002
rs6497676 GRIN2A 16 0.33 0.45 0.002
ΔT2LL rs7483764 GRM5 11 0.11 0.15 0.00002
rs982010 GRM5 11 0.11 0.10 0.00003
rs905646 GRM5 11 0.11 0.10 0.00004
rs11020772 GRM5 11 0.11 0.15 0.00006
rs3734464 PARK2 6 0.11 0.56 0.0004
rs13123618 SEC24B 4 0.18 0.57 0.0006
Table 6.8: The top 6 SNPs from the MULM analysis of NBV, NGMV, NWMV andΔT2LL
that scored highly on the corresponding sRRR analysis. In each analysis the SNPs are
ranked according to their p-values and for each marker also provided are: the corresponding
gene annotation where applicable, the chromosome, the MAF and the HWE p-value. SNPs
and the genes belonging in the candidate glutamate group are denoted in italics.
6.1.5 Discussion
Using a sample of MS patients we have performed two CP-CGA studies. In the first study,
we examined for associations between a set of genes with epigenetic regulatory functions
and a set of disease related neuroimaging phenotypes. The same phenotypes were used
in search for associations with genes involved in brain glutamate metabolism. For each
study, in addition to the sRRR model, we also performed a per-phenotype Lasso regression
analysis and a pairwise MULM analysis, which allowed us to explore the results across the
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different models and detect the SNPs with the strongest effects on the imaging phenotypes.
In our studies, we have assessed the effect of the HLADRB1*1501 SNPwhich has been
previously implicated in disease susceptibility. However, we have not identified association
of this marker based on any of the methods used. Multiple studies have addressed the
question to which extent the HLA DRB1*1501 SNP is related to the expression of MS-
related phenotypes, with contradictory results. For example, Okuda et al. (2009) reported
an association of this SNP with T2LL in a sample of MS patients. Other studies reported
modest or no associations of this SNP with other MS-related phenotypes (Sombekke et al.,
2009; Baranzini et al., 2009; Zivadinov et al., 2003; Horakova et al., 2011).
Based on our studies, we also report on several possible genetic associations with MS,
emphasising on the SIRT4 and GRIN2A genes. Due to the absence of a control group
in our studies, the findings are expected to be mostly associated with disease progression,
rather than development, by comparing the two groups of MS patients with different level
of disease severity (RRMS and SPMS). The findings could also possibly be explaining
disease heterogeneity, which is generally observed between MS patients.
6.2 Williams Syndrome study
6.2.1 Introduction
Williams-Beuren syndrome or simply Williams syndrome (WS) is a rare genetic disorder
caused by the deletion of the 7q11.23 region of chromosome 7, containing approximately
28 genes. The disease is associated with numerous symptoms including neurodevelopmen-
tal abnormalities that lead to cognitive disabilities, and distinctive behavioural character-
istics (Pober, 2010). The cognitive phenotype of WS patients is characterised by severe
visuospatial disabilities, but with verbal and short-term memory and language skills being
relatively strong (Meyer-Lindenberg et al., 2006). Highly sociable personalities is another
striking characteristic of the disorder. However, despite their uncommonly low social anxi-
ety, sufferers show increased non-social anxiety and fears (Meyer-Lindenberg et al., 2006).
These particular disease characteristics have been linked to abnormalities in the brain.
Particular structures with notable structural differences include the intraparietal sulcus (IPS)
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and the orbitofrontal cortex (OFC) showing reduced grey matter in WS patients compared
to healthy controls (Meyer-Lindenberg et al., 2004; Reiss et al., 2004; Kippenhan et al.,
2005; Boddaert et al., 2006). Correcting for the overall brain volume, a relative increase in
amygdala grey matter density and volume has also been observed in WS patients relative
to controls (Reiss et al., 2004; Capita˜o et al., 2011).
Dysfunctions in these brain regions, linked to the visuospatial and hypersociable char-
acteristics of the disease, have also been reported by several fMRI studies. In particular,
hypoactivation in WS patients relative to controls was observed in the dorsal stream which
forms part of the visual cortex of the brain and is responsible for spatial processing (Meyer-
Lindenberg et al., 2004). This activation was assessed by two fMRI experiments. In the first
experiment, participants were involved with either matching 2 shapes which had a complex
special arrangement, or determining whether these could be assembled into a square, both
of these tests requiring visuospatial skills. The second experiment examined activation
during visual attention to location or content of images representing either faces or houses.
Both experiments found consistent dorsal stream dysfunction in WS patients, localised ad-
jacent to the IPS. Structural alterations in this region were also found based on the same
set of individuals. Using functional network analysis, the authors demonstrated that while
in controls IPS was found to be significantly connected to the dorsal stream region, in
cases the corresponding path was not significant. This suggested that the dysfunction in the
dorsal stream was caused by possible abnormalities of the IPS region.
The unique overfriendly personality of WS patients that is combined with excessive
anxieties and phobias related to non-social elements, has been linked to dysfunctions in
amygdala, which has a central role in fear and pleasure response (Meyer-Lindenberg et al.,
2005). A lower activation in amygdala in WS patients relative to controls was observed
while matching images illustrating angry and fearful faces, whereas a higher activation
in the amygdala of WS patients relative to controls was observed while matching images
with fearful scenes. In the same experiment, abnormal activations were also observed in
prefrontal cortex regions, including the OFC, which had been linked to disease-related
structural abnormalities. OFC is known to be crucial for amygdala regulation and is also
involved in the response to fear and reward. While OFC and amygdala were significantly
connected in controls, no interaction was observed between these two regions in WS pa-
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tients. Abnormal function in these key regions, IPS, amygdala and OFC, has been reported
by several other fMRI studies (see for example Sarpal et al., 2008; Haas et al., 2009; Mun˜oz
et al., 2010; Mimura et al., 2010; Haas et al., 2010).
Being a consequence of a chromosomal deletion, WS has a known genetic origin. How-
ever, WS is a multi-system disease and research to identify the exact genetic etiology of
each of its features is still ongoing. The ELN gene is an exception as it has been exten-
sively linked to cardiovascular abnormalities, which is another symptom present in WS
patients (Schubert, 2009). The common WS deletion involves approximately 28 genes,
however, smaller or partial deletions can also occur in some individuals. Patients with
such atypical deletions have one or more genes that are not deleted compared to the typi-
cal WS patient, and consequently their disease phenotype commonly varies in some of its
features. Examining these variations, specific to patients with atypical deletions, and also
using mouse knockout models, has led to the implication of several susceptibility genes.
The cognitive and behavioural characteristics of the WS patients have been associated with
the LIMK1, CLIP2 (also known as CYLN2), GTF2I and GTF2IRD1 genes (reviewed by
Meyer-Lindenberg et al., 2006; Pober, 2010; Schubert, 2009).
Findings from such studies can have a great impact, not only in understanding the
mechanism of the disease, but also in uncovering the genetic components contributing in
cognitive or behavioural variation observed in the general population (Pober, 2010). In that
sense, WS offers a unique opportunity to examine imaging genetics associations, by exam-
ining how variability in the genes highlighted in the WS region generally affects the func-
tion of the brain. In our study, we used a sample of 113 healthy individuals and attempted
to search for genetic associations from the WS-related region with voxel-wise phenotypes
extracted from fMRI scans acquired during a matching task of face and shape stimuli. The
phenotypes used in this study were localised in the three key regions, IPS, amygdala and
OFC, known to be highly involved in WS phenotype. The study was performed using the
sRRR model, combined with stability selection, with B = 1000 extracted sub-samples.
We used sparse group Lasso for phenotype selection, where voxels were grouped into the
three regions, and variable selection was performed both at the region level as well as at
the voxel level. A Lasso penalty was adopted for SNP selection.
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6.2.2 Methods
Subject collection: 113 randomly selected healthy German volunteers (64 females, 49
males; mean age 32.92, standard deviation 10.07) were recruited at Mannheim and Bonn.
Genotyping: Genotyping was performed using Illumina 650 Quad chip. A set of 191
SNPs located in the segment of chromosome 7, involved in theWS deletion, were extracted.
Quality control procedures involved removing SNPs with MAF < 0.1 and HWE p−value
< 0.01. SNPs with missing values for at least one of the 113 individuals and those with
no gene annotation were also removed. A final set of 89 SNPs, corresponding to 19 genes
from the WS-related region were used for the imaging genetics study. Figure 6.4 shows



































































































Figure 6.4: Schematic illustration of the ordering of genes in our study. The number of
SNPs available for each gene are given in the bracket.
Imaging paradigm: For this fMRI study we used the face matching task described in
Hariri et al. (2002). During this task, three images, two of which were identical, were
simultaneously presented to the participants who had to match the two identical images via
button press. Blocks of images displaying angry or fearful faces were used as the stimulus
task to examine brain activation to facial expressions. As a control task, these images were
alternated with blocks of non-social images displaying simple geometric shapes.
Imaging acquisition and processing: Blood oxygen level dependence (BOLD) fMRI
was performed on two Siemens Trio 3T scanners at the Central Institute of Mental Health
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Mannheim and the University of Bonn. At both sites, identical sequences and scanner pro-
tocols were used (parameters: 28.4mm slices, 1mm gap, FOV 192mm, TR 2sec, TE 30ms,
flip angle 90◦). Quality assurance (QA) measures were conducted on every measurement
day at both sites according to a multicentre QA protocol revealing stable signals over time.
Image processing was conducted using SPM5: images were realigned to the first image
of the scan run, spatially normalised into the MNI space with voxels of 3 × 3 × 3 mm,
smoothed with a 9mm full width half maximum Gaussian filter, and ratio normalised to
the whole-brain global mean. For each subject, statistical contrast images of face stimuli
versus shape stimuli were extracted using a linear model. Complete information for subject
collection and imaging acquisition can be found in (Esslinger et al., 2009).
Phenotype extraction: For our experiment, masks of the OFC, the amygdala and the
IPS were considered, since as discussed earlier, these correspond to brain regions that are
highly affected in WS. The amygdala and OFC masks were create based on the AAL at-
las, where OFC consisted of the following AAL anatomical labels: frontal superior orbital,
frontal middle orbital, frontal inferior orbital and gyrus rectus. A 20mm sphere around the
Talairach coordinates [-29,-79,32] and [32,-75,29] was used to mask the left and right IPS,
respectively, which were then combined to form the IPS mask. A total of 1439 voxels,
representing BOLD contrast from the two stimuli, were extracted from all 3 masks. The ef-
fects of age and sex were subsequently regressed out from the voxel-wise phenotypes. The
voxel distribution in these three regions is given in Table 6.9 and the pairwise correlations
of the 1439 voxels are shown in Figure 6.5
IPS AMG OFC Total
# voxels 342 145 952 1439
Table 6.9: The three ROIs, IPS, amygdala (AMG) and OFC and the number of voxels
belonging to each region.
6.2.3 Results
Table 6.10 shows the top 10 SNPs in each of the rank 1 and rank 2 analyses of the sRRR
model. Plots illustrating the selection probabilities from these analyses, for all the 98 SNPs
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Figure 6.5: Pairwise correlations of the 1439 voxels from the 3 ROIs: IPS, amygdala
(AMG) and OFC. Relatively high correlations are observed between subsets of voxels from
AMG and OFC, whereas IPS appears to be mostly uncorrelated with the other two regions.
and all the 1439 voxels, are given in Figures 6.6 and 6.7, respectively.
In rank 1, all 10 SNPs shown in the corresponding table had a selection probability
greater than 0.5. The majority of the SNPs in this table belong to the HIP1 gene, coding for
the huntingtin interacting protein 1 (maximum reported probability for this gene is 0.74).
As illustrated in Figure 6.4, it lies on the boundary of the chromosomal region examined
in this study. Notably, HIP1 is also the gene with the larger number of available SNPs
within our dataset and thus the findings can be debatable. However, reduced expression
levels from the HIP1 gene have been reported in a gene expression study of a sample of
WS patients with a common deletion size and controls, suggesting its contribution in the
phenotype of WS (Merla et al., 2006). Moreover, deletions of the HIP1 gene have been
associated with neurological diseases related to epilepsy and neurodevelopment (Ramocki
et al., 2010). There is also evidence of its involvement in Huntington’s disease which is a
neurodegenerative disease (Kalchman et al., 1997).
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SNPs from the GTF2I and GTF2IRD1 genes coding for the general transcription factor
II I, also score among the top results of the rank 1 analysis, with selection probabilities of
0.53 and 0.51 respectively. Both genes have been previously associated to cognitive and
behavioural abnormalities observed in WS patients by examining individuals with atypical
deletions and knockout mouse models (see for example Dai et al., 2009; Antonell et al.,
2010; Sakurai et al., 2011). A SNP from the ELN gene, coding for the elastin protein,
also appears in the list of highly selected SNPs. As noted earlier, the ELN gene has a key
role in the cardiovascular abnormalities observed in WS patients. However, it has not been
associated with any brain related, cognitive and behavioural WS abnormalities. Phenotype
selection suggested the IPS and OFC regions being the mostly associated with the genetic
findings. In particular, 218 voxels from the IPS region and 431 voxels from the OFC region
had selection probabilities ≥ 0.5.
In the second rank of the sRRR model, one SNP from the POM121C gene, coding for
membrane glycoprotein C, scored top with a selection probability of 0.5. This gene has not
been previously associated with the cognitive and behavioural features of WS. From Figure
6.4 it can be noted that it lies on the boundary of the chromosomal region examined, next to
the HIP1 gene. No other SNP had a selection probability greater than 0.5, however, among
the top SNPs from the rank 2 analysis were SNPs from the HIP1 gene and from the key
hypothesised GTF2IRD1 gene. Another hypothesised gene, LIMK1, coding for the LIM
domain kinase 1, which has been previously associated to the cognitive phenotype of WS
(see for example Frangiskakis et al., 1996; Hoogenraad et al., 2004), also appears in the top
results of the second rank of the sRRR model. In this rank, 33 voxels from the IPS region,
24 from the OFC region as well as 2 from amygdala had selection probabilities ≥ 0.5.
6.2.4 Discussion
Genetic disorders, like WS, for which genetic origin is known, or similarly other diseases
for which strong evidence for the underlying genetic components exists, provide the means
for examining related variations observed in the general population. For example, the same
sample of healthy individuals used in this study (with two additional male participants) was
previously used in a study, where variation in brain function has been associated to a key
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SNP Gene MAF HWE Πˆxk
Rank 1
rs757359 HIP1 0.33 0.28 0.74
rs4728351 HIP1 0.34 0.84 0.70
rs2240133 HIP1 0.35 0.54 0.57
rs2240132 HIP1 0.46 0.85 0.57
rs10247961 HIP1 0.15 0.46 0.56
rs13238568 GTF2I 0.40 0.12 0.53
rs4588797 HIP1 0.28 0.82 0.53
rs2856728 ELN 0.14 0.69 0.53
rs2014588 HIP1 0.50 0.71 0.53
rs13244581 GTF2IRD1 0.18 0.52 0.51
Rank 2
rs17207196 POM121C 0.45 1.00 0.50
rs1167796 HIP1 0.50 0.71 0.49
rs1167827 HIP1 0.46 0.85 0.48
rs1167795 HIP1 0.39 0.24 0.46
rs6964720 HIP1 0.15 0.71 0.45
rs6962352 HIP1 0.38 0.55 0.45
rs794356 HIP1 0.47 0.35 0.45
rs7790360 GTF2IRD1 0.10 1.00 0.40
rs150862 LIMK1 0.24 0.46 0.37
rs37624 GTF2IRD1 0.30 0.82 0.36
Table 6.10: The top ten SNPs ranked according to their selection probabilities for rank 1
and 2 of the sRRR analysis. For each marker also provided are: the corresponding gene
annotation, the MAF, the HWE p-value and the selection probability.
genetic marker, implicated in both schizophrenia and bipolar disorders (Esslinger et al.,
2009). In fact, the authors reported abnormal functional connectivity in key brain regions
in those (healthy) individuals carrying the risk allele.
Similarly, in this study, we have reported a number of possible associations with BOLD
activation patterns from healthy individuals in IPS, OFC and amygdala during a matching
task of facial expression stimuli. Among the reported genes were also GTF2I, GTF2IRD1
and LIMK1 which have been previously hypothesised to be associated with cognitive and
behavioural abnormalities observed in WS patients. Variation in the cognition and be-
haviour between healthy individuals, although present, is probably present to a smaller ex-
tent, when compared to case/control variation. In that sense, the collection of larger sample
sizes is probably required to best capture such discrepancies in the general population.
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Figure 6.6: Selection probabilities for all 98 SNPs for the rank 1 (left) and rank 2 (right)
analysis of the sRRR model. SNPs belonging in the key hypothesised genes LIMK1,
CLIP2, GTF2I and GTF2IRD1 are illustrated in red. A horizontal line on the 0.5 prob-
ability threshold is illustrated in dark blue.
Figure 6.7: Selection probabilities for all 1439 voxels for the rank 1 (left) and rank 2
(right) analysis of the sRRR model. Voxels belonging in OFC, IPS and amygdala regions
are illustrated in blue, red and green colours respectively. A horizontal line on the 0.5
probability threshold is illustrated in grey.
144
Chapter 7
A voxel-wise genome-wide study
7.1 Introduction
Alzheimer’s Disease (AD) is a neurodegenerative disorder characterised by the progressive
loss of neural cells, believed to be caused by the excessive aggregation of protein β amy-
loid and protein tau outside and inside the neurons, respectively (Braak and Braak, 1991).
A progressively advancing atrophy pattern in a number of brain regions has been repeat-
edly found in the structural MRI scans of people who suffer from AD (Thompson et al.,
2003; Atiya et al., 2003), and abnormalities are detectable on MRI years before the disease
diagnosis (DeKosky and Marek, 2003). The identification of both imaging and genetic
biomarkers is expected to play a crucial role for the early diagnosis of AD (Frisoni et al.,
2010; Jack et al., 2011).
As AD evolves over time, an accurate assessment of the longitudinal changes happen-
ing in the brain, and quantified using structural MRI, can play an important role in the
prediction of disease development and progression. Increasing attention has been paid in
examining patterns of longitudinal changes in individuals suffering with mild cognitive
impairment (MCI), who have some cognitive disabilities (commonly related to memory
loss and termed amnestic MCI), but not to the extent of being diagnosed with dementia
(Petersen, 2004). Such individuals are at higher risk of developing AD, or other types of
dementia in the near future. They are usually divided into two sub-groups, namely progres-
sive MCI (P-MCI), corresponding to the MCI subjects who converted to AD within a given
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time window, otherwise also known as converters, and stable MCI (S-MCI), that is those
who have not converted to AD, who are also called non-converters.
Several studies have been reported, where using experimental data generated by the
ADNI database1, efforts have been made towards the identification of localised brain re-
gions that show clear longitudinal differences between AD or P-MCI patients and cogni-
tive normal (CN) individuals, and between P-MCI and S-MCI individuals. Amongst these
works, Misra et al. (2009) examined the differences between P-MCI and S-MCI from both
baseline scans as well as longitudinal profiles, constructed as the rate of change between
baseline and follow up scans. They reported significant GM and WM atrophy in a num-
ber of brain regions, detectable from baseline scans. The longitudinal analysis also revealed
significant differences in periventricular WM and the temporal horn’s CSF volume. Similar
results were reported in another study comparing tensor based morphometry (TBM) lon-
gitudinal images in both AD and MCI patients versus CN individuals (Leow et al., 2009).
This indicated widespread brain atrophy for the AD patients as well as expansion in the
CSF. Less profound atrophy patterns were found in the MCI group, mainly localised to the
temporal and parietal lobes. A statistical classifier, using features extracted from longitudi-
nal changes for the early prediction of conversion to MCI, was tested by Davatzikos et al.
(2009) using a sample consisting of AD patients and CN individuals. The predictive ability
of the classifier was then assessed on an independent dataset consisting of CN and MCI
individuals, and showed promise for early prediction of conversion to MCI. The findings
above clearly indicate that imaging-based signatures of the disease can be used to make a
more accurate and earlier prediction of disease development and progression, which may
in future impact AD treatment.
Additional insight into the disease mechanism can be gained by exploring its genetic
foundations. The rarest type of AD, early onset AD, which appears in an earlier age (typi-
cally before 65), follows Mendelian inheritance. This form of AD is caused by completely
penetrant effects of three genes - APP, PSEN1 and PSEN2 (Goate et al., 1991; Sherrington
et al., 1995; Levy-Lahad et al., 1995). However, the more common type - late onset AD
- is multi-factorial and ongoing research seeks to elucidate the genetic components that
1http://www.loni.ucla.edu/ADNI
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contribute to an increased risk. Despite many studies suggesting potential susceptibility
loci, only a handful of markers have been replicated so far. The APOE-4 variant of the
APOE gene, responsible for the production of apolipoprotein E, is considered an excep-
tion as it has been replicated in many studies, including those of Corder et al. (1993), Zuo
et al. (2006), Barabash et al. (2009) and Filippini et al. (2009). However, the presence
of the APOE-4 allele is expected to contribute only marginally to disease susceptibility.
Other genetic variants, as well as their epistatic effects and their interactions with the en-
vironment, may also act as important contributing factors. Follow-up studies using large
samples and meta-analyses have implicated other genes such as CR1, CLU and PICALM
(Jun et al., 2010). Recent accounts of the genetic findings related to AD may be found in
the reviews by Bertram et al. (2010) and Braskie et al. (2011). In the latter, a comprehensive
list of gene-brain region associations is also provided. Up-to-date lists of potentially impli-
cated genes, sorted by importance, are also collected at the Alzgene web-page2 (Bertram
et al., 2007).
A recent BW-GWA study is presented by Shen et al. (2010) who searched for genome-
wide brain-wide associations in a sample of 733 individuals from the ADNI database. The
GWA involved 530, 992 markers and 142 phenotypes extracted from MRI baseline scans,
including ROI GM averages as well as volume and thickness measures. Using a MULM
approach, the authors reported their most significant findings to be the SNPs located in
the APOE gene and the nearby gene TOMM40, as well as in the genes EPHA4, TP63 and
NXPH1. Using a sample from the same cohort, and using 448, 293 SNPs, Stein et al. (2010)
performed another BW-GWA MULM study consisting of a voxel-wise search for genetic
variants that influence brain structure. No association survived the corrected significance
threshold, but the SNPs rs2132683 and rs713155, located in chromosome 6, as well as
SNPs in genes CSMD2 and CADPS2 scored high in the final ranking. In a follow-up work,
Hibar et al. (2011) performed another BW-GWA study where only SNPs with known gene
annotations were considered. In this approach, SNPs were first grouped into genes and the
principal components explaining most of the variability within each gene were extracted.
A multivariate test was then conducted for each gene-voxel pair assessing the effect of the
2http://www.alzgene.org
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entire gene on each voxel. Again, no association survived the multiple testing correction.
However the gene GAB2, which has been previously reported as an AD susceptibility
gene, ranked top among their results. Other highly ranked associations reported in this
study include the genes LRDD, PTPRB, ZNF462 and IGSF5.
In this work, we present an application of sRRR to identify potential genetic associa-
tions with imaging-based multivariate signatures of the disease. Our samples consist of 101
AD patients, 107 P-MCIs, 114 S-MCIs and 153 CNs, extracted from the ADNI database.
To distinguish the signals of association and identify genetic variation specific to the devel-
opment of AD and to the progression from MCI to AD, we perform three separate imaging
genetic studies: an analysis that compares AD patients to CN individuals, one that com-
pares P-MCI patients with CN individuals, and a comparison between P-MCI and S-MCI
individuals. In each case, our multivariate phenotype consists of voxel-wise Jacobian de-
terminants representing the longitudinal changes observed over a 24 month period, from
baseline scans to follow-ups. As suggested in the earlier discussion, imaging biomarkers
extracted from longitudinal images can provide a detailed and accurate description of the
signature of the disease. Moreover, motivated from the earlier SNR results in Section 4.2
in Chapter 4, where we discussed that a voxel-wide brain-wide approach may suffer from
the high noise level present in the data, we first perform a de-noising step where voxels
that are not believed to contain any signal are removed from the analysis. We do this by
identifying subsets of voxels that best discriminate between any two groups of individuals,
using penalised linear discriminant analysis (LDA). Using a statistical classifier trained on
these subsets of voxels, we are able to obtain state-of-the-art cross-validated classification
results, and therefore define robust imaging signatures of disease status in AD, P-MCI and
S-MCI populations. These biomarkers are then used to detect genetic association within
the sRRR framework, where a Lasso penalty is adopted for SNP selection.
7.2 Methods
7.2.1 Sample collection
Imaging data: Images were obtained from the ADNI database. Image acquisition was car-
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ried out at multiple sites based on a standardised MRI protocol (Jack Jr. et al., 2008) using
1.5T scanners manufactured by General Electric Healthcare (GE), Siemens Medical Solu-
tions, and Philips Medical Systems. Out of two available 1.5T T1-weighted MR images
based on a 3D MPRAGE sequence, we used the image that has been designated as best
by the ADNI quality assurance team (Jack Jr. et al., 2008). Acquisition parameters on the
SIEMENS scanner (parameters for other manufacturers differ slightly) are TE of 3.9 ms,
TR of 8.9 ms, TI of 1000 ms and flip angle 8◦, to obtain 166 slices of 1.2-mm thickness
with a 256 x 256 matrix. All images were preprocessed by the ADNI consortium using
the following pipeline: (1) GradWarp: A system-specific correction of image geometry
distortion due to gradient non-linearity (Jovicich et al., 2006); (2) B1 non-uniformity cor-
rection: Correction for image intensity non-uniformity (Jack Jr. et al., 2008); and (3) N3:
A histogram peak sharpening algorithm for bias field correction (Sled et al., 1998). Since
the Philips systems used in the study were equipped with B1 correction, and their gradient
systems tend to be linear (Jack Jr. et al., 2008), the preprocessing steps (1) and (2) were
applied by ADNI only to images acquired with GE and Siemens scanners.
In this work, we used the 510 subjects for whom both baseline and 24 month follow-up
images were available as of October 2010. All follow-up scans were aligned with their
baseline scans using a non-rigid registration algorithm regularised by a B-spline control
point spacing with normalised mutual information (NMI) as a similarity measure (Rueck-
ert et al., 1999). Registration was carried out in a coarse-to-fine fashion with control point
spacings at 20 mm, 10 mm, 5 mm and 2.5 mm. The Jacobian determinants extracted from
the resulting deformation fields represent the expansion / contraction on a voxel basis and
therefore intra-subject development (Boyes et al., 2006). After extracting Jacobian maps
for all subjects, the images were transformed to the MNI-152 brain template (Mazziotta
et al., 1995) using a non-rigid registration (10 mm B-spline control-point spacing) that was
estimated for the baseline scans. We used 1,650,857 voxel intensities (Jacobian determi-
nants) representing longitudinal changes to perform the following analyses, after correcting
them for age at both baseline and follow up, as well as sex, using a linear regression model.
Genotype data: Genotype data were also obtained from the ADNI database for the 510
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subjects for which baseline and 24 month follow up images were available. The subjects
were genotyped using the Human610-Quad BeadChip (Illumina, Inc., San Diego, CA)
which resulted in a set of 620, 901 SNP and CNV markers. The APOE SNPs, rs429358
and rs7412, are not on the Human610-Quad BeadChip, and therefore were genotyped sep-
arately. These two SNPs together define a 3 allele haplotype, namely the 2, 3 and 4
variants, and the presence of each of these variants for each of the individuals was avail-
able in the ADNI database. More details about this genotyping procedure may be found
in Saykin et al. (2010). From the set of 510 individuals, 35 individuals were removed to
reduce population stratification effects, following the procedure of Stein et al. (2010). We
also performed quality control on this initial set of genotypes, discarding the SNPs with a
HWE p-value < 5.7 × 10−7 and MAF < 0.1 and also removed SNPs having one or more
missing values. In the final quality controlled genotype data we also included the APOE-4
variant, coded as the number of observed 4 variants.
Group comparisons: We conducted three separate experiments; in each one we only
used two groups of individuals among the groups AD, P-MCI, S-MCI and CN, to distin-
guish the signals of association and identify genetic variation specific to the development
of AD, or to the progression fromMCI to AD. Specifically, we performed an analysis com-
paring AD patients with CN, an analysis comparing P-MCI with CN and a final analysis
comparing P-MCI to S-MCI. In each experiment, the individuals belong to one of two pos-
sible classes, which we denote here by D (diseased) and H (healthy), with sample sizes of
nD and nH , respectively, such that the total sample n = nD+nH . In our AD versus CN ex-
periment, D corresponds to subjects with AD, whereas H represents individuals from the
CN group. For the P-MCI versus CN comparison, the P-MCI individuals belong to class
D and the CN individuals to class H . Finally, in the P-MCI versus S-MCI comparison, the
P-MCI status is indicated by D and the S-MCI status by H . The class label attached to
each subject is represented by a binary variable z, such that zi = 1 if individual i is in class
D and zi = 0 otherwise. We collect the observed class variables on all individuals in an n
dimensional vector z.
Each study consists of p SNPs x1, . . . , xp (all those surviving quality control), and q =
1, 650, 857 voxels, y1, . . . , yq, all observed on a random sample of n unrelated individuals.
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The specific values for p and n in each experiment are given in Table 7.1, whereas in Table
7.2 we report for each group the sample size, sex distribution, average age and average score
on the mini-mental state examination (MMSE) (Folstein et al., 1975). In the same table we
also report the corresponding temporal changes recorded after the follow-up period.
Experiment n nH nD p
AD vs CN 254 101 153 322875
P-MCI vs CN 260 107 153 309730
P-MCI vs S-MCI 221 107 114 304209
Table 7.1: Number of individuals included in each experiment (n), corresponding number
of individuals in each class (nH and nD), and the final number of SNPs that survived quality
control in each class (p).
Group nG (male) age-bl mmse-bl age-fu mmse-fu
CN 153 (81) 76.26 (4.77) 29.23 (0.89) 2.10 (0.12) 0.18 (1.25)
S-MCI 114 (77) 74.76 (7.03) 27.62 (1.65) 2.09 (0.08) 0.37 (2.64)
P-MCI 107 (69) 75.05 (6.79) 26.74 (1.73) 2.08 (0.07) 3.60 (3.74)
AD 101 (55) 75.50 (7.22) 23.25 (1.95) 2.10 (0.14) 5.17 (5.72)
Table 7.2: Sample size (nG), number of males (male), mean age at baseline (age-bl),
mean MMSE score at baseline (msse-bl), mean age difference at follow-up (age-fu)
and mean absolute difference in the MMSE score after follow-up (mmse-fu) for each
disease class. The corresponding standard deviations are given in brackets.
In the next Section, we use penalised LDA to identify a reduced set of voxels that best
summarises the signature of the disease. This may be considered as a de-noising step where
we reduce the number of voxels to be used for genetic association, by selecting only the
ones that best discriminate the different classes in the population.
7.2.2 Penalised linear discriminant analysis
Our aim is to extract a multivariate imaging-based signature of the disease starting from all
voxels in the brain. Methods to extract imaging biomarkers may be divided into two cate-
gories: (1) those encoding prior knowledge about the disease and its underlying processes
(i.e. candidate phenotypes) and (2) those that do not require any a priori hypotheses about
which structures are involved in the disease process and are extracted using data-driven
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approaches. For example, it is well known that AD is linked to tissue loss over time espe-
cially in the hippocampus, hence hippocampal volume, shape or atrophy are often used as
a priori biomarkers (Csernansky et al., 2005; Chupin et al., 2009; Wolz et al., 2010a,b). A
comparison of different techniques applied to structural MRI scans from a sample of the
ADNI database has been recently published by Cuingnet et al. (2011).
Here, we present a data-driven biomarker extraction method that does not rely on prior
knowledge. We quantify q brain-wide voxel-wise longitudinal changes over a 24 month
period, by computing Jacobian determinants for all n individuals, and then search for a
sub-set of voxels, S˜, that best discriminates between two classes of individuals. Ideally,
we require that the cardinality of S˜, |S˜| << q, effectively filtering out voxels that are
noisy with respect to the disease, in the sense that no disease related temporal changes
are observed at those voxels. This can also be considered as a preprocessing, de-noising
step prior to the association mapping, to enhance the SNR present in the phenotype data as
discussed in Chapter 4, Section 4.2.
Brain-wide voxel selection is achieved by means of penalised LDA (Fisher et al., 1936;
Witten and Tibshirani, 2011). LDA amounts to finding a linear transformation of the orig-
inal variables t = Yw, where w is the q × 1 direction vector that best discriminates the
different classes in the sample. This is achieved by finding the direction that maximises the
between-class variance, while minimising the within-class variance. In the two-class case,
we denote by ΣB the between-class scatter matrix


















are the 1× q mean vectors of class H , class D and the overall mean, respectively. We also














which is equivalent to
max
w
w′ΣBw subject to w′ΣWw = 1. (7.1)
In the presence of multiple classes, say J , up-to J − 1 direction vectors can be found.
Therefore, for the two class case we only seek to find one direction vector that best sep-
arates the two classes. Under the assumption that ΣW is non-singular, and thus invert-
ible, the optimisation problem defined in Equation (7.1) has the closed form solution
w = Σ−1W (mH − mD)′. It is easy to show that this solution is equivalent (up to a scal-
ing constant) to the ordinary least squares solution of regressing the class indicator vector
z onY, after mean centering both z and the columns ofY (Duda et al., 2001).
To avoid problems related with possible singularities of ΣW , this is commonly esti-
mated by a positive definite matrix. Here, we use a diagonal estimate of ΣW , Σ˜W , where
diag(Σ˜W )=(s21, . . . , s2q) which is frequently used in the literature (Witten and Tibshirani,
2011). We then estimate the direction vector wˆ to be sparse, i.e. having non-zero coeffi-
cients for only the voxels that are considered to be important in the model and thus are most
discriminative, by adopting penalisation techniques in the optimisation problem (7.1), with
ΣW replaced by Σ˜W . By imposing an additional constraint on the l1 norm of the direction









subject to w′Σ˜Ww = 1 (7.2)
where λ is a regularisation parameter that determines the amount of sparsity in the model.
When λ is zero, all variables contribute in the direction vector w. For larger values of λ,
more coefficients ofw are set to zero and thus less variables are retained in the model. The
sj’s are used as weights to the regularisation parameter λ, in order to penalise more the
variables with greater within-class variability.
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Because the optimisation problem in (7.2) involves the maximisation of a non-concave
function, standard convex optimisation methods cannot be used. Instead, a non-concave
function can be maximised using a minorisation-maximisation (MM) algorithm (Hunter
and Lange, 2004). This approach works by first finding a function that minorises the ob-
jective function, i.e. given an objective function f(w), finding g(w|w0) ≤ f(w), where
g(w|w0) depends on w and a given fixed point w0. The MM algorithm then works by
maximising this function in an iterative manner. In this way, it is guaranteed that at each
step of the algorithm the objective function is maximised or kept unchanged relative to the
previous step.
As described by Witten and Tibshirani (2011), for the problem defined in Equation
(7.2), we can find a concave function that minorises our objective function. The maximisa-
tion of the concave function can then be performed using convex optimisation techniques.
The steps of the final algorithm used to obtain the sparse direction vector wˆ are detailed
below.
Algorithm Penalised LDA
Input: s1, . . . , sq,mH ,mD and λ
Output: wˆ
1. Initialise w0 ←Σ˜−1W (mH −mD)′
2. Normalise w0 such that w0′Σ˜Ww0 = 1
3. repeat
4. for j ← 1 to q




6. Normalise wˆ such that wˆ′Σ˜W wˆ = 1
7. w0 ← wˆ
8. until wˆ converges
Once the sparse vector wˆ is estimated, the set S˜ is constructed such that it consists of
all the voxels corresponding to a non-zero element in wˆ. A validation of how accurately
S˜ reflects the imaging-based signature of the disease can be obtained by estimating its
classification accuracy. In practice, the direction vector obtained from LDA (either sparse
or non-sparse) can be directly used for classification purposes. However, in this work, the
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predictive ability of the voxels in S˜ is evaluated using a support vector machine (SVM)
classifier with a Gaussian kernel for non-linear classification (Smola and Scho¨lkopf, 2004),
as similar models have been used in related works.
In penalised LDA, the parameter λ determines the number of voxels to be retained in
the model. Similarly with the sRRRmodel we use stability selection described in Chapter 5
to identify the most important voxels. For a given λ in the range [λmin, λmax], the stabil-
ity selection approach consists of performing repeated random sampling with replacement
from the n subjects, selecting the same proportion of individuals from each class H and
D, and fitting the penalised LDA model on each random sub-sample. Each one of the B
random sub-samples provides a sparse estimate wˆ(b)(λ), with b = 1, . . . , B. For each such
estimate, we keep track of voxels having non-zero coefficients and compute a measure of
voxel importance, by estimating its selection probability Πj(λ) across all B sub-samples.
The final set of voxels to be included in the final set S˜ is obtained by deciding on a threshold
π on maxλ∈(λmin,λmax)Πj(λ).
7.3 Results
7.3.1 Disease signatures from imaging data
We report on the three classification experiments separately: AD vs CN, P-MCI vs CN, and
P-MCI vs S-MCI. For each experiment, the selection of discriminative voxels was carried
out using penalised LDA combined with stability selection with B = 100 sub-samples.
In order to determine a probability threshold for the final selection of voxels to be re-
tained in the signature, we assess the discriminative power of the selected set of voxels for
different probability thresholds. To do this, we apply the SVM classifier with a Gaussian
kernel. With this choice of classifier, there are three parameters to be optimised, which we
collect in a parameter vector θ = {π, σ, C}: π controls the voxels selected in S˜ during the
feature selection stage with penalised LDA, whereas σ and C are the kernel width and the
regularisation parameter of the SVM classifier, respectively. The optimal parameter vector
θ∗ = {π∗, σ∗, C∗}was obtained by 10-fold cross validation of three performance measures:
accuracy, sensitivity and specificity. These cross validated performance measures are all re-
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ported in Table 7.3. The accuracy index, representing the percentage of correctly classified
individuals, is between 82.1% (for the P-MCI vs S-MCI group) and 90.3% (for the AD
vs CN group) and requires less than 13k voxels in all cases. In Figure 7.1 we illustrate the
two-dimensional patterns, extracted using multidimensional scaling, for the selected voxels
from each of the three comparisons. Notably, a non-linear classifier, as the one used here,
seems more suitable for separating the different classes of individuals.
Groups vox acc sen spe
AD vs CN 11394 90.28 87.45 92.13
P-MCI vs CN 12664 86.89 81.21 90.92
P-MCI vs S-MCI 10593 82.11 81.48 82.93
Table 7.3: Number of selected voxels (vox) and 10-fold cross validated performance mea-
sures in % - accuracy (acc), sensitivity (sen) and specificity (spe) - using a SVM classi-
fier with Gaussian kernel.


















Figure 7.1: Two-dimensional representation of all the subjects obtained by multidimen-
sional scaling of the imaging signatures identified by penalised LDA: AD versus CN (left),
P-MCI versus CN (middle) and P-MCI versus S-MCI (right). The blue crosses refer to the
H class, i.e. the CN individuals in the left and middle plots and the S-MCI individuals in
the right plot. The red triangles refer to the D class, i.e. AD patients in the left and the
P-MCI patients in the middle and right plots.
In order to assess the statistical significance of the accuracy of the estimated signatures,
reported in Table 7.3, we carried out non-parametric inference using permutation testing.
By first permuting the individual class labels, z, a 10-fold cross-validation procedure was
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performed. In particular, the SVM classifier, with the optimal parameters {σ∗, C∗}, was
trained on the data containing the selected voxels and the permuted class labels, and the
corresponding cross-validated accuracy measure was produced. The same routine was re-
peated M times. This enabled the estimation of the sampling distribution of the accuracy
index under the null hypothesis of no association between the voxel intensities in S˜ and
the class indicators. An empirical p-value was then easily computed. Using M = 1000
permuted data sets, the accuracy results, shown in Table 7.3, were all found to be highly
significant (with p-values < 0.001).
The classification performance reported is comparable to findings documented in the
literature. For instance, for the AD versus CN comparison, typical classification accuracy
has been reported to vary from 85% to 95% (Fan et al., 2008a; Vemuri et al., 2008; Klo¨ppel
et al., 2008; Batmanghelich et al., 2009), for the P-MCI versus CN group comparison the
accuracy varies from 70% to 81.8% (Fan et al., 2008a; Batmanghelich et al., 2009), and
for the P-MCI versus S-MCI from 70% to 81.5% (Misra et al., 2009). Our results compare
favourably to a recent meta-analysis (Cuingnet et al., 2011) of classification methods on a
similar subset of baseline MRI scans from the ADNI cohort. While our results for AD ver-
sus CN classification were comparable to the best results reported in this study, we achieved
significantly better results for P-MCI versus CN classification and for the clinically most
interesting discrimination of progressive from stable MCI subjects.
Figures 7.2, 7.3 and 7.4 showMRI scans with the selected voxels in S˜ illustrated in yel-
low, for all comparisons in Table 7.3. As an illustration, the insets show the whole range of
selection probabilities for all voxels in those regions, without any thresholding. The voxels
selected by penalised LDA, in each one of the three comparisons, mostly formed connected
regions in the hippocampus and lateral ventricles, reflecting hippocampal atrophy and ven-
tricular enlargement. Parts of the temporal lobe, amygdala and caudate nucleus were also
amongst the other key structures contributing to the selected voxels in the AD versus CN
and P-MCI versus CN comparisons. A more widespread pattern of selected voxels was
obtained from the P-MCI versus S-MCI comparison, where again, the main selected struc-
tures were the lateral ventricles and the hippocampus, but several parts of the lobes of the
brain also contributed a relatively large amount of voxels. These patterns of widespread
atrophy are in agreement with previous findings, from both neuropathological studies, as
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well as baseline and longitudinal morphological studies (Braak et al., 1999; Misra et al.,
2009; Leow et al., 2009; Hua et al., 2009; Cuingnet et al., 2011). Being highly discrimi-
native, the selected voxels provide a quantitative characterisation of the disease that can be







Figure 7.2: Brain images showing the results from the penalised LDA analysis of the AD
versus CN comparison. The selected voxels are illustrated in yellow for the 3 planes of
view of the brain (coronal, sagittal and axial from left to right). Illustrations of the actual







Figure 7.3: Brain images showing the results from the penalised LDA analysis of the P-
MCI versus CN comparison. The selected voxels are illustrated in yellow for the 3 planes
of view of the brain (coronal, sagittal and axial from left to right). Illustrations of the actual








Figure 7.4: Brain images showing the results from the penalised LDA analysis of the P-
MCI versus S-MCI comparison. The selected voxels are illustrated in yellow for the 3
planes of view of the brain (coronal, sagittal and axial from left to right). Illustrations of
the actual selection probabilities are shown in colour scale in the insets below.
7.3.2 Genetic association results
Using the sRRR model combined with stability selection with B = 1000 sub-samples, we
searched for genetic associations with the imaging signatures estimated from each com-
parison (shown in Figures 7.2, 7.3, and 7.4). This was achieved by conducting the three
corresponding imaging genetics studies. For each study, we report on the top 10 SNPs with
selection probability greater than or equal to 0.5. Some remarks on several top scoring
SNPs, corresponding to genes that are implicated in AD or that show potential susceptibil-
ity, are given below.
AD versus CN analysis
The top scoring SNPs from the first three ranks of the sRRR model are summarised in
Table 7.4. Here, the APOE-4 variant of the APOE gene scores top of the list with a
selection probability approximately equal to 1. This means that the allele was chosen as
an important variable in almost all of the 1000 sub-samples. This variant of the APOE
gene has long been known as the main high risk factor for AD, and has been replicated in
numerous studies, including case control studies as well as studies involving biomarkers
extracted from brain images (Zuo et al., 2006; Barabash et al., 2009; Filippini et al., 2009).
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As reviewed by Braskie et al. (2011), the APOE gene has been associated with a number
of brain regions, including hippocampus, parahippocampal gyrus, amygdala and temporal
lobe, which also constitute the regions within which the majority of our selected voxels lie.
While the 4 variant is associated with an increased risk of developing the disease, the 2
variant is considered to be protective and is associated with a lower disease risk, whereas
the 3 variant is supposed to have a neutral effect on disease risk. Accordingly, the variants
of the APOE gene are expected to be involved in the aggregation and clearance of the
amyloid β protein, which provides a possible explanation for its key role in AD (Kim et al.,
2009a). The APOE gene also shows regulation and alternative splicing in the temporal lobe
of AD patients compared to controls (Twine et al., 2011).
The SNP rs2075650, which belongs to the TOMM40 gene, also scores very highly
with a selection probability of 0.96. The TOMM40 gene is located in close proximity to
the APOE gene and has also been linked to AD in some more recent studies. For example,
an association between the same SNP rs2075650 with hippocampus and amygdala was re-
ported by Shen et al. (2010), who performed a MULM genome-wide association analysis
with 142 phenotypes extracted from baseline MRI scans, and observed on 733 individuals
from the ADNI study. Other studies reporting association with this SNP and AD include the
works by Potkin et al. (2009a) and Harold et al. (2009). In a phylogenetic analysis, Roses
et al. (2009) have shown, from two independent cohorts, that the rs10524523 marker, also
located in the TOMM40 gene, is associated with increased disease risk. They also high-
lighted some possible interactions with the APOE gene, and in particular with the APOE-3
variant which, as mentioned earlier, is supposed to have a neutral effect in AD (Grossman
et al., 2010). This gene codes for the translocase of the outer mitochondrial membrane
through which proteins are imported into mitochondria. Mitochondrial dysfunction is also
known to contribute to neurodegeneration leading to the onset of AD (Wang et al., 2009).
The BZW1 gene, coding for basic leucine zipper and W2 domains 1, scores third in
the list, with selection probability of 0.8. No prior association between BZW1 and AD
has been previously reported. However, the gene was listed amongst the differentially
expressed genes (with a p-value 0.026), from a microarray analysis on a mouse model
related to a neurodegenerative disease called amyotrophic lateral sclerosis (Brockington
et al., 2010). It has also shown differential expression in the central nervous system of
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mice during infection with mouse-adapted scrapie agents (Booth et al., 2004).
The PDZD2 gene, coding for the protein containing PDZ domain 2, has been selected
with a probability of 0.65. This gene is known to interact with CST3 (Lindahl et al., 1992),
which codes for cystatin 3 protein and has been previously reported as a susceptibility risk
factor in AD. However, the results regarding the association of the CST3 gene with AD
are conflicting; while several studies have reported an association with the CST3 gene (for
example Cathcart et al., 2005), others failed to do so (for example Monastero et al., 2005).
The second rank analysis selects two SNPs in MTRF1, which is a gene encoding mi-
tochondrial translational release factor 1. Both SNPs score top with selection probability
of 0.82. There is no evidence associating this gene with AD in the literature, however its
function may suggest a possible contribution to mitochondrial dysfunction related to the
disease. With a probability of 0.68, we selected a SNP in the OSTF1 gene, coding for
osteoclast stimulating factor 1. This gene is interacting with the SMN1 and SMN2 genes
which are responsible for the survival of motor neuron genes (Kurihara et al., 2001), and
which have been linked to amyotrophic lateral sclerosis (Corcia et al., 2009). Amongst
the other top scoring results is the ARHGEF10 gene selected with probability 0.63. The
ARHGEF10 gene, coding for rho guanine nucleotide exchange factor 10, has been sug-
gested in the literature for possible association with schizophrenia (Jungerius et al., 2007).
In the third rank, the model selects the ADCY2 gene, coding for adenylate cyclase
2, ranked top with a selection probability of 0.79. In a gene expression study in mice,
Tsolakidou et al. (2010) revealed new pathways related to stress response, expressed in the
periventricular nucleus of the hypothalamus, involving the ADCY2 gene together with the
well-established early onset AD risk factor, the APP gene.
To examine the expression of the selected genes in the brain, we used the Allen Human
Brain atlas3. This atlas provides the tools to visualise histology and gene expression data
from microarray and in situ hybridization studies on the brain. We were able to confirm
that the reported genes are expressed in areas where our selected voxels lie such as in the
hippocampus region, the inferior and middle temporal gyrus, the occipitotemporal gyrus,
the parahippocampal gyrus, the fusiform gyrus, the amygdala and the caudate nucleus.
3http://human.brain-map.org/
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P-MCI versus CN analysis
The results from the P-MCI versus CN experiment are given in Table 7.5. The APOE-4
variant again scores top of the list with a selection probability approximately equal to one.
The same TOMM40 SNP that scored second in the AD vs CN rank 1 comparison, also
scored among the top SNPs in the P-MCI vs CN comparison with a selection probability
of 0.62. MYO3B, coding for the myosin III B protein, is another gene amongst the top
scoring genes in the rank 1 analysis. This gene is known to be expressed in the retina and
is possibly associated with visual disorders (Brown and Bridgman, 2004). However its
association with AD is not clear.
Two SNPs of the COX7A2L gene, coding for the cytochrome c oxidase subunit VIIa
polypeptide 2 like, are also amongst the top results of the rank 1 analysis, selected with
probabilities around 0.6. This COX7A2L gene belongs in the ‘Alzheimer’s disease’ KEGG
pathway4 (Kanehisa et al., 2010) and is involved in the mitochondrial dysfunction net-
work. Recently, Lambert et al. (2010) performed a GWA gene set enrichment analysis
using a large sample of AD patients and controls, and found the ‘Alzheimer’s disease’
KEGG pathway to be significantly over-represented in their sample, with a p-value 0.001,
after false discovery correction. Within this pathway, 46 genes, including the COX72AL
gene and other key AD risk factors, showed significant associations with the disease (un-
corrected p-values≤ 0.01) and thus were mostly involved in the over-representation of this
pathway. Moreover, physical interactions between the key AD risk factor TOMM40 and
the COX7A2L gene have been previously reported (McFarland et al., 2008). Notably, the
SNPs in the COX7A2L gene and the SNP in the TOMM40 gene are selected with similar
probabilities in this rank, as shown in the corresponding Table 7.5.
The SORBS2 gene, coding for the sorbin and SH3 domain protein 2, scored top in the
second rank of the analysis with a selection probability of 0.81. This gene is known to in-
teract with the SYNJ1 gene, coding for the synaptojanin protein (Zucconi et al., 2001). The
latter seems to be highly expressed in the brain and it has shown possible associations with
a number of neurological diseases including schizophrenia and bipolar disorder (Stopkova
et al., 2004a,b), as well as Down’s syndrome (Chang and Min, 2009). It is also reported to
4http://www.genome.jp/kegg/
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interact with the BIN1 gene (Micheva et al., 1997), one of the top 10 susceptibility genes
in AD, according to the Alzgene database as of July 2011.
The NRXN1 gene, coding for the neurexin 1 protein, is among the top results in rank 3
of the P-MCI vs CN analysis with a selection probability of 0.58. This gene was mentioned
in Ravetti et al. (2010) who analysed hippocampal gene expression data. In this study, using
a sample consisting of subjects with different degrees of disease severity, from control
to severe AD, the authors calculated the Jensen-Shannon divergence of each individual
from the average control profile as well as from the average severe AD profile. They then
computed the correlation coefficients between the gene expressions and the divergence
measures, and reported the top 100 genes correlated with the control divergence, and the
top 100 genes correlated with the severe AD divergence. The expression of NRXN1 was
among these lists, showing a relatively high positive correlation (0.748) with the average
severe AD profile, and a negative correlation (-0.706) with the average control profile. The
NRXN1 has also been linked to schizophrenia and autistic spectrum disorder (Reichelt
et al., 2011; Mu¨hleisen et al., 2011).
We examined the expressions of these genes in the brain using the Allen Brain Atlas.
We found that these were expressed in the regions where the selected voxels mostly lie,
including the hippocampus region, the inferior, middle and superior temporal gyrus, the
occipitotemporal gyrus, the parahippocampal gyrus, the fusiform gyrus, the amygdala, the
caudate nucleus and the insula.
P-MCI versus S-MCI analysis
In this final experiment, the APOE-4 variant again scores top of the list with very high
selection probability. Other top scoring genes are shown in Table 7.6. None of the genes
reported in this analysis, other than the APOE gene, show any connection to AD through
the current literature. However, using the Allen Brain Atlas, we confirmed that all the
genes reported in the table are expressed in the brain and in regions where our selected
voxels mostly lie, including the hippocampus, the amygdala and the temporal and frontal
lobes. Therefore, these results are also worth further investigation. Note also that these
results arise from the P-MCI versus S-MCI analysis, and are therefore related to disease
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progression rather than development which is a possible reason for the limited validation
through the current literature.
AD vs CN
SNP Gene Chr MAF HWE Πˆxk
APOE-4 APOE 19 0.28 0.08 0.99
Rank 1
rs2075650 TOMM40 19 0.25 0.87 0.96
rs3815501 BZW1 2 0.15 0.47 0.80
rs11132507 4 0.28 0.64 0.76
rs1681052 LOC647946 18 0.08 0.65 0.72
rs17345545 1 0.27 0.42 0.65
rs13340334 PDZD2 5 0.11 0.34 0.65
rs17686103 BC035019 5 0.30 0.18 0.64
rs8025706 FAM174B 15 0.31 0.04 0.63
rs17380902 2 0.14 0.43 0.63
rs7999394 MTRF1 13 0.41 0.03 0.82
Rank 2
rs3794328 MTRF1 13 0.41 0.03 0.82
rs11144246 OSTF1 9 0.12 0.76 0.68
rs11590365 1 0.11 0.55 0.67
rs11204949 1 0.11 0.55 0.67
rs12405278 FLG 1 0.11 0.55 0.67
rs6932730 6 0.21 0.34 0.64
rs4685279 GALNTL2 3 0.29 0.17 0.64
rs3824139 ARHGEF10 8 0.17 0.001 0.63
rs6910087 MICA 6 0.13 0.17 0.63
rs727432 ADCY2 5 0.28 0.88 0.79
Rank 3
rs11783329 8 0.40 0.44 0.66
rs17309585 8 0.41 1.00 0.60
rs12534148 PDE1C 7 0.27 0.15 0.56
rs6982054 8 0.21 0.45 0.55
rs7233804 18 0.20 0.33 0.54
rs10491327 5 0.18 0.14 0.54
rs4850480 2 0.37 0.29 0.53
rs221730 PDE10A 6 0.46 0.53 0.52
rs11216322 PCSK7 11 0.13 0.25 0.52
Table 7.4: The top ten SNPs with selection probabilities ≥ 0.5 (ranked according to their
selection probabilities) for rank 1, 2 and 3 of the AD versus CN sRRR analysis. For each
marker also provided are: the corresponding gene annotation where applicable, the chro-
mosome, the MAF, the HWE p-value and the selection probability.
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P-MCI vs CN
SNP Gene Chr MAF HWE Πˆxk
Rank 1
APOE-4 APOE 19 0.27 0.08 0.99
rs2883782 MYO3B 2 0.48 0.39 0.81
rs2798062 9 0.26 0.10 0.78
rs10934170 3 0.15 0.62 0.76
rs7843577 8 0.45 1.00 0.72
rs17826780 4 0.10 0.32 0.69
rs914166 21 0.15 0.62 0.64
rs10206058 COX7A2L 2 0.36 0.50 0.62
rs2075650 TOMM40 19 0.25 0.18 0.62
rs1981664 COX7A2L 2 0.42 0.45 0.61
Rank 2
rs13132552 SORBS2 4 0.35 1.00 0.81
rs11069874 13 0.16 0.24 0.71
rs885339 13 0.16 0.24 0.71
rs12633719 3 0.23 0.49 0.68
rs2381958 5 0.20 0.34 0.68
rs4265409 1 0.44 0.71 0.67
rs10041184 5 0.22 0.15 0.66
rs7584948 ANTXR1 2 0.19 0.10 0.65
rs501435 ODZ4 11 0.15 0.81 0.62
rs9522086 13 0.14 0.31 0.62
Rank 3
rs12597064 16 0.24 1.00 0.63
rs1529442 AQPEP 5 0.32 0.20 0.62
rs6864491 AQPEP 5 0.45 0.80 0.59
rs10445932 NRXN1 2 0.11 0.75 0.58
rs633398 NDST3 4 0.37 0.89 0.57
rs631271 NDST3 4 0.37 1.00 0.56
rs2294938 LOC642587 1 0.36 0.14 0.54
rs1366203 AQPEP 5 0.29 0.13 0.53
rs2837630 DSCAM 21 0.15 0.81 0.50
Table 7.5: The top ten SNPs with selection probabilities ≥ 0.5 (ranked according to their
selection probabilities) for rank 1, 2 and 3 of the P-MCI versus CN sRRR analysis. For
each marker also provided are: the corresponding gene annotation where applicable, the
chromosome, the MAF, the HWE p-value and the selection probability.
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P-MCI vs S-MCI
SNP Gene Chr MAF HWE Πˆxk
Rank 1
APOE-4 APOE 19 0.35 0.30 0.93
rs2038358 14 0.24 0.46 0.78
rs9633774 10 0.42 0.22 0.74
rs11256463 10 0.41 0.33 0.73
rs10861171 TXNRD1 12 0.12 1.00 0.68
rs8090480 MBD2 18 0.41 0.21 0.67
rs965566 5 0.32 0.64 0.66
rs8094493 MBD2 18 0.41 0.21 0.65
rs10511576 9 0.21 0.84 0.65
rs6463119 7 0.45 0.59 0.64
Rank 2
rs12420917 11 0.40 0.58 0.63
rs4872533 8 0.48 0.35 0.56
rs17738959 5 0.29 0.63 0.54
rs4735853 C8orf42 8 0.38 0.06 0.52
Rank 3
rs2703862 8 0.10 0.07 0.64
rs2507717 8 0.11 0.08 0.62
rs9261743 6 0.24 0.36 0.58
rs4728674 KIAA1324L 7 0.41 0.41 0.57
rs6555554 5 0.25 1.00 0.54
rs10082970 12 0.21 0.43 0.53
rs2031581 10 0.13 0.77 0.51
rs2765650 10 0.13 0.77 0.51
rs10838852 OR4X1 11 0.46 1.00 0.51
rs1483123 OR4S1 11 0.46 1.00 0.51
Table 7.6: The top ten SNPs with selection probabilities ≥ 0.5 (ranked according to their
selection probabilities) for rank 1, 2 and 3 of the P-MCI versus S-MCI sRRR analysis. For
each marker also provided are: the corresponding gene annotation where applicable, the
chromosome, the MAF, the HWE p-value and the selection probability.
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Figure 7.5: Stability selection probabilities for the AD versus CN analysis for ranks 1, 2 and
3 (from left to right). Lines corresponding to SNPs with (maximum) selection probabilities
greater than or equal to the threshold πx = 0.5 are illustrated in red. The probability
threshold is illustrated by a horizontal blue line at Πˆxk = 0.5.
Figure 7.6: Stability selection probabilities for the P-MCI versus CN analysis for ranks
1, 2 and 3 (from left to right). Lines corresponding to SNPs with (maximum) selection
probabilities greater than or equal to the threshold πx = 0.5 are illustrated in red. The
probability threshold is illustrated by a horizontal blue line at Πˆxk = 0.5.
Chapter 7. A voxel-wise genome-wide study 167
Figure 7.7: Stability selection probabilities for the P-MCI versus S-MCI analysis for ranks
1, 2 and 3 (from left to right). Lines corresponding to SNPs with (maximum) selection
probabilities greater than or equal to the threshold πx = 0.5 are illustrated in red. The
probability threshold is illustrated by a horizontal blue line at Πˆxk = 0.5.
7.4 Discussion
AD is a highly prevalent disease with an estimate of 5.4 million patients, in the US alone
(Alzheimer’s Association, 2011). As the risk for developing the disease increases with age,
and due to the ageing population, numbers are expected to increase dramatically over the
next few decades, making Alzheimer’s one of the greatest concerns to society. Elucidat-
ing the genetic etiology of the disease holds great promise for uncovering its pathogenesis
and thus contributing to an earlier diagnosis and treatment of the disorder. Much effort
has been spent on identifying such genetic risk factors, but only a few markers have been
detected and successfully replicated so far, mostly due to the lack of statistical power of
existing case-control studies, which requires very large cohorts. The genetic variants dis-
covered through these efforts are believed to account for only a small proportion of the total
heritability.
A critical issue in the design of imaging genetics studies involves the definition and ex-
traction of an appropriate multivariate disease phenotype. For our studies, we took voxel-
wise Jacobian determinants, each one representing the longitudinal change observed be-
tween baseline and 24 month follow up images. Since AD is a progressive disorder, with
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patterns of widespread brain atrophy that develop over time, longitudinal changes observed
in MRI scans provide sensitive biomarkers reflecting disease development and progression.
Particular interest lies in the changes observed in the P-MCI group, where a more rapid at-
rophy is expected to take place over time. Due to the fast decline observed in the P-MCI
individuals, discriminating between MCI groups by using some measures of longitudinal
changes in the brain has been particularly successful.
Instead of reducing the dimensionality by extracting ROI averages, we propose the use
of penalised LDA as a voxel-filtering procedure. This allows us to estimate disease sig-
natures for each comparison that have high classification performance. Similar arguments
have been made in other studies, for example by Hua et al. (2009) and Chen et al. (2010)
who observed increased power in detecting AD-related changes, when using data-driven
ROIs estimated from training samples, compared to using anatomically defined ROIs. In
the former work, TBM longitudinal images were used to track brain degeneration, and the
data-driven ROI consisted of voxels showing significant atrophic rates in a sample of AD
patients. In the latter work, fluorodeoxyglucose positron emission tomography (FDG-PET)
images were used to examine the longitudinal metabolic declines, and the pre-defined ROIs
consisted of the most significant voxels resulting from group comparisons.
Genetic association was carried out using the sRRR model, by searching for genetic
variants that are highly predictive of the imaging signatures detected in the first analysis
stage. Combining the voxel filtering technique with the multivariate imaging genetics anal-
ysis, our experiments greatly benefit from the enhanced signals of association present at
the filtered voxels, which are highly discriminative for the disease, as well as from the
structural homogeneity, by taking into account the simultaneous genetic effects on nearby
voxels. We opted not to do variable selection in the phenotypic domain for these studies, to
avoid introducing additional regularisation parameters, and since the initial discriminative
analysis allowed us to detect specific brain regions to use as plausible phenotypes.
All three GWA studies presented here identified the APOE-4 variant of the APOE
gene as the most important marker to explain the longitudinal phenotypes. In all exper-
iments this SNP ranked first with a selection probability greater than 0.9. This consis-
tent result reflects both the importance of the APOE-4 variant in disease development but
also its key involvement in the progression from MCI to AD. Together with APOE-4, the
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rs2075650 marker from TOMM40 gene, another key risk factor of AD, was also selected
amongst the top results of the AD versus CN and P-MCI versus CN analysis. Remark-
ably this marker did not rank high in the P-MCI versus S-MCI analysis. Among our other
reported results, the COX7A2L and NRXN1 genes from the P-MCI versus CN analysis
also seem particularly interesting. The first is known to contribute in the mitochondrial
dysfunction network of a KEGG pathway related to AD, while the latter has shown to be
differentially expressed in AD. The other factors identified from our analyses were novel,
in that they haven’t been reported in the literature before in association with AD. Among
these, we highlighted a number of genes, including BZW1, PDZD2, ARHGEF10, ADCY2
and SORBS2. Some of these genes have been previously associated with other neurolog-
ical disorders, whereas others had possible links to AD through physical interactions with
other susceptibility markers. Further biological investigations of the reported results are
necessary in order to validate their involvement in the disease.
Work under progress also involves a further study on the ADNI sample for which we
have extracted a subset of the genetic variables involved in protein kinases. This selection
was based on prior evidence of the involvement of protein kinases in AD pathogenesis (see
for example Kumar et al., 2011; Petersen et al., 2007). A manuscript for this analysis is
currently being prepared, see [6] in the list of publications.
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Chapter 8
Conclusions and Further Work
Over the last few years, imaging genetics studies for several neurological disorders have
become popular as brain phenotypes extracted using neuroimaging techniques may consti-
tute superior indicators of genetic effects, as compared to categorical disease phenotypes,
and are expected to ultimately yield higher statistical power. Although MULM is the com-
monly used approach, it suffers from a number of shortcomings, most notably due to its
inability to detect small effects frommultiple SNPs, or joint effects on multiple phenotypes.
Moreover, in that context hypothesis testing involves a serious multiple testing problem.
In this thesis, we made a number of contributions to this area of research, which we
summarise below while indicating several limitations, but also possible future directions.
First of all, we proposed the use of the sRRR, a penalised multivariate multiple regression
model that performs simultaneous genotype and phenotype variable selection. Our model
takes advantage of the multivariate structure of the imaging phenotypes by assuming a low
rank representation of the underlying association. Sparsity in the regression coefficients
that yields to variable selection is achieved by using penalty constraints. A limitation of
the suggested procedure comes from the fact that the derived algorithm assumes that the
covariance matrix of the predictors is the identity matrix. Similarly, whereas a matrix Γ is
introduced in the RRR model, this is also set to be the identity matrix in the corresponding
sparse model. However, to release this limitation, we suggested the use of several structural
penalties that can incorporate prior information in the model and can thus direct the detec-
tion of the true associations. Moreover, we assessed the performance of the proposed model
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using extensive simulations under realistic scenarios, and demonstrated its superiority over
the more traditional MULM approach.
The difficult model selection problem, and in particular the selection and ranking of
SNPs and phenotypes, was approached using a data re-sampling technique. Rather than
using some cross-validated measure of predictive performance to guide the variable selec-
tion process, the data re-sampling technique puts more emphasis on estimating the relative
importance of each SNP and phenotype in the model. This is achieved by mimicking the
process of extracting small random samples from the underlying population, and fitting a
penalised model on each sample. Thus, this procedure provides a mechanism to rank SNPs
and phenotypes, based on a robust metric representing the frequency with which they have
been selected in the model across all the sub-samples.
The sRRR model also assumes that the underlying contributions from multiple SNPs
will be captured by different latent factors, or ranks. For each factor, the penalisation term
featuring in the model forces the selection of only a few important SNPs contributing to
it. An important lesson learned from the extensive simulation experiments presented in
Chapter 4 was that when the signal is small, the first rank may capture spurious associa-
tions with the disease, and therefore more than one rank needs to be extracted to detect all
potential and meaningful associations. An important issue is then how many latent factors
or ranks to extract, and how to remove the effects found in previous ranks before moving
on to the next ones. In the studies presented here, we thresholded the SNP or phenotype
selection probabilities associated to a given latent factor, so that the effects of all variables
having a selection probability at least as high as 0.5 were removed prior to extracting the
consecutive factor. A threshold of 0.5means that any SNP or phenotype selected in at least
half of all the sub-samples is deemed to be important for that factor, and its effect will be
removed before re-fitting the model and extracting the next rank. Although a higher, and
therefore stricter, threshold may be used, we opted for a less conservative one to ensure that
the identified associations within each rank are removed prior to the subsequent analysis.
We demonstrated the applicability of this procedure using three real imaging genetics
data sets. The first set of data consisted of a sample of multiple sclerosis patients with
varying disease severity. Using this sample, we performed two CP-CGA studies, each
considering different sets of candidate genes selected based on prior biological knowledge.
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Imaging measures capturing disease-related differences were used as phenotypes. For this
study, in addition to the sRRR model, we also used two further comparative approaches,
the MULM and the Lasso regression and explored the results from the three procedures to
identify the most important associations. We performed another real CP-CGA study on a
sample of healthy subjects. In this study, interest lied in examining the effect of a set of
genetic markers involved in Williams syndrome, a disorder with known genetic origin, on
fMRI activation. For this study we extracted a set of voxel-wise phenotypes from three
regions known to be highly affected in Williams syndrome.
A separate issue arising from whole-brain, voxel-wise phenotypes relates to the selec-
tion of the specific voxels to be used in the study, and whether or not to take summary
measures, instead of individual voxels. Such procedures attempt to reduce the dimension-
ality of the phenotype, at the cost of losing some information. For instance, in cases when
an anatomical atlas is available, it is common to average across all voxels within each ROI,
thus drastically reducing the number of measurements that define the phenotype. In this
thesis, we made a first attempt to quantify the loss of statistical power that may potentially
arise when individual voxels are replaced by ROI averages. This argument was developed
by first defining and quantifying the SNR that we expect to see when using the two com-
peting design matrices in a linear regression model: one based on the individual voxels,
and one based on ROI averages. Through these results we were able to formalise the in-
tuition that a voxel-wise approach is to be preferred, provided that the majority of voxels
considered as phenotypes are highly representative of the disease.
Driven by these results, we suggested a two step procedure for brain-wide voxel-wise
experiments, where we first suggest to detect a signature of the disease consisting of as few
voxels as possible and subsequently use this signature for the imaging genetics study. Our
initial feature selection step was intended to reduce the dimensionality, while also detect-
ing regions that are influenced by the disease in a data-driven fashion, without any prior
knowledge, or subjective assumptions. This was achieved using a penalised LDA proce-
dure which enabled the extraction of subsets of voxels that are highly discriminative of
disease status. Alternative variable selection approaches such as penalised logistic regres-
sion or even simple univariate t-tests could have also been used for this purpose. In the
derivation of the penalised LDA algorithm, we estimate the within-group scatter matrix to
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be diagonal, which is commonly done for problems such as ours in which the data points
lie in extremely high dimensional spaces. Although the resulting approach then becomes
more similar to a univariate one, the penalised LDA formulation is attractive for a number
of reasons. Firstly, one can find better estimates of the within-group scatter matrix and
use that for the derivation of the algorithm. Second, as done with the sRRR model, dif-
ferent penalties can be easily adapted in the penalised LDA formulation that better exploit
the structural patterns observed in the brain images. For example, the sparse group Lasso
penalty could be adopted to select subsets of voxels within ROIs defined according to an
anatomical atlas. This extra information can further eliminate the noisy variables from our
sets of selected voxels, by encouraging voxels within a ROI to stay grouped together during
the voxel selection process.
Three BW-GWA studies were also presented in the end of this thesis based on a sam-
ple of Alzheimer’s disease patients, individuals with stable and progressive mild cognitive
impairment and healthy controls. In each of the studies, different groups of individuals,
grouped according to disease status, were used to identify genetic variation specific to dif-
ferent stages of the disease. For these studies, we followed the two step procedure, where
we first estimated reliable disease imaging signatures, with classification performance com-
parable to state-of-art results, which were subsequently used as phenotypes in the imaging
genetics studies. In all studies performed in the thesis, including the CP-CGA studies men-
tioned previously, we reported on a number of findings, confirming the key role of some
genetic markers, but also highlighting other potential candidates that warrant further inves-
tigation.
An interesting extension of the current methodology relies on exploiting the use of
multiple imaging modalities for the derivation of ‘stronger’ disease signatures which could
potentially boost the power to detect true genetic associations when used as phenotypes in
imaging genetics studies. In particular, a number of recent studies indicate that superior dis-
criminative performance between different clinical groups can be achieved by combining
different imaging phenotypes. For example, in the context of Alzheimer’s disease, Kohan-
nim et al. (2010) combined multiple biomarkers, including MRI and FDG-PET measures,
as well as CSF and other biomarkers, for disease status classification using SVM classifiers,
and reported an increase in power to predict future decline. In another recent study, Li et al.
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(2011) obtained improved classification performance when considering a combination of
features representing both static and longitudinal measures, as well as summary measures
from constructed brain networks. Using a kernel approach, Zhang et al. (2011) also inte-
grated information from baseline MRI, FDG-PET and CSF biomarkers, which were then
used for classification using SVMs. According to their findings, a remarkable improve-
ment was observed when fusing multiple modalities. Evidence from other similar studies
suggest that more complex phenotypes derived from combining cross-sectional and longi-
tudinal changes, from multiple modalities, and possibly taking into account connectivity
networks, may carry higher discriminative power, and therefore provide higher signal to
detect associations with the disease (for example Walhovd et al., 2010; Vemuri et al., 2009;
Fan et al., 2008b).
Another promising future direction lies in extending the ideas of the data re-sampling
technique combined with the sRRR model. We have already made a first attempt to study
the joint probabilities, defined as the frequency of selecting a genetic marker and a phe-
notype jointly. This approach exploits better the multivariate nature of the model and the
data, and is therefore expected to provide an improved distinction between the true and
false associations. Therefore, examining its performance in simulated and real data is of
great interest. Further extensions on this idea can be considered, such as taking into account
the probabilities of selecting a genetic marker jointly with a set of localised voxels. The
importance measure of each genetic marker could then represent the frequency with which
the marker was selected jointly with all, or a proportion, of the voxels within a predefined
cluster. Such an approach can potentially further aid in distinguishing true from false sig-
nals, as random associations may appear scattered in the brain, whereas true associations
are expected to appear in a homogeneous manner in neighbouring voxels. A metric weight-
ing the selection probabilities can also be introduced, which could represent the amount of
neighbouring voxels that were simultaneously selected with the marker. Further elaboration
on these ideas could potentially lead to improved power to detect true genetic associations
with voxel-wise phenotypes.
The assessment of alternative importance measures derived from the re-sampling pro-
cedure is another possible direction for future research. For example, in the context of as-
sociation studies, stability selection combined with sparse logistic regression was recently
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applied in Eleftherohorinou et al. (2011). The authors defined the final importance measure
of each variable as a weighted sum of the probabilities across the regularisation path, rather
than taking the maximum as proposed in the original work by Meinshausen and Bu¨hlmann
(2010). The weights used by the authors represented prior belief associated to each pa-
rameter value. Similar ideas could be applied to weight the probabilities at each parameter
value of the sRRR model, giving for example greater weight at probabilities corresponding
to smaller sets of selected variables, i.e. towards the left side of the stability plots. This in-
tuitively makes sense as more spurious associations are expected to occur when increasing
the number of variables that are allowed to enter the model. Another related idea could be
to use a measure of weighted curvature, where again, curvatures in the left side of the plot
should have more weight. As seen in the simulated and real examples of this thesis, the
curves corresponding to true associations are expected to have a greater curvature at points
near the origin. Thus, combining such information with the selection probabilities might
yield more robust importance measures for each variable.
Other approaches that attempt to produce sparse solutions of the MMLR model, while
taking into account the multivariate nature of the response, have been proposed in the lit-
erature over the last few years. These differ from the sRRR model, and other LVMs, in
that no assumption of a reduced-rank representation is made. On the contrary, these mod-
els account for the presence of multiple responses by assuming that these share the same
sparsity pattern, i.e. the same set of predictors is important for all the responses considered
(see for example Lounici et al., 2010; Simila¨ and Tikka, 2007; Liu et al., 2009; Turlach
et al., 2005). The problem is then approached using the group Lasso penalty, where for
each predictor, groups of coefficients of size q are formed. Each such group constitutes
the regression coefficients associating the predictor with each of the q responses, i.e. an
entire row of the regression coefficient matrix C defined in Equation (3.1). By adopting
the group Lasso penalty in this context, the inner norm of the penalty (typically being the
l2 norm) produces a measure of strength for each predictor based on all q responses. Sub-
sequently, the outer l1 norm performs predictor selection. Kim and Xing (2009b) extended
this approach to also perform response selection, by assuming that a predefined hierarchi-
cal tree grouping structure exists in the response domain, and different subsets of groups of
responses are associated with different sets of predictors. Other similar ideas that directly
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apply sparsity in the MMLR model have also been proposed (see for example Kim and
Xing, 2009a; Peng et al., 2010). It would be interesting to see how these relate to sRRR
and assess their performance in the field of imaging genetics.
Work currently underway includes the analysis of a dataset provided by collaborators
from the University of Leipzig. This consists of 34 dyslexic patients and 23 controls.
Genome-wide data on approximately 500k SNPs are available, however, due to the lim-
ited sample size, a first analysis will be performed on reduced sets of candidate SNPs for
dyslexia disease. fMRI data are also available for the individuals in the study. This analysis
could be approached in a similar fashion to the voxel-wise study presented in Chapter 7,
where disease signatures forming reduced sets of voxels that best discriminate cases from
controls are to be extracted prior to the imaging genetics study.
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